<?xml version="1.0" encoding="UTF-8"?>
<COCHRANE_REVIEW TYPE="INTERVENTION" REVMAN_VERSION="5" ID="000000000000000000" VERSION_NO="3.0" STAGE="R" STATUS="A">
<COVER_SHEET>
<TITLE>Celecoxib for osteoarthritis [Data only. When citing this record quote "Cochrane Database of Systematic Reviews 2017, Issue 5".]</TITLE>
<CONTACT>
<PERSON ID="A0437C7382E26AA2015C072953315C6F" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Livia</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Puljak</LAST_NAME>
<SUFFIX />
<POSITION>Knowledge Translation Coordinator</POSITION>
<EMAIL_1>livia.puljak@gmail.com</EMAIL_1>
<EMAIL_2>livia.puljak@mefst.hr</EMAIL_2>
<URL>http://neuron.mefst.hr/docs/znanost/Zavod_anat_hist/Pain/Livia_Puljak_CV.pdf</URL>
<MOBILE_PHONE />
<ADDRESS>
<DEPARTMENT>Cochrane Croatia</DEPARTMENT>
<ORGANISATION>University of Split School of Medicine</ORGANISATION>
<ADDRESS_1>Soltanska 2</ADDRESS_1>
<ADDRESS_2 />
<CITY>Split</CITY>
<ZIP>21000</ZIP>
<REGION />
<COUNTRY CODE="HR">Croatia</COUNTRY>
<PHONE_1>+38521557807</PHONE_1>
<PHONE_2 />
<FAX_1>+38521557811</FAX_1>
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
</CONTACT>
<CREATORS>
<PERSON ID="A0437C7382E26AA2015C072953315C6F" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Livia</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Puljak</LAST_NAME>
<SUFFIX />
<POSITION>Knowledge Translation Coordinator</POSITION>
<EMAIL_1>livia.puljak@gmail.com</EMAIL_1>
<EMAIL_2>livia.puljak@mefst.hr</EMAIL_2>
<URL>http://neuron.mefst.hr/docs/znanost/Zavod_anat_hist/Pain/Livia_Puljak_CV.pdf</URL>
<MOBILE_PHONE />
<ADDRESS>
<DEPARTMENT>Cochrane Croatia</DEPARTMENT>
<ORGANISATION>University of Split School of Medicine</ORGANISATION>
<ADDRESS_1>Soltanska 2</ADDRESS_1>
<ADDRESS_2 />
<CITY>Split</CITY>
<ZIP>21000</ZIP>
<REGION />
<COUNTRY CODE="HR">Croatia</COUNTRY>
<PHONE_1>+38521557807</PHONE_1>
<PHONE_2 />
<FAX_1>+38521557811</FAX_1>
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="89803548511136667712110328163654" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Ana</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Marin</LAST_NAME>
<SUFFIX />
<POSITION />
<EMAIL_1>ana25marin@yahoo.com</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE />
<ADDRESS>
<DEPARTMENT />
<ORGANISATION>Cochrane Croatia</ORGANISATION>
<ADDRESS_1 />
<ADDRESS_2 />
<CITY>Split</CITY>
<ZIP />
<REGION />
<COUNTRY CODE="HR">Croatia</COUNTRY>
<PHONE_1 />
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="08916022463541742339101202212329" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Davorka</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Vrdoljak</LAST_NAME>
<SUFFIX />
<POSITION>Instructor</POSITION>
<EMAIL_1>davorka.vrdoljak@mefst.hr</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE>00385996880260</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Department of Family Medicine</DEPARTMENT>
<ORGANISATION>School of Medicine in Split</ORGANISATION>
<ADDRESS_1>Soltanska 2</ADDRESS_1>
<ADDRESS_2 />
<CITY>Split</CITY>
<ZIP>21000</ZIP>
<REGION />
<COUNTRY CODE="HR">Croatia</COUNTRY>
<PHONE_1>0038521557807</PHONE_1>
<PHONE_2 />
<FAX_1>0038521557811</FAX_1>
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="z1305031147166131096470272264106" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Filipa</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Markotic</LAST_NAME>
<SUFFIX />
<POSITION>Clinical Pharmacologist</POSITION>
<EMAIL_1>filipa.markotic@gmail.com</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE />
<ADDRESS>
<DEPARTMENT>Centre for Clinical Pharmacology</DEPARTMENT>
<ORGANISATION>University Clinical Hospital Mostar</ORGANISATION>
<ADDRESS_1>Kralja Tvrtka b.b.</ADDRESS_1>
<ADDRESS_2 />
<CITY>Mostar</CITY>
<ZIP>88000</ZIP>
<REGION />
<COUNTRY CODE="BA">Bosnia and Herzegovina</COUNTRY>
<PHONE_1 />
<PHONE_2 />
<FAX_1 />
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="78499350764600977878101202214250" ROLE="AUTHOR">
<PREFIX>Mrs</PREFIX>
<FIRST_NAME>Ana</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Utrobicic</LAST_NAME>
<SUFFIX />
<POSITION>Librarian</POSITION>
<EMAIL_1>ana.utrobicic@mefst.hr</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE>00385996880260</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Central Medical Library</DEPARTMENT>
<ORGANISATION>University of Split, School of Medicine</ORGANISATION>
<ADDRESS_1>Soltanska 2</ADDRESS_1>
<ADDRESS_2 />
<CITY>Split</CITY>
<ZIP>21000</ZIP>
<REGION />
<COUNTRY CODE="HR">Croatia</COUNTRY>
<PHONE_1>0038521557807</PHONE_1>
<PHONE_2 />
<FAX_1>0038521557811</FAX_1>
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
<PERSON ID="5474" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Peter</FIRST_NAME>
<MIDDLE_INITIALS />
<LAST_NAME>Tugwell</LAST_NAME>
<SUFFIX />
<POSITION>Professor of Medicine, &amp; Epidemiology and Community Medicine, Canada</POSITION>
<EMAIL_1>tugwell.bb@uottawa.ca</EMAIL_1>
<EMAIL_2 />
<URL />
<MOBILE_PHONE />
<ADDRESS>
<DEPARTMENT>Department of Medicine</DEPARTMENT>
<ORGANISATION>Faculty of Medicine, University of Ottawa</ORGANISATION>
<ADDRESS_1 />
<ADDRESS_2 />
<CITY>Ottawa</CITY>
<ZIP>K1H 8M5</ZIP>
<REGION>ON</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>613-562-5800 ext: 1945</PHONE_1>
<PHONE_2 />
<FAX_1>613-562-5659</FAX_1>
<FAX_2 />
</ADDRESS>
<FOOTNOTE />
</PERSON>
</CREATORS>
<DATES>
<UP_TO_DATE>
<DATE DAY="" MONTH="" YEAR="" />
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="" MONTH="" YEAR="" />
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="" MONTH="" YEAR="" />
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="" YEAR="" />
<REVIEW_PUBLISHED ISSUE="" YEAR="" />
<LAST_CITATION_ISSUE ISSUE="" YEAR="" />
</DATES>
<WHATS_NEW />
<HISTORY />
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES />
<EXTERNAL_SOURCES />
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO" />
<KEYWORDS />
</COVER_SHEET>
<MAIN_TEXT>
<SUMMARY>
<TITLE>Benefits and harms of celecoxib to treat people with osteoarthritis</TITLE>
<SUMMARY_BODY>
<P>
<B>Review question</B>
</P>
<P>We evaluated benefits and harms of celecoxib, a drug used to treat people with osteoarthritis, to improve pain, movement, quality of life and drug safety.</P>
<P>
<B>Background</B>
</P>
<P>Osteoarthritis is a joint disease (mostly knees and hips) caused when cartilage wears away leading to pain, joint stiffness and inflammation, which can cause limited mobility and reduces quality of life. Celecoxib is marketed as being as effective as traditional anti-inflammatory drugs (tNSAIDs such as naproxen and diclofenac) but with fewer gut and other problems.</P>
<P>
<B>Study characteristics</B>
</P>
<P>We searched up to April 2017 and included 36 trials that involved 17,206 adults who received 200 mg celecoxib daily (9402 participants), or either another drug (naproxen - 6 trials, or diclofenac - 3 trials, total of 1869 participants) or a fake treatment (placebo - 32 trials, 5935 participants).</P>
<P>On average, participants were aged 62 years and had osteoarthritis for 7.9 years. Participants had knee, hip, or both, osteoarthritis; most were women and white.</P>
<P>
<B>Study funding sources</B>
</P>
<P>Most studies (34/36) were funded by the studied drugs manufacturers, and (34/36) included authors who worked for drug companies.</P>
<P>
<B>Key results</B>
</P>
<P>Celecoxib, compared with placebo, slightly reduced pain, improved physical function, and probably did not increase numbers of people who withdrew from trials because of problems with the treatment. However, these results were unlikely to be clinically significant. Very low quality evidence meant that we are uncertain if celecoxib caused harms, such as gut or heart problems when compared with placebo. However, drug regulatory agencies have warned of increased risk of heart problems with celecoxib.</P>
<P>Celecoxib and tNSAIDs reduced pain by the same amount; celecoxib slightly improved physical function compared with tNSAIDs. Evidence comparing celecoxib and tNSAIDs was low to very low quality, so it is uncertain if harms (such as heart or gut problems) occurred from taking these drugs.</P>
<P>None of the high-quality studies assessed quality of life.</P>
<P>
<B>Quality of evidence</B>
</P>
<P>Evidence quality was poor and results should be interpreted cautiously. Because it is known that sponsorship by the manufacturing drug company may lead to more favorable results and conclusions than sponsorship from other sources, we are highly reserved about results due to significant drug industry involvement and few data.</P>
<P>We were unable to obtain data from three trials which included 15,539 participants (awaiting assessment); Pfizer declined to provide data for two reports that involved 14,042 participants.</P>
<P>We need access to all trials results to better understand the benefits and harms of celecoxib and other treatments. New trials researching benefits and harms of celecoxib versus tNSAIDs for people with osteoarthritis, that have longer follow-up periods, more direct comparisons with other tNSAIDs, and funded by non-commercial sources, are needed.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P />
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P />
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P />
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P />
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P />
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P />
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P />
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY>
<BACKGROUND>
<P />
<CONDITION>
<P />
</CONDITION>
<INTERVENTION>
<P />
</INTERVENTION>
<THEORY>
<P />
</THEORY>
<IMPORTANCE>
<P />
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES>
<P />
</OBJECTIVES>
<METHODS>
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P />
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P />
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P />
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P />
<CRIT_OUTCOMES_PRIMARY>
<P />
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY>
<P />
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS>
<P />
<ELECTRONIC_SEARCHES>
<P />
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES>
<P />
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION>
<P />
<STUDY_SELECTION>
<P />
</STUDY_SELECTION>
<DATA_EXTRACTION>
<P />
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT>
<P />
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES>
<P />
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS>
<P />
</UNIT_OF_ANALYSIS>
<MISSING_DATA>
<P />
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT>
<P />
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT>
<P />
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS>
<P />
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS>
<P />
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS>
<P />
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION>
<P />
<SEARCH_RESULTS>
<P />
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR>
<P />
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR>
<P />
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P />
<ALLOCATION>
<P />
</ALLOCATION>
<BLINDING>
<P />
</BLINDING>
<EXCLUSIONS>
<P />
</EXCLUSIONS>
<SELECTIVE_REPORTING>
<P />
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES>
<P />
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS>
<P />
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P />
<SUMMARY_OF_RESULTS>
<P />
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS>
<P />
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE>
<P />
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES>
<P />
</POTENTIAL_BIASES>
<AGREEMENT>
<P />
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P />
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P />
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P />
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P />
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P />
</CONTRIBUTIONS>
<PRO_REV_DIFF>
<P />
</PRO_REV_DIFF>
<PUBLIC_NOTES>
<P />
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES>
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Asmus-2014-Study-1" NAME="Asmus 2014 Study 1" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Asmus-2014-Study-2" NAME="Asmus 2014 Study 2" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bensen-1999" NAME="Bensen 1999" YEAR="1999">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bingham-2007-Study-1" NAME="Bingham 2007 Study 1" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bingham-2007-Study-2" NAME="Bingham 2007 Study 2" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Birbara-2006-Study-1" NAME="Birbara 2006 Study 1" YEAR="2006">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Birbara-2006-Study-2" NAME="Birbara 2006 Study 2" YEAR="2006">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Boswell-2008-Study-A" NAME="Boswell 2008 Study A" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Boswell-2008-Study-B" NAME="Boswell 2008 Study B" YEAR="">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clegg-2006" NAME="Clegg 2006" YEAR="2006">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Conaghan-2013" NAME="Conaghan 2013" YEAR="2013">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dahlberg-2009" NAME="Dahlberg 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-DeLemos-2011" NAME="DeLemos 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Emery-2008" NAME="Emery 2008" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Essex-2012a" NAME="Essex 2012a" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Essex-2012b" NAME="Essex 2012b" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Essex-2014" NAME="Essex 2014" YEAR="2014">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fleischmann-2005" NAME="Fleischmann 2005" YEAR="2006">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gibofsky-2003" NAME="Gibofsky 2003" YEAR="2003">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hochberg-2011-Study-307" NAME="Hochberg 2011 Study 307" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hochberg-2011-Study-309" NAME="Hochberg 2011 Study 309" YEAR="">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kivitz-2001" NAME="Kivitz 2001" YEAR="2001">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lehmann-2005" NAME="Lehmann 2005" YEAR="2005">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McKenna-2001a" NAME="McKenna 2001a" YEAR="2001">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McKenna-2001b" NAME="McKenna 2001b" YEAR="2001">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pincus-2004-PACES_x002d_a" NAME="Pincus 2004 PACES-a" YEAR="2004">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pincus-2004-PACES_x002d_b" NAME="Pincus 2004 PACES-b" YEAR="">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rother-2007" NAME="Rother 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schnitzer-2011" NAME="Schnitzer 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sheldon-2005" NAME="Sheldon 2005" YEAR="2005">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smugar-2006-Study-1" NAME="Smugar 2006 Study 1" YEAR="2006">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smugar-2006-Study-2" NAME="Smugar 2006 Study 2" YEAR="">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sowers-2005" NAME="Sowers 2005" YEAR="2005">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tannenbaum-2004" NAME="Tannenbaum 2004" YEAR="2004">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Williams-2000" NAME="Williams 2000" YEAR="2000">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Williams-2001" NAME="Williams 2001" YEAR="2001">
<IDENTIFIERS />
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES />
<AWAITING_STUDIES />
<ONGOING_STUDIES />
</STUDIES>
<OTHER_REFERENCES>
<ADDITIONAL_REFERENCES />
<OTHER_VERSIONS_REFERENCES />
<PENDING_REFERENCES />
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Asmus-2014-Study-1">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Asmus-2014-Study-2">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Bensen-1999">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Bingham-2007-Study-1">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Bingham-2007-Study-2">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Birbara-2006-Study-1">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Birbara-2006-Study-2">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Boswell-2008-Study-A">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Boswell-2008-Study-B">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Clegg-2006">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Conaghan-2013">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Dahlberg-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-DeLemos-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Emery-2008">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Essex-2012a">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Essex-2012b">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Essex-2014">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Fleischmann-2005">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Gibofsky-2003">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hochberg-2011-Study-307">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hochberg-2011-Study-309">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kivitz-2001">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lehmann-2005">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-McKenna-2001a">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-McKenna-2001b">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Pincus-2004-PACES_x002d_a">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Pincus-2004-PACES_x002d_b">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Rother-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Schnitzer-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Sheldon-2005">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Smugar-2006-Study-1">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Smugar-2006-Study-2">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Sowers-2005">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Tannenbaum-2004">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Williams-2000">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Williams-2001">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P />
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<FOOTNOTES>
<P />
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES>
<P />
</FOOTNOTES>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES>
<P />
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS />
<SOF_TABLES />
<ADDITIONAL_TABLES />
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Celecoxib versus placebo</NAME>
<CONT_OUTCOME CHI2="2.113621527835521" CI_END="-0.120348508304554" CI_START="-0.3205804162213416" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.2204644622629478" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.01" NO="1" P_CHI2="0.5491620122287727" P_Q="1.0" P_Z="1.5886797745428235E-5" Q="0.0" RANDOM="YES" SCALE="1.5" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="936" TOTAL_2="686" UNITS="" WEIGHT="100.0" Z="4.316019463650526">
<NAME>Pain</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.019860307775404262" CI_START="-0.3325787697044006" EFFECT_SIZE="-0.17621953873990243" ESTIMABLE="YES" MEAN_1="-99.2" MEAN_2="-86.1" ORDER="2495" SD_1="74.3" SD_2="74.2" SE="0.079776583752477" STUDY_ID="STD-Clegg-2006" TOTAL_1="318" TOTAL_2="313" WEIGHT="40.997703319698786" />
<CONT_DATA CI_END="-0.01635664412780205" CI_START="-0.45060309133222487" EFFECT_SIZE="-0.23347986773001345" ESTIMABLE="YES" MEAN_1="-41.8" MEAN_2="-35.6" ORDER="2496" SD_1="26.5" SD_2="26.5" SE="0.11077919049270889" STUDY_ID="STD-Hochberg-2011-Study-307" TOTAL_1="242" TOTAL_2="124" WEIGHT="21.261505996367493" />
<CONT_DATA CI_END="0.04821607908813469" CI_START="-0.38713846772847704" EFFECT_SIZE="-0.16946119432017118" ESTIMABLE="YES" MEAN_1="-42.9" MEAN_2="-38.4" ORDER="2497" SD_1="26.5" SD_2="26.5" SE="0.11106187415958478" STUDY_ID="STD-Hochberg-2011-Study-309" TOTAL_1="244" TOTAL_2="122" WEIGHT="21.1534107278925" />
<CONT_DATA CI_END="-0.1323627211608479" CI_START="-0.6239995278332567" EFFECT_SIZE="-0.3781811244970523" ESTIMABLE="YES" MEAN_1="-20.7" MEAN_2="-12.4" ORDER="2498" SD_1="22.7" SD_2="21.0" SE="0.12541985734186373" STUDY_ID="STD-Rother-2007" TOTAL_1="132" TOTAL_2="127" WEIGHT="16.587379956041232" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.618146220501309" CI_END="-0.07214094192876767" CI_START="-0.2721190985195301" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.1721300202241489" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.02" NO="2" P_CHI2="0.6552823780524739" P_Q="1.0" P_Z="7.406959187226078E-4" Q="0.0" RANDOM="YES" SCALE="1.5" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="936" TOTAL_2="686" UNITS="" WEIGHT="100.0" Z="3.3740549072854793">
<NAME>Physical function</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.051326743990669624" CI_START="-0.26099844175934905" EFFECT_SIZE="-0.10483584888433971" ESTIMABLE="YES" MEAN_1="-288.1" MEAN_2="-255.5" ORDER="2499" SD_1="309.0" SD_2="312.2" SE="0.07967625635307583" STUDY_ID="STD-Clegg-2006" TOTAL_1="318" TOTAL_2="313" WEIGHT="40.996908399087275" />
<CONT_DATA CI_END="-0.00600337934719386" CI_START="-0.44013367341205384" EFFECT_SIZE="-0.22306852637962385" ESTIMABLE="YES" MEAN_1="-36.3" MEAN_2="-30.6" ORDER="2500" SD_1="25.5" SD_2="25.5" SE="0.11074955904527438" STUDY_ID="STD-Hochberg-2011-Study-307" TOTAL_1="242" TOTAL_2="124" WEIGHT="21.219001162233063" />
<CONT_DATA CI_END="0.04821607908813469" CI_START="-0.38713846772847704" EFFECT_SIZE="-0.16946119432017118" ESTIMABLE="YES" MEAN_1="-36.8" MEAN_2="-32.3" ORDER="2501" SD_1="26.5" SD_2="26.5" SE="0.11106187415958478" STUDY_ID="STD-Hochberg-2011-Study-309" TOTAL_1="244" TOTAL_2="122" WEIGHT="21.09982980899195" />
<CONT_DATA CI_END="-0.031285270866970444" CI_START="-0.5208713695868405" EFFECT_SIZE="-0.2760783202269055" ESTIMABLE="YES" MEAN_1="-18.1" MEAN_2="-12.3" ORDER="2502" SD_1="22.5" SD_2="19.2" SE="0.12489670794505989" STUDY_ID="STD-Rother-2007" TOTAL_1="132" TOTAL_2="127" WEIGHT="16.68426062968772" />
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="34.596819783431975" CI_END="1.153603034662048" CI_START="0.8462910427305773" CI_STUDY="95" CI_TOTAL="95" DF="27" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.9880708047004035" ESTIMABLE="YES" EVENTS_1="428" EVENTS_2="303" I2="21.95814479766145" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.06205638982962604" LOG_CI_START="-0.07248025573760247" LOG_EFFECT_SIZE="-0.005211932953988216" METHOD="PETO" NO="3" P_CHI2="0.1493759985964369" P_Q="1.0" P_Z="0.8792993113721372" Q="0.0" RANDOM="NO" SCALE="35.6" SORT_BY="STUDY" STUDIES="28" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="7685" TOTAL_2="5280" WEIGHT="100.0" Z="0.1518575230798328">
<NAME>Number withdrawn due to adverse events</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5980900764491854" CI_START="0.18940245044470763" EFFECT_SIZE="0.5501655900825186" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" LOG_CI_END="0.20360125470407875" LOG_CI_START="-0.7226144064957315" LOG_EFFECT_SIZE="-0.2595065758958264" ORDER="250" O_E="-2.0186666666666664" SE="0.5440636642302349" STUDY_ID="STD-Asmus-2014-Study-1" TOTAL_1="188" TOTAL_2="187" VAR="3.3783182222222217" WEIGHT="2.1098760872910347" />
<DICH_DATA CI_END="1.260141562062084" CI_START="0.19032564632649362" EFFECT_SIZE="0.4897318217783519" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="12" LOG_CI_END="0.10041933572790009" LOG_CI_START="-0.720502686712357" LOG_EFFECT_SIZE="-0.3100416754922284" ORDER="251" O_E="-3.07012987012987" SE="0.48221365961095547" STUDY_ID="STD-Asmus-2014-Study-2" TOTAL_1="194" TOTAL_2="191" VAR="4.300520113003878" WEIGHT="2.685822930964901" />
<DICH_DATA CI_END="4.776951065149925" CI_START="0.9185987122143581" EFFECT_SIZE="2.0947794864275635" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="8" LOG_CI_END="0.6791507924149819" LOG_CI_START="-0.03687416775609903" LOG_EFFECT_SIZE="0.3211383123294414" ORDER="48" O_E="4.18" SE="0.42059660598520876" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="203" VAR="5.652863157894737" WEIGHT="3.530407740489658" />
<DICH_DATA CI_END="2.856764687503413" CI_START="0.390461565634169" EFFECT_SIZE="1.0561518889492127" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.45587446889951344" LOG_CI_START="-0.4084217086611593" LOG_EFFECT_SIZE="0.02372638011917706" ORDER="1482" O_E="0.21195652173913082" SE="0.5076918530342182" STUDY_ID="STD-Bingham-2007-Study-1" TOTAL_1="241" TOTAL_2="127" VAR="3.879713101296467" WEIGHT="2.423014458534543" />
<DICH_DATA CI_END="0.6812965986664717" CI_START="0.09909129296576483" EFFECT_SIZE="0.25982794471541826" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="-0.16666377924505826" LOG_CI_START="-1.003964504778615" LOG_EFFECT_SIZE="-0.5853141420118366" ORDER="1483" O_E="-5.571428571428571" SE="0.4918345908838475" STUDY_ID="STD-Bingham-2007-Study-2" TOTAL_1="247" TOTAL_2="117" VAR="4.133918030021927" WEIGHT="2.5817741919608896" />
<DICH_DATA CI_END="4.78321076788184" CI_START="0.11193133068315053" EFFECT_SIZE="0.7317042750913709" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.6797195180894647" LOG_CI_START="-0.9510483331472702" LOG_EFFECT_SIZE="-0.1356644075289028" ORDER="49" O_E="-0.34042553191489366" SE="0.9579211082475123" STUDY_ID="STD-Birbara-2006-Study-1" TOTAL_1="157" TOTAL_2="78" VAR="1.08978421608571" WEIGHT="0.6806077777699652" />
<DICH_DATA CI_END="4.3631607711265525" CI_START="0.26964793302104206" EFFECT_SIZE="1.08467381427449" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.6398012159037845" LOG_CI_START="-0.5692029044356971" LOG_EFFECT_SIZE="0.03529915573404369" ORDER="50" O_E="0.161157024793388" SE="0.7101750049543266" STUDY_ID="STD-Birbara-2006-Study-2" TOTAL_1="157" TOTAL_2="85" VAR="1.982755823256523" WEIGHT="1.2382993025666515" />
<DICH_DATA CI_END="1.5897903261085915" CI_START="0.2441979199753634" EFFECT_SIZE="0.6230758307242167" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="0.20133984996910687" LOG_CI_START="-0.6122580396010836" LOG_EFFECT_SIZE="-0.20545909481598837" ORDER="2503" O_E="-2.0713153724247224" SE="0.47791142770803596" STUDY_ID="STD-Clegg-2006" TOTAL_1="318" TOTAL_2="313" VAR="4.378296503890924" WEIGHT="2.7343969658823215" />
<DICH_DATA CI_END="2.1352007540972835" CI_START="0.4393275005329674" EFFECT_SIZE="0.968531058063533" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="13" LOG_CI_END="0.3294387141609758" LOG_CI_START="-0.35721161040210114" LOG_EFFECT_SIZE="-0.013886448120562648" ORDER="56" O_E="-0.19654427645788353" SE="0.40334179962227595" STUDY_ID="STD-Conaghan-2013" TOTAL_1="235" TOTAL_2="228" VAR="6.146863040443734" WEIGHT="3.838927681701445" />
<DICH_DATA CI_END="2.701828741504354" CI_START="0.6761836142102631" EFFECT_SIZE="1.3516406043795741" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="15" LOG_CI_END="0.431657817307473" LOG_CI_START="-0.16993535759315273" LOG_EFFECT_SIZE="0.13086122985716012" ORDER="645" O_E="2.412935323383085" SE="0.3533788088708708" STUDY_ID="STD-DeLemos-2011" TOTAL_1="202" TOTAL_2="200" VAR="8.007906522646628" WEIGHT="5.00121343521044" />
<DICH_DATA CI_END="7.182206165185008" CI_START="0.43378883351003006" EFFECT_SIZE="1.765095134666727" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="0.8562578673894871" LOG_CI_START="-0.3627216316841897" LOG_EFFECT_SIZE="0.2467681178526487" ORDER="54" O_E="1.108247422680412" SE="0.716034591801714" STUDY_ID="STD-Essex-2012b" TOTAL_1="127" TOTAL_2="67" VAR="1.950437294906156" WEIGHT="1.218115268482964" />
<DICH_DATA CI_END="11.75089305821319" CI_START="0.1747573589775922" EFFECT_SIZE="1.4330230411551166" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.0700708738856686" LOG_CI_START="-0.7575645271927571" LOG_EFFECT_SIZE="0.15625317334645572" ORDER="55" O_E="0.3121693121693121" SE="1.0735620815346096" STUDY_ID="STD-Essex-2014" TOTAL_1="127" TOTAL_2="62" VAR="0.8676522005352355" WEIGHT="0.541878683290695" />
<DICH_DATA CI_END="1.8534434606690866" CI_START="0.5509360642874251" EFFECT_SIZE="1.0105092011457846" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="17" LOG_CI_END="0.26797934240553745" LOG_CI_START="-0.2588987977693963" LOG_EFFECT_SIZE="0.004540272318070587" ORDER="52" O_E="0.10914454277286012" SE="0.30949082762761265" STUDY_ID="STD-Fleischmann-2005" TOTAL_1="446" TOTAL_2="232" VAR="10.440094632087956" WEIGHT="6.520198680042801" />
<DICH_DATA CI_END="3.25532916560611" CI_START="0.3866650595071892" EFFECT_SIZE="1.1219278254569565" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.512594909211006" LOG_CI_START="-0.41266507061845903" LOG_EFFECT_SIZE="0.04996491929627351" ORDER="53" O_E="0.3894736842105271" SE="0.543502292262595" STUDY_ID="STD-Gibofsky-2003" TOTAL_1="189" TOTAL_2="96" VAR="3.3853006125395027" WEIGHT="2.114236830534717" />
<DICH_DATA CI_END="2.8182426848653908" CI_START="0.47211220878772575" EFFECT_SIZE="1.1534846244539414" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="7" LOG_CI_END="0.44997838840420473" LOG_CI_START="-0.32595476859949696" LOG_EFFECT_SIZE="0.06201180990235392" ORDER="2504" O_E="0.6873315363881396" SE="0.4557869773550473" STUDY_ID="STD-Hochberg-2011-Study-307" TOTAL_1="247" TOTAL_2="124" VAR="4.813668460273759" WEIGHT="3.0063017479146743" />
<DICH_DATA CI_END="4.043009853261113" CI_START="0.7913133215756869" EFFECT_SIZE="1.788655236804254" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="6" LOG_CI_END="0.606704799758536" LOG_CI_START="-0.10165152296437481" LOG_EFFECT_SIZE="0.2525266383970806" ORDER="2505" O_E="3.3584905660377373" SE="0.4160920103877861" STUDY_ID="STD-Hochberg-2011-Study-309" TOTAL_1="247" TOTAL_2="124" VAR="5.775921026045625" WEIGHT="3.6072616175627847" />
<DICH_DATA CI_END="3.51048989054726" CI_START="0.9957643869283799" EFFECT_SIZE="1.8696579402872247" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="16" LOG_CI_END="0.5453677266981793" LOG_CI_START="-0.0018434101323229891" LOG_EFFECT_SIZE="0.27176215828292816" ORDER="57" O_E="6.0564705882352925" SE="0.3214345305130504" STUDY_ID="STD-Kivitz-2001" TOTAL_1="207" TOTAL_2="218" VAR="9.678653470000652" WEIGHT="6.044652448429863" />
<DICH_DATA CI_END="2.4820171606697676" CI_START="0.6533868841094699" EFFECT_SIZE="1.2734667089940956" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="16" LOG_CI_END="0.394804779885685" LOG_CI_START="-0.1848295876690503" LOG_EFFECT_SIZE="0.10498759610831733" ORDER="58" O_E="2.0853080568720372" SE="0.3404800967380454" STUDY_ID="STD-Lehmann-2005" TOTAL_1="420" TOTAL_2="424" VAR="8.626140760795757" WEIGHT="5.387322010428502" />
<DICH_DATA CI_END="19.569904435818767" CI_START="0.5531709814923205" EFFECT_SIZE="3.2902132521270993" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.291588704906958" LOG_CI_START="-0.25714061039264124" LOG_EFFECT_SIZE="0.5172240472571584" ORDER="59" O_E="1.4390243902439024" SE="0.9097312661407365" STUDY_ID="STD-McKenna-2001a" TOTAL_1="63" TOTAL_2="60" VAR="1.208297168937303" WEIGHT="0.7546231987007226" />
<DICH_DATA CI_END="2.1655175141785863" CI_START="0.46677653272825004" EFFECT_SIZE="1.0053918424328794" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="14" LOG_CI_END="0.3355617005481313" LOG_CI_START="-0.3308909863087946" LOG_EFFECT_SIZE="0.0023353571196683886" ORDER="60" O_E="0.035087719298244835" SE="0.3914776072537637" STUDY_ID="STD-McKenna-2001b" TOTAL_1="199" TOTAL_2="200" VAR="6.5250846414281325" WEIGHT="4.075140098389946" />
<DICH_DATA CI_END="1.6806377405025106" CI_START="0.42518976818337084" EFFECT_SIZE="0.8453342364322449" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="20" LOG_CI_END="0.22547411185980631" LOG_CI_START="-0.37141719493652864" LOG_EFFECT_SIZE="-0.07297154153836119" ORDER="2506" O_E="-1.3667953667953654" SE="0.35061690827178793" STUDY_ID="STD-Rother-2007" TOTAL_1="132" TOTAL_2="127" VAR="8.134564148930673" WEIGHT="5.080315485222167" />
<DICH_DATA CI_END="2.309648714558678" CI_START="0.6488564064317617" EFFECT_SIZE="1.224185592566863" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="18" LOG_CI_END="0.36354593100468136" LOG_CI_START="-0.18785140303666684" LOG_EFFECT_SIZE="0.08784726398400725" ORDER="646" O_E="1.928143712574851" SE="0.32389352347671163" STUDY_ID="STD-Schnitzer-2011" TOTAL_1="419" TOTAL_2="416" VAR="9.532251053830821" WEIGHT="5.953219097075777" />
<DICH_DATA CI_END="1.203075726669705" CI_START="0.33712588825877854" EFFECT_SIZE="0.6368578907386637" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="24" LOG_CI_END="0.08029296452996898" LOG_CI_START="-0.47220789625910337" LOG_EFFECT_SIZE="-0.1959574658645672" ORDER="62" O_E="-4.283870967741937" SE="0.32454174055087026" STUDY_ID="STD-Sheldon-2005" TOTAL_1="393" TOTAL_2="382" VAR="9.494210972097862" WEIGHT="5.929461755840417" />
<DICH_DATA CI_END="1.8839390903105258" CI_START="0.36238032842315626" EFFECT_SIZE="0.8262581111710495" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="9" LOG_CI_END="0.2750668574963221" LOG_CI_START="-0.44083538574453995" LOG_EFFECT_SIZE="-0.08288426412410897" ORDER="63" O_E="-1.0792079207920793" SE="0.42052452145293967" STUDY_ID="STD-Smugar-2006-Study-1" TOTAL_1="456" TOTAL_2="150" VAR="5.65480130371273" WEIGHT="3.53161817930746" />
<DICH_DATA CI_END="4.5123268811703365" CI_START="0.483475397142358" EFFECT_SIZE="1.4770237069559735" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="3" LOG_CI_END="0.6544005531974431" LOG_CI_START="-0.3156256211821625" LOG_EFFECT_SIZE="0.16938746600764026" ORDER="64" O_E="1.2013093289689039" SE="0.5697981765375845" STUDY_ID="STD-Smugar-2006-Study-2" TOTAL_1="460" TOTAL_2="151" VAR="3.0800508734605003" WEIGHT="1.9235978549349073" />
<DICH_DATA CI_END="1.9366020651642804" CI_START="0.6730795789790713" EFFECT_SIZE="1.141703684267846" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="21" LOG_CI_END="0.28704039064280934" LOG_CI_START="-0.17193358560019975" LOG_EFFECT_SIZE="0.05755340252130474" ORDER="65" O_E="1.8232044198894997" SE="0.2696035856029676" STUDY_ID="STD-Tannenbaum-2004" TOTAL_1="481" TOTAL_2="243" VAR="13.757789882996445" WEIGHT="8.592213633745526" />
<DICH_DATA CI_END="0.9120506225673598" CI_START="0.2366640336618184" EFFECT_SIZE="0.46459614639013536" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="20" LOG_CI_END="-0.03998105586947748" LOG_CI_START="-0.6258677377153931" LOG_EFFECT_SIZE="-0.33292439679243524" ORDER="66" O_E="-6.472303206997086" SE="0.34415273710213956" STUDY_ID="STD-Williams-2000" TOTAL_1="454" TOTAL_2="232" VAR="8.443014675659311" WEIGHT="5.272953462952103" />
<DICH_DATA CI_END="1.356838846755815" CI_START="0.2664822073295838" EFFECT_SIZE="0.601309746199092" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="12" LOG_CI_END="0.13252826908877197" LOG_CI_START="-0.5743317829471419" LOG_EFFECT_SIZE="-0.22090175692918496" ORDER="67" O_E="-2.950344827586207" SE="0.4152130935795848" STUDY_ID="STD-Williams-2001" TOTAL_1="482" TOTAL_2="243" VAR="5.800399671530209" WEIGHT="3.6225493747721176" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="28.38501954742075" CI_END="1.359861051512678" CI_START="0.6624968973947832" CI_STUDY="95" CI_TOTAL="95" DF="25" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.9491594847627857" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="56" I2="11.925373318012513" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.13349453510244957" LOG_CI_START="-0.17881615127414371" LOG_EFFECT_SIZE="-0.02266080808584708" METHOD="PETO" NO="4" P_CHI2="0.2904360608029447" P_Q="1.0" P_Z="0.7760852710246678" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="28" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="7745" TOTAL_2="5648" WEIGHT="100.0" Z="0.2844242585748617">
<NAME>Number experiencing any serious adverse events</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="15.875406991882377" CI_START="0.061639511645682855" EFFECT_SIZE="0.9892180417663683" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2007248679522327" LOG_CI_START="-1.2101408107457228" LOG_EFFECT_SIZE="-0.004707971396745059" ORDER="252" O_E="-0.00540540540540535" SE="1.4161544336447573" STUDY_ID="STD-Asmus-2014-Study-1" TOTAL_1="186" TOTAL_2="184" VAR="0.4986304168374042" WEIGHT="1.6781379581246747" />
<DICH_DATA CI_END="15.39205603945664" CI_START="0.05970602879886116" EFFECT_SIZE="0.9586441160125496" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.187296635877631" LOG_CI_START="-1.223981813897704" LOG_EFFECT_SIZE="-0.018342589010036717" ORDER="253" O_E="-0.021052631578947434" SE="1.4163968974188599" STUDY_ID="STD-Asmus-2014-Study-2" TOTAL_1="194" TOTAL_2="186" VAR="0.49845971685219165" WEIGHT="1.6775634682520886" />
<DICH_DATA CI_END="284.2081739859958" CI_START="0.07458878874976352" EFFECT_SIZE="4.604209318699302" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.4536365643232028" LOG_CI_START="-1.1273264453157614" LOG_EFFECT_SIZE="0.6631550595037208" ORDER="1484" O_E="0.34510869565217395" SE="2.1034753979147074" STUDY_ID="STD-Bingham-2007-Study-1" TOTAL_1="241" TOTAL_2="127" VAR="0.2260086838374291" WEIGHT="0.7606309972403144" />
<DICH_DATA CI_END="2.961187184303358" CI_START="6.702817001705855E-4" EFFECT_SIZE="0.044551426244489684" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.4714658611348646" LOG_CI_START="-3.173742637421765" LOG_EFFECT_SIZE="-1.3511383881434502" ORDER="1485" O_E="-0.6785714285714286" SE="2.141213516125243" STUDY_ID="STD-Bingham-2007-Study-2" TOTAL_1="247" TOTAL_2="117" VAR="0.2181122448979592" WEIGHT="0.7340555749016903" />
<DICH_DATA CI_END="11.609901695887325" CI_START="0.17251365099971963" EFFECT_SIZE="1.415226670645151" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.064828542467736" LOG_CI_START="-0.7631765335224092" LOG_EFFECT_SIZE="0.15082600447266328" ORDER="1012" O_E="0.3012048192771086" SE="1.073779230407674" STUDY_ID="STD-Birbara-2006-Study-1" TOTAL_1="168" TOTAL_2="81" VAR="0.8673013078353053" WEIGHT="2.9188978382845017" />
<DICH_DATA CI_END="11.609901695887325" CI_START="0.17251365099971963" EFFECT_SIZE="1.415226670645151" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.064828542467736" LOG_CI_START="-0.7631765335224092" LOG_EFFECT_SIZE="0.15082600447266328" ORDER="1013" O_E="0.3012048192771086" SE="1.073779230407674" STUDY_ID="STD-Birbara-2006-Study-2" TOTAL_1="168" TOTAL_2="81" VAR="0.8673013078353053" WEIGHT="2.9188978382845017" />
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="68" O_E="0.0" SE="0.0" STUDY_ID="STD-Boswell-2008-Study-A" TOTAL_1="109" TOTAL_2="107" VAR="0.0" WEIGHT="0.0" />
<DICH_DATA CI_END="4.975106358844346" CI_START="0.05317346139879427" EFFECT_SIZE="0.5143380463536659" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6968023696175144" LOG_CI_START="-1.274305067775602" LOG_EFFECT_SIZE="-0.28875134907904376" ORDER="69" O_E="-0.49595687331536387" SE="1.1578382658638928" STUDY_ID="STD-Boswell-2008-Study-B" TOTAL_1="185" TOTAL_2="186" VAR="0.745940526441976" WEIGHT="2.510458788024503" />
<DICH_DATA CI_END="116.92451939432895" CI_START="0.4553605172658577" EFFECT_SIZE="7.296767067164981" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0679055934634163" LOG_CI_START="-0.341644628259592" LOG_EFFECT_SIZE="0.8631304826019122" ORDER="70" O_E="0.9920760697305864" SE="1.4153817277060563" STUDY_ID="STD-Clegg-2006" TOTAL_1="318" TOTAL_2="313" VAR="0.4991750047031705" WEIGHT="1.6799707656274199" />
<DICH_DATA CI_END="19.01671594627203" CI_START="0.5618900765840315" EFFECT_SIZE="3.268838322619759" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.2791355194596166" LOG_CI_START="-0.2503486378158543" LOG_EFFECT_SIZE="0.5143934408218811" ORDER="71" O_E="1.4673913043478262" SE="0.8984265650522947" STUDY_ID="STD-Conaghan-2013" TOTAL_1="233" TOTAL_2="227" VAR="1.2388959416995111" WEIGHT="4.16949755917218" />
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="647" O_E="0.0" SE="0.0" STUDY_ID="STD-DeLemos-2011" TOTAL_1="202" TOTAL_2="200" VAR="0.0" WEIGHT="0.0" />
<DICH_DATA CI_END="284.17307275401805" CI_START="0.07468579590770286" EFFECT_SIZE="4.606917854072436" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.4535829233156474" LOG_CI_START="-1.1267619864773664" LOG_EFFECT_SIZE="0.6634104684191405" ORDER="72" O_E="0.34536082474226804" SE="2.1031123230055524" STUDY_ID="STD-Essex-2012b" TOTAL_1="127" TOTAL_2="67" VAR="0.22608672547560849" WEIGHT="0.7608936459495002" />
<DICH_DATA CI_END="4.773301798954783" CI_START="0.11457488657259113" EFFECT_SIZE="0.739527222076368" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.6788188941351703" LOG_CI_START="-0.9409105640279469" LOG_EFFECT_SIZE="-0.13104583494638822" ORDER="73" O_E="-0.3333333333333335" SE="0.9514371015151422" STUDY_ID="STD-Fleischmann-2005" TOTAL_1="462" TOTAL_2="231" VAR="1.104688503532434" WEIGHT="3.7178231553536047" />
<DICH_DATA CI_END="2.6236913066814846" CI_START="0.08615776666843859" EFFECT_SIZE="0.4754486127975074" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.418912736309097" LOG_CI_START="-1.0647055670933636" LOG_EFFECT_SIZE="-0.3228964153921334" ORDER="74" O_E="-0.9789473684210526" SE="0.8714847354476501" STUDY_ID="STD-Gibofsky-2003" TOTAL_1="189" TOTAL_2="96" VAR="1.316680582107604" WEIGHT="4.431281343755189" />
<DICH_DATA CI_END="29.67652524560033" CI_START="0.7143346892789872" EFFECT_SIZE="4.604234077476506" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="1.4724130490663956" LOG_CI_START="-0.14609825930197326" LOG_EFFECT_SIZE="0.6631573948822111" ORDER="2508" O_E="1.6893732970027249" SE="0.9507215542957683" STUDY_ID="STD-Hochberg-2011-Study-307" TOTAL_1="243" TOTAL_2="124" VAR="1.106351985855941" WEIGHT="3.7234215960733907" />
<DICH_DATA CI_END="11.744035102008365" CI_START="0.1800778774854474" EFFECT_SIZE="1.4542492614006224" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.0698173406463953" LOG_CI_START="-0.7445396368535514" LOG_EFFECT_SIZE="0.16263885189642194" ORDER="2509" O_E="0.3297002724795641" SE="1.0657622697953544" STUDY_ID="STD-Hochberg-2011-Study-309" TOTAL_1="245" TOTAL_2="122" VAR="0.8803985477655932" WEIGHT="2.9629765280946527" />
<DICH_DATA CI_END="2.582016891162869" CI_START="0.2889557163854812" EFFECT_SIZE="0.8637641694961535" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.41195907902832263" LOG_CI_START="-0.539168709503138" LOG_EFFECT_SIZE="-0.06360481523740766" ORDER="75" O_E="-0.4691943127962084" SE="0.5586971711418653" STUDY_ID="STD-Lehmann-2005" TOTAL_1="420" TOTAL_2="424" VAR="3.20366469468085" WEIGHT="10.78191612005275" />
<DICH_DATA CI_END="372.3848896839504" CI_START="0.1466175227450357" EFFECT_SIZE="7.38905609893065" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.570992050236215" LOG_CI_START="-0.8338141226232083" LOG_EFFECT_SIZE="0.8685889638065036" ORDER="76" O_E="0.5" SE="2.0" STUDY_ID="STD-McKenna-2001a" TOTAL_1="63" TOTAL_2="63" VAR="0.25" WEIGHT="0.8413736414077854" />
<DICH_DATA CI_END="6.8547392913343455" CI_START="0.002698820966569262" EFFECT_SIZE="0.13601365416684918" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8359909417676903" LOG_CI_START="-2.568825924561665" LOG_EFFECT_SIZE="-0.8664174913969873" ORDER="77" O_E="-0.49874686716791977" SE="2.0000062813971713" STUDY_ID="STD-McKenna-2001b" TOTAL_1="199" TOTAL_2="200" VAR="0.24999842965810518" WEIGHT="0.8413683564306722" />
<DICH_DATA CI_END="1.4248449550513311" CI_START="0.041618685220949206" EFFECT_SIZE="0.24351626983209743" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.15376760902588374" LOG_CI_START="-1.3807116437376994" LOG_EFFECT_SIZE="-0.6134720173559078" ORDER="78" O_E="-1.7386541471048513" SE="0.9013607088681332" STUDY_ID="STD-Pincus-2004-PACES_x002d_a" TOTAL_1="350" TOTAL_2="289" VAR="1.230843266951775" WEIGHT="4.142396326069879" />
<DICH_DATA CI_END="14.315141955795747" CI_START="0.14553029785824187" EFFECT_SIZE="1.4433595784522895" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.1557956590508125" LOG_CI_START="-0.8370465817787263" LOG_EFFECT_SIZE="0.15937453863604317" ORDER="79" O_E="0.2678018575851393" SE="1.1706053969914596" STUDY_ID="STD-Pincus-2004-PACES_x002d_b" TOTAL_1="373" TOTAL_2="273" VAR="0.7297581532660432" WEIGHT="2.4559970990418862" />
<DICH_DATA CI_END="358.80527512243873" CI_START="0.1410645900602949" EFFECT_SIZE="7.114402226935033" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.554858819376864" LOG_CI_START="-0.8505819888777393" LOG_EFFECT_SIZE="0.8521384152495625" ORDER="80" O_E="0.49034749034749037" SE="2.0003727879726245" STUDY_ID="STD-Rother-2007" TOTAL_1="132" TOTAL_2="127" VAR="0.2499068290574082" WEIGHT="0.8410600751068179" />
<DICH_DATA CI_END="1.3598104571308713" CI_START="0.1521531734507855" EFFECT_SIZE="0.45486204100147265" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.13347837663568865" LOG_CI_START="-0.817718985154043" LOG_EFFECT_SIZE="-0.34212030425917717" ORDER="648" O_E="-2.523353293413174" SE="0.558738038818167" STUDY_ID="STD-Schnitzer-2011" TOTAL_1="419" TOTAL_2="416" VAR="3.2031960616740927" WEIGHT="10.780338938215234" />
<DICH_DATA CI_END="1.8425051305513294" CI_START="0.133182517536273" EFFECT_SIZE="0.495368016590015" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.265408705848337" LOG_CI_START="-0.8755527799392129" LOG_EFFECT_SIZE="-0.30507203704543795" ORDER="81" O_E="-1.5638709677419351" SE="0.6702064246020488" STUDY_ID="STD-Sheldon-2005" TOTAL_1="393" TOTAL_2="382" VAR="2.226295593253152" WEIGHT="7.49258572058204" />
<DICH_DATA CI_END="0.6470319040106242" CI_START="0.025594537453993" EFFECT_SIZE="0.12868753747402395" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="-0.18907430450261645" LOG_CI_START="-1.5918527146385892" LOG_EFFECT_SIZE="-0.8904635095706029" ORDER="82" O_E="-3.01980198019802" SE="0.8239989819789898" STUDY_ID="STD-Smugar-2006-Study-1" TOTAL_1="456" TOTAL_2="150" VAR="1.4728097472213468" WEIGHT="4.9567332004820175" />
<DICH_DATA CI_END="52.4742129467474" CI_START="0.2738810011018716" EFFECT_SIZE="3.7910011835777584" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="1.7199459333821567" LOG_CI_START="-0.5624380933495412" LOG_EFFECT_SIZE="0.5787539200163078" ORDER="83" O_E="0.7414075286415711" SE="1.3406836752853433" STUDY_ID="STD-Smugar-2006-Study-2" TOTAL_1="460" TOTAL_2="151" VAR="0.5563490585454499" WEIGHT="1.8723897331287134" />
<DICH_DATA CI_END="4.065982523783019" CI_START="0.7502303750794275" EFFECT_SIZE="1.7465461900230783" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="8" LOG_CI_END="0.6091655076416876" LOG_CI_START="-0.1248053562579061" LOG_EFFECT_SIZE="0.24218007569189073" ORDER="84" O_E="3.0" SE="0.43113811866899343" STUDY_ID="STD-Tannenbaum-2004" TOTAL_1="481" TOTAL_2="481" VAR="5.379812695109261" WEIGHT="18.105730389503645" />
<DICH_DATA CI_END="11.12020648651447" CI_START="0.09142725108809233" EFFECT_SIZE="1.008310423725745" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.0461128515555025" LOG_CI_START="-1.0389243378195467" LOG_EFFECT_SIZE="0.003594256867977887" ORDER="85" O_E="0.0055172413793103114" SE="1.224761166139448" STUDY_ID="STD-Williams-2001" TOTAL_1="482" TOTAL_2="243" VAR="0.6666489275461336" WEIGHT="2.2436033428403412" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.9324332404662483" CI_END="14.901356983515567" CI_START="0.2444525718290594" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.9085793246190461" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="23.711355881929595" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="1.1732258189906977" LOG_CI_START="-0.611805389264153" LOG_EFFECT_SIZE="0.2807102148632722" METHOD="PETO" NO="5" P_CHI2="0.2688532222120261" P_Q="1.0" P_Z="0.5376044651775731" Q="0.0" RANDOM="NO" SCALE="860.5054001752553" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2010" TOTAL_2="1253" WEIGHT="100.0" Z="0.6164395431073761">
<NAME>Number experiencing gastro-intestinal events (perforation, ulcer, bleeds)</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="384.070407328942" CI_START="0.15108507614994726" EFFECT_SIZE="7.617565670096613" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.5844108460122106" LOG_CI_START="-0.8207784321918987" LOG_EFFECT_SIZE="0.8818162069101559" ORDER="86" O_E="0.5075000000000001" SE="2.0002250379758704" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="203" VAR="0.24994375000000002" WEIGHT="27.479518095318397" />
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="87" O_E="0.0" SE="0.0" STUDY_ID="STD-Boswell-2008-Study-A" TOTAL_1="109" TOTAL_2="107" VAR="0.0" WEIGHT="0.0" />
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="88" O_E="0.0" SE="0.0" STUDY_ID="STD-Boswell-2008-Study-B" TOTAL_1="185" TOTAL_2="186" VAR="0.0" WEIGHT="0.0" />
<DICH_DATA CI_END="366.62068876150846" CI_START="0.14431248311801925" EFFECT_SIZE="7.273784569095499" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.564216968977096" LOG_CI_START="-0.8406961005434362" LOG_EFFECT_SIZE="0.8617604342168298" ORDER="2511" O_E="0.4960380348652932" SE="2.000062791627882" STUDY_ID="STD-Clegg-2006" TOTAL_1="318" TOTAL_2="313" VAR="0.24998430283227138" WEIGHT="27.48397658763204" />
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="90" O_E="0.0" SE="0.0" STUDY_ID="STD-Essex-2014" TOTAL_1="96" TOTAL_2="47" VAR="0.0" WEIGHT="0.0" />
<DICH_DATA CI_END="3.248448187395724" CI_START="8.122702918057922E-4" EFFECT_SIZE="0.05136747956725073" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.5116759441789367" LOG_CI_START="-3.090299430479494" LOG_EFFECT_SIZE="-1.289311743150279" ORDER="91" O_E="-0.6631578947368421" SE="2.1158181651400265" STUDY_ID="STD-Gibofsky-2003" TOTAL_1="189" TOTAL_2="96" VAR="0.22337950138504153" WEIGHT="24.558969969977042" />
<DICH_DATA CI_END="354.3828354091645" CI_START="0.04025653017527818" EFFECT_SIZE="3.777065435923725" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.5494726785998587" LOG_CI_START="-1.395163660909637" LOG_EFFECT_SIZE="0.577154508845111" ORDER="92" O_E="0.24752475247524752" SE="2.317098912092674" STUDY_ID="STD-Smugar-2006-Study-1" TOTAL_1="456" TOTAL_2="150" VAR="0.18625624938731497" WEIGHT="20.47753534707252" />
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="93" O_E="0.0" SE="0.0" STUDY_ID="STD-Smugar-2006-Study-2" TOTAL_1="460" TOTAL_2="151" VAR="0.0" WEIGHT="0.0" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.5362025263616805" CI_END="15.875655767140648" CI_START="0.7301306334299829" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="3.4046002116810667" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="1.2007316735021902" LOG_CI_START="-0.13659942987655382" LOG_EFFECT_SIZE="0.5320661218128182" METHOD="PETO" NO="6" P_CHI2="0.9698823207237861" P_Q="1.0" P_Z="0.11886163603895152" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1785" TOTAL_2="1162" WEIGHT="99.99999999999999" Z="1.5595695538858427">
<NAME>Number experiencing cardiovascular events (myocardial infarction, stroke)</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="366.62068876150846" CI_START="0.14431248311801925" EFFECT_SIZE="7.273784569095499" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.564216968977096" LOG_CI_START="-0.8406961005434362" LOG_EFFECT_SIZE="0.8617604342168298" ORDER="2512" O_E="0.4960380348652932" SE="2.000062791627882" STUDY_ID="STD-Clegg-2006" TOTAL_1="318" TOTAL_2="313" VAR="0.24998430283227138" WEIGHT="15.426444249676313" />
<DICH_DATA CI_END="372.3848896839504" CI_START="0.1466175227450357" EFFECT_SIZE="7.38905609893065" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.570992050236215" LOG_CI_START="-0.8338141226232083" LOG_EFFECT_SIZE="0.8685889638065036" ORDER="2513" O_E="0.5" SE="2.0" STUDY_ID="STD-Rother-2007" TOTAL_1="132" TOTAL_2="132" VAR="0.25" WEIGHT="15.427412916428985" />
<DICH_DATA CI_END="18.671148663410307" CI_START="0.20092375811768334" EFFECT_SIZE="1.9368730876922111" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2711710369011553" LOG_CI_START="-0.6969687073066936" LOG_EFFECT_SIZE="0.2871011647972309" ORDER="649" O_E="0.49461077844311374" SE="1.1560950281965483" STUDY_ID="STD-Schnitzer-2011" TOTAL_1="419" TOTAL_2="416" VAR="0.7481917808289852" WEIGHT="46.17065417410836" />
<DICH_DATA CI_END="354.3828354091645" CI_START="0.04025653017527818" EFFECT_SIZE="3.777065435923725" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.5494726785998587" LOG_CI_START="-1.395163660909637" LOG_EFFECT_SIZE="0.577154508845111" ORDER="96" O_E="0.24752475247524752" SE="2.317098912092674" STUDY_ID="STD-Smugar-2006-Study-1" TOTAL_1="456" TOTAL_2="150" VAR="0.18625624938731497" WEIGHT="11.493808270253924" />
<DICH_DATA CI_END="354.9898388644554" CI_START="0.040132555065535785" EFFECT_SIZE="3.774473374648897" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.5502159221022676" LOG_CI_START="-1.3965031897418898" LOG_EFFECT_SIZE="0.5768563661801889" ORDER="97" O_E="0.2471358428805237" SE="2.3183223428719435" STUDY_ID="STD-Smugar-2006-Study-2" TOTAL_1="460" TOTAL_2="151" VAR="0.1860597180442568" WEIGHT="11.48168038953241" />
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Celecoxib versus tNSAIDs</NAME>
<CONT_OUTCOME CHI2="2.8480348249345044" CI_END="1.606583391018387" CI_START="-10.653743001879818" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.523579805430715" ESTIMABLE="YES" I2="64.88806979307226" I2_Q="0.0" ID="CMP-002.01" NO="1" P_CHI2="0.09148581772574638" P_Q="1.0" P_Z="0.14809314579753918" Q="0.0" RANDOM="YES" SCALE="20.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="13.289076693621206" TOTALS="YES" TOTAL_1="594" TOTAL_2="586" UNITS="" WEIGHT="100.0" Z="1.4462997502207724">
<NAME>Pain</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>tNSAIDs</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors tNSAIDs</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.3156624824477188" CI_START="-5.315662482447719" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="40.0" MEAN_2="42.0" ORDER="2514" SD_1="25.6" SD_2="25.6" SE="1.6916956171650301" STUDY_ID="STD-Dahlberg-2009" TOTAL_1="458" TOTAL_2="458" WEIGHT="60.569065540145104" />
<CONT_DATA CI_END="-1.7476580190931035" CI_START="-15.0523419809069" EFFECT_SIZE="-8.400000000000002" ESTIMABLE="YES" MEAN_1="30.8" MEAN_2="39.2" ORDER="2517" SD_1="27.9886" SD_2="27.1529" SE="3.3941143987235085" STUDY_ID="STD-Sowers-2005" TOTAL_1="136" TOTAL_2="128" WEIGHT="39.4309344598549" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.5956267264411927" CI_START="-11.4043732735588" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.9999999999999964" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.029557091596757554" Q="0.0" RANDOM="YES" SCALE="20.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="136" TOTAL_2="128" UNITS="" WEIGHT="100.0" Z="2.1759755131600023">
<NAME>Physical function</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>tNSAIDs</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors tNSAIDs</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.5956267264411927" CI_START="-11.4043732735588" EFFECT_SIZE="-5.9999999999999964" ESTIMABLE="YES" MEAN_1="31.3" MEAN_2="37.3" ORDER="2519" SD_1="23.3" SD_2="21.5" SE="2.7573839704136454" STUDY_ID="STD-Sowers-2005" TOTAL_1="136" TOTAL_2="128" WEIGHT="100.0" />
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="10.628965840747242" CI_END="1.2684529557758437" CI_START="0.7402467224313811" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.9690036857883804" ESTIMABLE="YES" EVENTS_1="114" EVENTS_2="117" I2="34.14222884069516" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="0.10327436479714734" LOG_CI_START="-0.13062350684729743" LOG_EFFECT_SIZE="-0.013674571025074987" METHOD="PETO" NO="3" P_CHI2="0.15564222936373429" P_Q="1.0" P_Z="0.8187336049553345" Q="0.0" RANDOM="NO" SCALE="17.56473850848002" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1577" TOTAL_2="1573" WEIGHT="100.0" Z="0.22917409658112678">
<NAME>Number withdrawn due to adverse events</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>tNSAIDs</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors tNSAIDs</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.655095263043958" CI_START="0.8947543722620165" EFFECT_SIZE="2.0408740382259714" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="8" LOG_CI_END="0.6679285729201524" LOG_CI_START="-0.048296170731053606" LOG_EFFECT_SIZE="0.3098162010945494" ORDER="108" O_E="4.030379746835443" SE="0.4207139597903784" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="198" VAR="5.6497099823746195" WEIGHT="10.664829055641194" />
<DICH_DATA CI_END="2.607880408076274" CI_START="0.7969976057250933" EFFECT_SIZE="1.4416915208373007" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="19" LOG_CI_END="0.41628767168280334" LOG_CI_START="-0.09854298327382746" LOG_EFFECT_SIZE="0.1588723442044879" ORDER="2520" O_E="4.0" SE="0.30241407517436786" STUDY_ID="STD-Dahlberg-2009" TOTAL_1="458" TOTAL_2="458" VAR="10.934426229508198" WEIGHT="20.64066773746331" />
<DICH_DATA CI_END="2.491405028789388" CI_START="0.47905947690881984" EFFECT_SIZE="1.0924885307681027" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="12" LOG_CI_END="0.3964443367172593" LOG_CI_START="-0.3196105640598382" LOG_EFFECT_SIZE="0.0384168863287106" ORDER="133" O_E="0.5" SE="0.4206141932453913" STUDY_ID="STD-Emery-2008" TOTAL_1="126" TOTAL_2="126" VAR="5.652390438247012" WEIGHT="10.669888891236194" />
<DICH_DATA CI_END="2.955903343189299" CI_START="0.3439456502027573" EFFECT_SIZE="1.008300598685604" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.4706902287059268" LOG_CI_START="-0.46351017859666016" LOG_EFFECT_SIZE="0.003590025054633284" ORDER="109" O_E="0.027450980392156765" SE="0.5487539436161365" STUDY_ID="STD-Essex-2012b" TOTAL_1="127" TOTAL_2="128" VAR="3.32081507112649" WEIGHT="6.268627092266312" />
<DICH_DATA CI_END="1.1365888783635527" CI_START="0.11240326705818857" EFFECT_SIZE="0.3574301375514737" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" LOG_CI_END="0.055603402114333525" LOG_CI_START="-0.9492210655932644" LOG_EFFECT_SIZE="-0.44680883173946545" ORDER="110" O_E="-2.953125" SE="0.5902388662927772" STUDY_ID="STD-Essex-2014" TOTAL_1="127" TOTAL_2="129" VAR="2.870413028492647" WEIGHT="5.41841339882242" />
<DICH_DATA CI_END="1.6164314316881754" CI_START="0.5246492322185728" EFFECT_SIZE="0.9209014657221313" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="29" LOG_CI_END="0.20855728675700724" LOG_CI_START="-0.2801309583555879" LOG_EFFECT_SIZE="-0.0357868357992903" ORDER="111" O_E="-1.0" SE="0.2870578942249655" STUDY_ID="STD-Kivitz-2001" TOTAL_1="207" TOTAL_2="207" VAR="12.135593220338983" WEIGHT="22.908083350734312" />
<DICH_DATA CI_END="1.2174522535783483" CI_START="0.30987337174088725" EFFECT_SIZE="0.6142117181801927" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="22" LOG_CI_END="0.08545193792440152" LOG_CI_START="-0.5088157422598" LOG_EFFECT_SIZE="-0.2116819021676992" ORDER="127" O_E="-4.0" SE="0.34907577701265957" STUDY_ID="STD-McKenna-2001b" TOTAL_1="199" TOTAL_2="199" VAR="8.206549118387908" WEIGHT="15.491316148505025" />
<DICH_DATA CI_END="1.5148516373143117" CI_START="0.22397635226533774" EFFECT_SIZE="0.5824868616104864" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="0.18037010065953807" LOG_CI_START="-0.6497978326605647" LOG_EFFECT_SIZE="-0.23471386600051333" ORDER="112" O_E="-2.2727272727272734" SE="0.48764475342977376" STUDY_ID="STD-Sowers-2005" TOTAL_1="136" TOTAL_2="128" VAR="4.2052603462904194" WEIGHT="7.938174325331239" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.895106614207021" CI_END="1.2770017905910191" CI_START="0.6568866867550814" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.9158850775078939" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="82" I2="32.147113499862314" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.10619150622445973" LOG_CI_START="-0.18250953997026131" LOG_EFFECT_SIZE="-0.03815901687290079" METHOD="PETO" NO="4" P_CHI2="0.20712001695997706" P_Q="1.0" P_Z="0.6043774211305166" Q="0.0" RANDOM="NO" SCALE="976.5796536339299" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1204" TOTAL_2="1200" WEIGHT="100.0" Z="0.5181158831402207">
<NAME>Number experiencing any serious adverse events</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>tNSAIDs</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors tNSAIDs</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3014568549118712" CI_START="0.6197747640355231" EFFECT_SIZE="0.8981147561171785" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="68" LOG_CI_END="0.11442977522337058" LOG_CI_START="-0.20776611132236658" LOG_EFFECT_SIZE="-0.046668168049498" ORDER="2522" O_E="-3.0" SE="0.18925945865232655" STUDY_ID="STD-Dahlberg-2009" TOTAL_1="458" TOTAL_2="458" VAR="27.918032786885245" WEIGHT="80.28912636643405" />
<DICH_DATA CI_END="19.35282527145773" CI_START="0.5643221858014535" EFFECT_SIZE="3.304728227649383" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.2867443755686907" LOG_CI_START="-0.24847287551102107" LOG_EFFECT_SIZE="0.5191357500288348" ORDER="134" O_E="1.4698795180722892" SE="0.9017942127321779" STUDY_ID="STD-Emery-2008" TOTAL_1="126" TOTAL_2="123" VAR="1.2296601875828226" WEIGHT="3.5363645763389457" />
<DICH_DATA CI_END="2.938621894121037" CI_START="0.42738785080784336" EFFECT_SIZE="1.1206834056348223" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.4681437099717019" LOG_CI_START="-0.3691778275208183" LOG_EFFECT_SIZE="0.04948294122544176" ORDER="135" O_E="0.4709897610921505" SE="0.49184681593156354" STUDY_ID="STD-Essex-2012a" TOTAL_1="294" TOTAL_2="292" VAR="4.133712532230861" WEIGHT="11.888092918162382" />
<DICH_DATA CI_END="16.202665111980412" CI_START="0.06269790631499123" EFFECT_SIZE="1.0079053424028093" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2095864557913898" LOG_CI_START="-1.2027469614185309" LOG_EFFECT_SIZE="0.003419747186429325" ORDER="113" O_E="0.0039215686274509665" SE="1.4170165905121086" STUDY_ID="STD-Essex-2012b" TOTAL_1="127" TOTAL_2="128" VAR="0.49802383698577474" WEIGHT="1.4322606140082679" />
<DICH_DATA CI_END="0.9533084170540844" CI_START="0.018636373327002676" EFFECT_SIZE="0.13328995294467577" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="-0.020766572440967464" LOG_CI_START="-1.729638598275692" LOG_EFFECT_SIZE="-0.8752025853583297" ORDER="128" O_E="-2.0" SE="1.003799887028271" STUDY_ID="STD-McKenna-2001b" TOTAL_1="199" TOTAL_2="199" VAR="0.9924433249370277" WEIGHT="2.8541555250563544" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.842364195622825" CI_END="2.4312887366942735" CI_START="0.1514049573508451" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.6067200074884513" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" I2="38.04679122004495" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="0.38583653815504837" LOG_CI_START="-0.8198599047905683" LOG_EFFECT_SIZE="-0.21701168331776" METHOD="PETO" NO="5" P_CHI2="0.1837107946540384" P_Q="1.0" P_Z="0.4804726546160084" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="877" TOTAL_2="878" WEIGHT="100.0" Z="0.7055425700487137">
<NAME>Number experiencing gastro-intestinal events (perforation, ulcer, bleeds)</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>tNSAIDs</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors tNSAIDs</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.972693403334655" CI_START="0.05318770834145358" EFFECT_SIZE="0.5142821855830063" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6965916831725634" LOG_CI_START="-1.2741887213940597" LOG_EFFECT_SIZE="-0.2887985191107482" ORDER="114" O_E="-0.4962025316455696" SE="1.157646165162772" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="198" VAR="0.7461881108796667" WEIGHT="37.42824713565291" />
<DICH_DATA CI_END="2.162219751032808" CI_START="0.008433767220724125" EFFECT_SIZE="0.1350394685277707" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.3348998301404462" LOG_CI_START="-2.073978390059376" LOG_EFFECT_SIZE="-0.8695392799594648" ORDER="2523" O_E="-1.0" SE="1.4149869906848755" STUDY_ID="STD-Dahlberg-2009" TOTAL_1="458" TOTAL_2="458" VAR="0.4994535519125683" WEIGHT="25.05222302687944" />
<DICH_DATA CI_END="119.74275476340345" CI_START="0.46331610232621256" EFFECT_SIZE="7.448405629313134" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0782492451641277" LOG_CI_START="-0.33412260584066794" LOG_EFFECT_SIZE="0.8720633196617297" ORDER="135" O_E="1.0" SE="1.417039166713468" STUDY_ID="STD-Emery-2008" TOTAL_1="126" TOTAL_2="126" VAR="0.49800796812749004" WEIGHT="24.97971360683599" />
<DICH_DATA CI_END="6.820467167072353" CI_START="0.0026853936013588454" EFFECT_SIZE="0.1353352832366127" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8338141226232082" LOG_CI_START="-2.570992050236215" LOG_EFFECT_SIZE="-0.8685889638065036" ORDER="115" O_E="-0.5" SE="2.0" STUDY_ID="STD-Essex-2014" TOTAL_1="96" TOTAL_2="96" VAR="0.25" WEIGHT="12.539816230631667" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.253092833755319" CI_START="0.1736671466016267" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.4664987211828483" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="11" I2="0.0" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="0.0979832463287145" LOG_CI_START="-0.7602823312311736" LOG_EFFECT_SIZE="-0.3311495424512296" METHOD="PETO" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.1304198437259062" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="458" TOTAL_2="458" WEIGHT="100.0" Z="1.5124483462254175">
<NAME>Number experiencing cardiovascular events (myocardial infarction, stroke)</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>tNSAIDs</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors tNSAIDs</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.253092833755319" CI_START="0.1736671466016267" EFFECT_SIZE="0.4664987211828483" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="11" LOG_CI_END="0.0979832463287145" LOG_CI_START="-0.7602823312311736" LOG_EFFECT_SIZE="-0.3311495424512296" ORDER="2524" O_E="-3.0" SE="0.5041494487418058" STUDY_ID="STD-Dahlberg-2009" TOTAL_1="458" TOTAL_2="458" VAR="3.9344262295081966" WEIGHT="100.0" />
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>Celecoxib versus placebo (all eligible studies)</NAME>
<CONT_OUTCOME CHI2="163.2694002027614" CI_END="-0.32140112307134083" CI_START="-0.49273562971732554" CI_STUDY="95" CI_TOTAL="95" DF="30" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4070683763943332" ESTIMABLE="YES" I2="81.62546076439092" I2_Q="0.0" ID="CMP-003.01" NO="1" P_CHI2="1.1102230246251565E-16" P_Q="1.0" P_Z="1.239956254994947E-20" Q="0.0" RANDOM="YES" SCALE="8.709321604678811" SORT_BY="STUDY" STUDIES="31" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0465341692844332" TOTALS="YES" TOTAL_1="7609" TOTAL_2="5460" UNITS="" WEIGHT="100.00000000000001" Z="9.313236108667844">
<NAME>All pain &lt; 24 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.23724505128833562" CI_START="-0.6498600956166899" EFFECT_SIZE="-0.44355257345251276" ESTIMABLE="YES" MEAN_1="-27.3" MEAN_2="-14.9" ORDER="233" SD_1="28.6402" SD_2="27.1293" SE="0.10526087407294447" STUDY_ID="STD-Asmus-2014-Study-1" TOTAL_1="186" TOTAL_2="184" WEIGHT="3.315929722508564" />
<CONT_DATA CI_END="0.0814168256867246" CI_START="-0.3212133370556036" EFFECT_SIZE="-0.1198982556844395" ESTIMABLE="YES" MEAN_1="-28.0" MEAN_2="-24.6" ORDER="234" SD_1="29.2496" SD_2="27.2764" SE="0.10271366359744963" STUDY_ID="STD-Asmus-2014-Study-2" TOTAL_1="194" TOTAL_2="186" WEIGHT="3.346702301575368" />
<CONT_DATA CI_END="-0.6141219750770044" CI_START="-1.022387742358631" EFFECT_SIZE="-0.8182548587178177" ESTIMABLE="YES" MEAN_1="-27.5" MEAN_2="-17.4" ORDER="137" SD_1="9.9499" SD_2="14.2478" SE="0.10415134423437748" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="203" WEIGHT="3.3293565411856054" />
<CONT_DATA CI_END="-0.1887330394167836" CI_START="-0.704893998192669" EFFECT_SIZE="-0.4468135188047263" ESTIMABLE="YES" MEAN_1="-24.9" MEAN_2="-15.4" ORDER="1486" SD_1="20.7846" SD_2="22.1269" SE="0.13167613355329413" STUDY_ID="STD-Bingham-2007-Study-1" TOTAL_1="192" TOTAL_2="85" WEIGHT="2.9910090646451253" />
<CONT_DATA CI_END="-0.22051474421166134" CI_START="-0.803585737947824" EFFECT_SIZE="-0.5120502410797426" ESTIMABLE="YES" MEAN_1="-27.8" MEAN_2="-16.2" ORDER="1487" SD_1="23.4509" SD_2="19.3649" SE="0.14874533367331036" STUDY_ID="STD-Bingham-2007-Study-2" TOTAL_1="202" TOTAL_2="60" WEIGHT="2.7824915645037813" />
<CONT_DATA CI_END="0.13149834952478867" CI_START="-0.41212291187105665" EFFECT_SIZE="-0.140312281173134" ESTIMABLE="YES" MEAN_1="-28.9" MEAN_2="-21.0" ORDER="138" SD_1="57.6" SD_2="53.0" SE="0.1386814415172576" STUDY_ID="STD-Birbara-2006-Study-1" TOTAL_1="157" TOTAL_2="78" WEIGHT="2.9048745169872694" />
<CONT_DATA CI_END="0.11637193621892347" CI_START="-0.405488854782043" EFFECT_SIZE="-0.14455845928155978" ESTIMABLE="YES" MEAN_1="-31.6" MEAN_2="-23.1" ORDER="139" SD_1="59.8" SD_2="56.2" SE="0.13313019910501872" STUDY_ID="STD-Birbara-2006-Study-2" TOTAL_1="169" TOTAL_2="85" WEIGHT="2.973086337242153" />
<CONT_DATA CI_END="0.13743012385210446" CI_START="-0.3965972841810806" EFFECT_SIZE="-0.12958358016448807" ESTIMABLE="YES" MEAN_1="-19.6" MEAN_2="-16.9" ORDER="140" SD_1="19.8" SD_2="21.7" SE="0.136233984972562" STUDY_ID="STD-Boswell-2008-Study-A" TOTAL_1="109" TOTAL_2="107" WEIGHT="2.934900787855151" />
<CONT_DATA CI_END="-0.01540778372366397" CI_START="-0.42367168206258815" EFFECT_SIZE="-0.21953973289312606" ESTIMABLE="YES" MEAN_1="-28.0" MEAN_2="-21.7" ORDER="141" SD_1="27.2" SD_2="30.0" SE="0.10415086745451899" STUDY_ID="STD-Boswell-2008-Study-B" TOTAL_1="185" TOTAL_2="186" WEIGHT="3.3293623035357256" />
<CONT_DATA CI_END="-0.1120223553796936" CI_START="-0.4795993045106719" EFFECT_SIZE="-0.29581082994518276" ESTIMABLE="YES" MEAN_1="-1.9" MEAN_2="-1.42" ORDER="143" SD_1="1.62" SD_2="1.62" SE="0.09377135295096706" STUDY_ID="STD-Conaghan-2013" TOTAL_1="233" TOTAL_2="227" WEIGHT="3.452983709503216" />
<CONT_DATA CI_END="-0.12505004895247082" CI_START="-0.5186193678514103" EFFECT_SIZE="-0.32183470840194056" ESTIMABLE="YES" MEAN_1="-33.4" MEAN_2="-23.8" ORDER="632" SD_1="29.8466" SD_2="29.6985" SE="0.10040218136745471" STUDY_ID="STD-DeLemos-2011" TOTAL_1="202" TOTAL_2="200" WEIGHT="3.3744560545571582" />
<CONT_DATA CI_END="0.2298339290750902" CI_START="-0.46907386821270886" EFFECT_SIZE="-0.11961996956880934" ESTIMABLE="YES" MEAN_1="-36.2" MEAN_2="-33.5" ORDER="162" SD_1="19.0919" SD_2="28.4858" SE="0.1782960816629016" STUDY_ID="STD-Essex-2012b" TOTAL_1="100" TOTAL_2="46" WEIGHT="2.4391612877905513" />
<CONT_DATA CI_END="-0.17525013979278525" CI_START="-0.8841185310237993" EFFECT_SIZE="-0.5296843354082923" ESTIMABLE="YES" MEAN_1="-39.7" MEAN_2="-28.6" ORDER="163" SD_1="18.7061" SD_2="24.6804" SE="0.18083709619729685" STUDY_ID="STD-Essex-2014" TOTAL_1="96" TOTAL_2="47" WEIGHT="2.4110694972379925" />
<CONT_DATA CI_END="-0.06412829045128926" CI_START="-0.38303080135151146" EFFECT_SIZE="-0.22357954590140036" ESTIMABLE="YES" MEAN_1="-27.4" MEAN_2="-21.3" ORDER="144" SD_1="27.72" SD_2="26.33" SE="0.08135417625417725" STUDY_ID="STD-Fleischmann-2005" TOTAL_1="444" TOTAL_2="231" WEIGHT="3.5942510456027223" />
<CONT_DATA CI_END="-0.5831008777063086" CI_START="-1.0993546806964676" EFFECT_SIZE="-0.841227779201388" ESTIMABLE="YES" MEAN_1="-33.9" MEAN_2="-20.7" ORDER="145" SD_1="15.4" SD_2="16.1" SE="0.13169981873705408" STUDY_ID="STD-Gibofsky-2003" TOTAL_1="178" TOTAL_2="96" WEIGHT="2.9907169775165072" />
<CONT_DATA CI_END="-0.01635664412780205" CI_START="-0.45060309133222487" EFFECT_SIZE="-0.23347986773001345" ESTIMABLE="YES" MEAN_1="-41.8" MEAN_2="-35.6" ORDER="146" SD_1="26.5" SD_2="26.5" SE="0.11077919049270889" STUDY_ID="STD-Hochberg-2011-Study-307" TOTAL_1="242" TOTAL_2="124" WEIGHT="3.248705914381276" />
<CONT_DATA CI_END="0.04821607908813469" CI_START="-0.38713846772847704" EFFECT_SIZE="-0.16946119432017118" ESTIMABLE="YES" MEAN_1="-42.9" MEAN_2="-38.4" ORDER="147" SD_1="26.5" SD_2="26.5" SE="0.11106187415958478" STUDY_ID="STD-Hochberg-2011-Study-309" TOTAL_1="244" TOTAL_2="122" WEIGHT="3.2452451895621683" />
<CONT_DATA CI_END="-0.8076599295717815" CI_START="-1.2122554108124524" EFFECT_SIZE="-1.009957670192117" ESTIMABLE="YES" MEAN_1="-23.3" MEAN_2="-11.1" ORDER="148" SD_1="9.5" SD_2="14.0712" SE="0.10321502956994835" STUDY_ID="STD-Kivitz-2001" TOTAL_1="207" TOTAL_2="217" WEIGHT="3.340660205851248" />
<CONT_DATA CI_END="-0.0828554020431424" CI_START="-0.35352289803719894" EFFECT_SIZE="-0.21818915004017067" ESTIMABLE="YES" MEAN_1="-26.6" MEAN_2="-21.4" ORDER="149" SD_1="23.65" SD_2="23.97" SE="0.06904909940413374" STUDY_ID="STD-Lehmann-2005" TOTAL_1="420" TOTAL_2="424" WEIGHT="3.723914080322556" />
<CONT_DATA CI_END="-0.4970785503448537" CI_START="-1.2377204706382186" EFFECT_SIZE="-0.8673995104915361" ESTIMABLE="YES" MEAN_1="-38.2" MEAN_2="-25.04" ORDER="150" SD_1="16.2" SD_2="13.8" SE="0.1889427372480958" STUDY_ID="STD-McKenna-2001a" TOTAL_1="63" TOTAL_2="60" WEIGHT="2.323189223709052" />
<CONT_DATA CI_END="-0.22146897331130824" CI_START="-0.6182977241945015" EFFECT_SIZE="-0.41988334875290484" ESTIMABLE="YES" MEAN_1="-34.9" MEAN_2="-23.1" ORDER="151" SD_1="28.1" SD_2="28.0" SE="0.10123368439760315" STUDY_ID="STD-McKenna-2001b" TOTAL_1="199" TOTAL_2="200" WEIGHT="3.364492336329541" />
<CONT_DATA CI_END="-0.12301126753520539" CI_START="-0.5433368824240588" EFFECT_SIZE="-0.3331740749796321" ESTIMABLE="YES" MEAN_1="-19.0" MEAN_2="-10.5" ORDER="152" SD_1="25.7" SD_2="25.2" SE="0.10722789250321134" STUDY_ID="STD-Pincus-2004-PACES_x002d_a" TOTAL_1="181" TOTAL_2="172" WEIGHT="3.2920470866311393" />
<CONT_DATA CI_END="-0.3246456314865879" CI_START="-0.7389496747483488" EFFECT_SIZE="-0.5317976531174684" ESTIMABLE="YES" MEAN_1="-21.8" MEAN_2="-7.6" ORDER="153" SD_1="26.5" SD_2="26.8" SE="0.1056917490652222" STUDY_ID="STD-Pincus-2004-PACES_x002d_b" TOTAL_1="189" TOTAL_2="182" WEIGHT="3.3107066178293625" />
<CONT_DATA CI_END="-0.1323627211608479" CI_START="-0.6239995278332567" EFFECT_SIZE="-0.3781811244970523" ESTIMABLE="YES" MEAN_1="-20.7" MEAN_2="-12.4" ORDER="154" SD_1="22.7" SD_2="21.0" SE="0.12541985734186373" STUDY_ID="STD-Rother-2007" TOTAL_1="132" TOTAL_2="127" WEIGHT="3.0682753029084022" />
<CONT_DATA CI_END="-0.20603426793008386" CI_START="-0.4793388364346728" EFFECT_SIZE="-0.3426865521823783" ESTIMABLE="YES" MEAN_1="-33.4" MEAN_2="-24.3" ORDER="637" SD_1="27.0" SD_2="26.05" SE="0.0697218343450136" STUDY_ID="STD-Schnitzer-2011" TOTAL_1="419" TOTAL_2="416" WEIGHT="3.7171498449230493" />
<CONT_DATA CI_END="-0.08956200099247574" CI_START="-0.37214746228928564" EFFECT_SIZE="-0.2308547316408807" ESTIMABLE="YES" MEAN_1="-24.1" MEAN_2="-18.1" ORDER="155" SD_1="26.4" SD_2="25.51" SE="0.07208945254244668" STUDY_ID="STD-Sheldon-2005" TOTAL_1="393" TOTAL_2="382" WEIGHT="3.693024075569953" />
<CONT_DATA CI_END="-0.42474182812081374" CI_START="-0.8049410384451858" EFFECT_SIZE="-0.6148414332829998" ESTIMABLE="YES" MEAN_1="-30.5" MEAN_2="-17.6" ORDER="156" SD_1="21.1" SD_2="20.5" SE="0.09699137670981073" STUDY_ID="STD-Smugar-2006-Study-1" TOTAL_1="447" TOTAL_2="146" WEIGHT="3.415068535434616" />
<CONT_DATA CI_END="-0.41651601953984574" CI_START="-0.7914126355237961" EFFECT_SIZE="-0.6039643275318209" ESTIMABLE="YES" MEAN_1="-28.1" MEAN_2="-16.2" ORDER="157" SD_1="19.3" SD_2="20.8" SE="0.0956386492152629" STUDY_ID="STD-Smugar-2006-Study-2" TOTAL_1="459" TOTAL_2="150" WEIGHT="3.4310503952803115" />
<CONT_DATA CI_END="-0.059598455804291045" CI_START="-0.3689029572997333" EFFECT_SIZE="-0.2142507065520122" ESTIMABLE="YES" MEAN_1="-25.2" MEAN_2="-19.8" ORDER="158" SD_1="24.7" SD_2="26.1" SE="0.0789056594751732" STUDY_ID="STD-Tannenbaum-2004" TOTAL_1="481" TOTAL_2="243" WEIGHT="3.6209829042795745" />
<CONT_DATA CI_END="-0.666381408044034" CI_START="-0.9953771818386334" EFFECT_SIZE="-0.8308792949413337" ESTIMABLE="YES" MEAN_1="-26.4" MEAN_2="-13.0" ORDER="159" SD_1="16.6" SD_2="15.1" SE="0.08392903553067202" STUDY_ID="STD-Williams-2000" TOTAL_1="453" TOTAL_2="231" WEIGHT="3.5657013089312932" />
<CONT_DATA CI_END="-0.23044696636119347" CI_START="-0.5924987996364867" EFFECT_SIZE="-0.41147288299884005" ESTIMABLE="YES" MEAN_1="-24.2" MEAN_2="-17.4" ORDER="160" SD_1="16.5" SD_2="16.5" SE="0.09236185872064788" STUDY_ID="STD-Williams-2001" TOTAL_1="236" TOTAL_2="243" WEIGHT="3.469435265809575" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="48.62280011898938" CI_END="-0.34028034850479333" CI_START="-0.6433221916049929" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4918012700548931" ESTIMABLE="YES" I2="79.43351683669376" I2_Q="0.0" ID="CMP-003.02" NO="2" P_CHI2="4.775497505216109E-7" P_Q="1.0" P_Z="1.9968617175881613E-10" Q="0.0" RANDOM="YES" SCALE="10.363659041664906" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.05008612323084895" TOTALS="YES" TOTAL_1="2075" TOTAL_2="1647" UNITS="" WEIGHT="100.0" Z="6.361582064031559">
<NAME>Pain VAS at 6 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.23724505128833562" CI_START="-0.6498600956166899" EFFECT_SIZE="-0.44355257345251276" ESTIMABLE="YES" MEAN_1="-27.3" MEAN_2="-14.9" ORDER="235" SD_1="28.6402" SD_2="27.1293" SE="0.10526087407294447" STUDY_ID="STD-Asmus-2014-Study-1" TOTAL_1="186" TOTAL_2="184" WEIGHT="9.771002452599095" />
<CONT_DATA CI_END="0.0814168256867246" CI_START="-0.3212133370556036" EFFECT_SIZE="-0.1198982556844395" ESTIMABLE="YES" MEAN_1="-28.0" MEAN_2="-24.6" ORDER="236" SD_1="29.2496" SD_2="27.2764" SE="0.10271366359744963" STUDY_ID="STD-Asmus-2014-Study-2" TOTAL_1="194" TOTAL_2="186" WEIGHT="9.8563678767476" />
<CONT_DATA CI_END="0.2298339290750902" CI_START="-0.46907386821270886" EFFECT_SIZE="-0.11961996956880934" ESTIMABLE="YES" MEAN_1="-36.2" MEAN_2="-33.5" ORDER="4" SD_1="19.0919" SD_2="28.4858" SE="0.1782960816629016" STUDY_ID="STD-Essex-2012b" TOTAL_1="100" TOTAL_2="46" WEIGHT="7.299522368550977" />
<CONT_DATA CI_END="-0.17525013979278525" CI_START="-0.8841185310237993" EFFECT_SIZE="-0.5296843354082923" ESTIMABLE="YES" MEAN_1="-39.7" MEAN_2="-28.6" ORDER="5" SD_1="18.7061" SD_2="24.6804" SE="0.18083709619729685" STUDY_ID="STD-Essex-2014" TOTAL_1="96" TOTAL_2="47" WEIGHT="7.219060744618795" />
<CONT_DATA CI_END="-0.5831008777063086" CI_START="-1.0993546806964676" EFFECT_SIZE="-0.841227779201388" ESTIMABLE="YES" MEAN_1="-33.9" MEAN_2="-20.7" ORDER="6" SD_1="15.4" SD_2="16.1" SE="0.13169981873705408" STUDY_ID="STD-Gibofsky-2003" TOTAL_1="178" TOTAL_2="96" WEIGHT="8.86318156475949" />
<CONT_DATA CI_END="-0.4970785503448537" CI_START="-1.2377204706382186" EFFECT_SIZE="-0.8673995104915361" ESTIMABLE="YES" MEAN_1="-38.2" MEAN_2="-25.04" ORDER="7" SD_1="16.2" SD_2="13.8" SE="0.1889427372480958" STUDY_ID="STD-McKenna-2001a" TOTAL_1="63" TOTAL_2="60" WEIGHT="6.966830306286238" />
<CONT_DATA CI_END="-0.22146897331130824" CI_START="-0.6182977241945015" EFFECT_SIZE="-0.41988334875290484" ESTIMABLE="YES" MEAN_1="-34.9" MEAN_2="-23.1" ORDER="8" SD_1="28.1" SD_2="28.0" SE="0.10123368439760315" STUDY_ID="STD-McKenna-2001b" TOTAL_1="199" TOTAL_2="200" WEIGHT="9.905676821618053" />
<CONT_DATA CI_END="-0.12301126753520539" CI_START="-0.5433368824240588" EFFECT_SIZE="-0.3331740749796321" ESTIMABLE="YES" MEAN_1="-19.0" MEAN_2="-10.5" ORDER="9" SD_1="25.7" SD_2="25.2" SE="0.10722789250321134" STUDY_ID="STD-Pincus-2004-PACES_x002d_a" TOTAL_1="181" TOTAL_2="172" WEIGHT="9.7046868031678" />
<CONT_DATA CI_END="-0.3246456314865879" CI_START="-0.7389496747483488" EFFECT_SIZE="-0.5317976531174684" ESTIMABLE="YES" MEAN_1="-21.8" MEAN_2="-7.6" ORDER="10" SD_1="26.5" SD_2="26.8" SE="0.1056917490652222" STUDY_ID="STD-Pincus-2004-PACES_x002d_b" TOTAL_1="189" TOTAL_2="182" WEIGHT="9.756504036971942" />
<CONT_DATA CI_END="-0.666381408044034" CI_START="-0.9953771818386334" EFFECT_SIZE="-0.8308792949413337" ESTIMABLE="YES" MEAN_1="-26.4" MEAN_2="-13.0" ORDER="11" SD_1="16.6" SD_2="15.1" SE="0.08392903553067202" STUDY_ID="STD-Williams-2000" TOTAL_1="453" TOTAL_2="231" WEIGHT="10.461241601736985" />
<CONT_DATA CI_END="-0.23044696636119347" CI_START="-0.5924987996364867" EFFECT_SIZE="-0.41147288299884005" ESTIMABLE="YES" MEAN_1="-24.2" MEAN_2="-17.4" ORDER="12" SD_1="16.5" SD_2="16.5" SE="0.09236185872064788" STUDY_ID="STD-Williams-2001" TOTAL_1="236" TOTAL_2="243" WEIGHT="10.195925422943025" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.8177249937944215" CI_END="-9.49748339127401" CI_START="-12.6764173984444" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-11.086950394859205" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.03" NO="3" P_CHI2="0.4029824036253793" P_Q="1.0" P_Z="1.5075296041968712E-42" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="606" TOTAL_2="620" UNITS="" WEIGHT="100.0" Z="13.671264281228884">
<NAME>Pain VAS at 12 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-7.6975128765143115" CI_START="-12.502487123485691" EFFECT_SIZE="-10.100000000000001" ESTIMABLE="YES" MEAN_1="-27.5" MEAN_2="-17.4" ORDER="13" SD_1="9.9499" SD_2="14.2478" SE="1.2257812604906015" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="203" WEIGHT="43.77043834466554" />
<CONT_DATA CI_END="-3.7792032143423633" CI_START="-15.420796785657632" EFFECT_SIZE="-9.599999999999998" ESTIMABLE="YES" MEAN_1="-33.4" MEAN_2="-23.8" ORDER="633" SD_1="29.8466" SD_2="29.6985" SE="2.9698488500662954" STUDY_ID="STD-DeLemos-2011" TOTAL_1="202" TOTAL_2="200" WEIGHT="7.456553842416222" />
<CONT_DATA CI_END="-9.924055082469424" CI_START="-14.475944917530578" EFFECT_SIZE="-12.200000000000001" ESTIMABLE="YES" MEAN_1="-23.3" MEAN_2="-11.1" ORDER="237" SD_1="9.5" SD_2="14.0712" SE="1.1612177241433719" STUDY_ID="STD-Kivitz-2001" TOTAL_1="207" TOTAL_2="217" WEIGHT="48.77300781291824" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.0056334225616173" CI_END="-4.7020328217715255" CI_START="-7.99927713993907" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-6.350654980855298" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.04" NO="4" P_CHI2="0.5568831731142629" P_Q="1.0" P_Z="4.353439178445058E-14" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="2157" TOTAL_2="1696" UNITS="" WEIGHT="100.0" Z="7.549974366251261">
<NAME>Pain VAS at 13 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-1.8365529621526466" CI_START="-10.363447037847349" EFFECT_SIZE="-6.099999999999998" ESTIMABLE="YES" MEAN_1="-27.4" MEAN_2="-21.3" ORDER="14" SD_1="27.72" SD_2="26.33" SE="2.175268051595273" STUDY_ID="STD-Fleischmann-2005" TOTAL_1="444" TOTAL_2="231" WEIGHT="14.952731020484693" />
<CONT_DATA CI_END="-1.9873226565395892" CI_START="-8.412677343460416" EFFECT_SIZE="-5.200000000000003" ESTIMABLE="YES" MEAN_1="-26.6" MEAN_2="-21.4" ORDER="15" SD_1="23.65" SD_2="23.97" SE="1.6391512133904513" STUDY_ID="STD-Lehmann-2005" TOTAL_1="420" TOTAL_2="424" WEIGHT="26.333467221080316" />
<CONT_DATA CI_END="-5.501390401087313" CI_START="-12.698609598912682" EFFECT_SIZE="-9.099999999999998" ESTIMABLE="YES" MEAN_1="-33.4" MEAN_2="-24.3" ORDER="638" SD_1="27.0" SD_2="26.05" SE="1.8360590435834827" STUDY_ID="STD-Schnitzer-2011" TOTAL_1="419" TOTAL_2="416" WEIGHT="20.98808419169003" />
<CONT_DATA CI_END="-2.3453132333628703" CI_START="-9.65468676663713" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-24.1" MEAN_2="-18.1" ORDER="16" SD_1="26.4" SD_2="25.51" SE="1.8646703691827158" STUDY_ID="STD-Sheldon-2005" TOTAL_1="393" TOTAL_2="382" WEIGHT="20.348947176922564" />
<CONT_DATA CI_END="-1.4450900300666079" CI_START="-9.35490996993339" EFFECT_SIZE="-5.399999999999999" ESTIMABLE="YES" MEAN_1="-25.2" MEAN_2="-19.8" ORDER="44" SD_1="24.7" SD_2="26.1" SE="2.0178482875854944" STUDY_ID="STD-Tannenbaum-2004" TOTAL_1="481" TOTAL_2="243" WEIGHT="17.376770389822394" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.14911917110905332" CI_END="-10.010153081741134" CI_START="-14.826200745118467" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-12.4181769134298" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.05" NO="5" P_CHI2="0.9853521651839262" P_Q="1.0" P_Z="5.115638035766916E-24" Q="0.0" RANDOM="YES" SCALE="116.87695188435023" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1120" TOTAL_2="452" UNITS="" WEIGHT="100.0" Z="10.107532651328016">
<NAME>Pain on walking VAS at 6 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-5.714398726856107" CI_START="-18.885601273143894" EFFECT_SIZE="-12.3" ESTIMABLE="YES" MEAN_1="-31.5" MEAN_2="-19.2" ORDER="222" SD_1="27.4955" SD_2="26.4545" SE="3.360062391498148" STUDY_ID="STD-Gibofsky-2003" TOTAL_1="189" TOTAL_2="96" WEIGHT="13.369978104650565" />
<CONT_DATA CI_END="-3.783944503500102" CI_START="-22.216055496499898" EFFECT_SIZE="-13.0" ESTIMABLE="YES" MEAN_1="-38.0" MEAN_2="-25.0" ORDER="245" SD_1="19.3" SD_2="20.8" SE="4.7021555340786705" STUDY_ID="STD-McKenna-2001a" TOTAL_1="25" TOTAL_2="60" WEIGHT="6.8270235171878255" />
<CONT_DATA CI_END="-9.042095699986255" CI_START="-16.75790430001374" EFFECT_SIZE="-12.899999999999999" ESTIMABLE="YES" MEAN_1="-30.5" MEAN_2="-17.6" ORDER="17" SD_1="21.1" SD_2="20.5" SE="1.9683546893944994" STUDY_ID="STD-Smugar-2006-Study-1" TOTAL_1="447" TOTAL_2="146" WEIGHT="38.95997423221314" />
<CONT_DATA CI_END="-8.132078596016859" CI_START="-15.667921403983145" EFFECT_SIZE="-11.900000000000002" ESTIMABLE="YES" MEAN_1="-28.1" MEAN_2="-16.2" ORDER="18" SD_1="19.3" SD_2="20.8" SE="1.9224442049466346" STUDY_ID="STD-Smugar-2006-Study-2" TOTAL_1="459" TOTAL_2="150" WEIGHT="40.84302414594847" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="12.266441237367063" CI_START="1.7335587626329367" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="7.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.06" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.009184022968303503" Q="0.0" RANDOM="YES" SCALE="32.16" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="202" TOTAL_2="200" UNITS="" WEIGHT="100.0" Z="2.6051269298201674">
<NAME>Pain on walking WOMAC at 12 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="12.266441237367063" CI_START="1.7335587626329367" EFFECT_SIZE="7.0" ESTIMABLE="YES" MEAN_1="25.9" MEAN_2="18.9" ORDER="642" SD_1="27.0041" SD_2="26.8701" SE="2.687009189407601" STUDY_ID="STD-DeLemos-2011" TOTAL_1="202" TOTAL_2="200" WEIGHT="100.0" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="91.72382228324369" CI_END="-2.061467723443349" CI_START="-4.506182230565912" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.2838249770046306" ESTIMABLE="YES" I2="88.00747752744981" I2_Q="0.0" ID="CMP-003.07" NO="7" P_CHI2="7.66053886991358E-15" P_Q="1.0" P_Z="1.398976519722317E-7" Q="0.0" RANDOM="YES" SCALE="73.9476139538068" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="2.6994213978403225" TOTALS="YES" TOTAL_1="2583" TOTAL_2="1595" UNITS="" WEIGHT="100.0" Z="5.26538265937445">
<NAME>Pain WOMAC at 6 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="6.9162193443542765" CI_START="-22.716219344354272" EFFECT_SIZE="-7.899999999999999" ESTIMABLE="YES" MEAN_1="-28.9" MEAN_2="-21.0" ORDER="36" SD_1="57.6" SD_2="53.0" SE="7.5594344902369235" STUDY_ID="STD-Birbara-2006-Study-1" TOTAL_1="157" TOTAL_2="78" WEIGHT="0.6499442292735781" />
<CONT_DATA CI_END="6.467519749162582" CI_START="-23.467519749162584" EFFECT_SIZE="-8.5" ESTIMABLE="YES" MEAN_1="-31.6" MEAN_2="-23.1" ORDER="37" SD_1="59.8" SD_2="56.2" SE="7.6366299928082695" STUDY_ID="STD-Birbara-2006-Study-2" TOTAL_1="169" TOTAL_2="85" WEIGHT="0.6374489913181012" />
<CONT_DATA CI_END="2.8427623358944185" CI_START="-8.242762335894424" EFFECT_SIZE="-2.700000000000003" ESTIMABLE="YES" MEAN_1="-19.6" MEAN_2="-16.9" ORDER="38" SD_1="19.8" SD_2="21.7" SE="2.8279919323084624" STUDY_ID="STD-Boswell-2008-Study-A" TOTAL_1="109" TOTAL_2="107" WEIGHT="3.636133028818452" />
<CONT_DATA CI_END="1.2103135865985735" CI_START="-1.6103135865985738" EFFECT_SIZE="-0.20000000000000018" ESTIMABLE="YES" MEAN_1="-4.9" MEAN_2="-4.7" ORDER="218" SD_1="4.5" SD_2="4.8" SE="0.7195609703662655" STUDY_ID="STD-Essex-2012b" TOTAL_1="124" TOTAL_2="65" WEIGHT="12.089921986872572" />
<CONT_DATA CI_END="-2.7148267683938525" CI_START="-4.485173231606148" EFFECT_SIZE="-3.6" ESTIMABLE="YES" MEAN_1="-5.2" MEAN_2="-1.6" ORDER="220" SD_1="4.5" SD_2="1.6" SE="0.45162729447493993" STUDY_ID="STD-Essex-2014" TOTAL_1="125" TOTAL_2="61" WEIGHT="13.396611314834985" />
<CONT_DATA CI_END="-1.120016931824408" CI_START="-3.079983068175592" EFFECT_SIZE="-2.1" ESTIMABLE="YES" MEAN_1="-4.7" MEAN_2="-2.6" ORDER="223" SD_1="4.1243" SD_2="3.9192" SE="0.5000005489414976" STUDY_ID="STD-Gibofsky-2003" TOTAL_1="189" TOTAL_2="96" WEIGHT="13.18752264636793" />
<CONT_DATA CI_END="-0.7952157564326341" CI_START="-2.404784243567366" EFFECT_SIZE="-1.6" ESTIMABLE="YES" MEAN_1="-4.0" MEAN_2="-2.4" ORDER="241" SD_1="4.0" SD_2="4.2" SE="0.41061175098899844" STUDY_ID="STD-McKenna-2001b" TOTAL_1="199" TOTAL_2="200" WEIGHT="13.561803090544313" />
<CONT_DATA CI_END="-2.9769192887448277" CI_START="-13.62308071125517" EFFECT_SIZE="-8.299999999999999" ESTIMABLE="YES" MEAN_1="-20.7" MEAN_2="-12.4" ORDER="39" SD_1="22.7" SD_2="21.0" SE="2.7159074111784465" STUDY_ID="STD-Rother-2007" TOTAL_1="132" TOTAL_2="127" WEIGHT="3.8603822398525334" />
<CONT_DATA CI_END="-6.964186281383786" CI_START="-15.035813718616215" EFFECT_SIZE="-11.0" ESTIMABLE="YES" MEAN_1="-33.0" MEAN_2="-22.0" ORDER="247" SD_1="21.3542" SD_2="22.0454" SE="2.059126468879121" STUDY_ID="STD-Smugar-2006-Study-1" TOTAL_1="456" TOTAL_2="150" WEIGHT="5.605014642401156" />
<CONT_DATA CI_END="-10.064183475371642" CI_START="-18.13581652462836" EFFECT_SIZE="-14.100000000000001" ESTIMABLE="YES" MEAN_1="-30.8" MEAN_2="-16.7" ORDER="248" SD_1="21.4476" SD_2="22.1188" SE="2.059127900544278" STUDY_ID="STD-Smugar-2006-Study-2" TOTAL_1="460" TOTAL_2="151" WEIGHT="5.605009880201149" />
<CONT_DATA CI_END="-0.8902660706375203" CI_START="-2.18973392936248" EFFECT_SIZE="-1.54" ESTIMABLE="YES" MEAN_1="-2.94" MEAN_2="-1.4" ORDER="226" SD_1="3.6" SD_2="3.5" SE="0.33150299418126966" STUDY_ID="STD-Williams-2000" TOTAL_1="227" TOTAL_2="232" WEIGHT="13.845211360414597" />
<CONT_DATA CI_END="-0.39973286079394676" CI_START="-1.6002671392060528" EFFECT_SIZE="-0.9999999999999998" ESTIMABLE="YES" MEAN_1="-2.8" MEAN_2="-1.8" ORDER="229" SD_1="3.4" SD_2="3.3" SE="0.3062643721725928" STUDY_ID="STD-Williams-2001" TOTAL_1="236" TOTAL_2="243" WEIGHT="13.924996589100633" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="10.641826996570607" CI_END="-0.23474872150329018" CI_START="-0.3985451259516246" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3166469237274574" ESTIMABLE="YES" I2="24.824938400351297" I2_Q="0.0" ID="CMP-003.08" NO="8" P_CHI2="0.22283110356906544" P_Q="1.0" P_Z="3.511869760731685E-14" Q="0.0" RANDOM="YES" SCALE="6.409411385665495" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0038768633964336384" TOTALS="YES" TOTAL_1="1904" TOTAL_2="1424" UNITS="" WEIGHT="99.99999999999997" Z="7.57790219402498">
<NAME>Pain WOMAC at 12 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.32942682380670507" CI_START="-0.7283238458366317" EFFECT_SIZE="-0.5288753348216684" ESTIMABLE="YES" MEAN_1="-3.05" MEAN_2="-1.35" ORDER="216" SD_1="2.8" SD_2="3.56" SE="0.10176131428341935" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="203" WEIGHT="12.268166113599897" />
<CONT_DATA CI_END="-0.1887330394167836" CI_START="-0.704893998192669" EFFECT_SIZE="-0.4468135188047263" ESTIMABLE="YES" MEAN_1="-24.9" MEAN_2="-15.4" ORDER="1486" SD_1="20.7846" SD_2="22.1269" SE="0.13167613355329413" STUDY_ID="STD-Bingham-2007-Study-1" TOTAL_1="192" TOTAL_2="85" WEIGHT="8.230002134582907" />
<CONT_DATA CI_END="-0.22051474421166134" CI_START="-0.803585737947824" EFFECT_SIZE="-0.5120502410797426" ESTIMABLE="YES" MEAN_1="-27.8" MEAN_2="-16.2" ORDER="1487" SD_1="23.4509" SD_2="19.3649" SE="0.14874533367331036" STUDY_ID="STD-Bingham-2007-Study-2" TOTAL_1="202" TOTAL_2="60" WEIGHT="6.714986928390104" />
<CONT_DATA CI_END="-0.01540778372366397" CI_START="-0.42367168206258815" EFFECT_SIZE="-0.21953973289312606" ESTIMABLE="YES" MEAN_1="-28.0" MEAN_2="-21.7" ORDER="40" SD_1="27.2" SD_2="30.0" SE="0.10415086745451899" STUDY_ID="STD-Boswell-2008-Study-B" TOTAL_1="185" TOTAL_2="186" WEIGHT="11.85820306431169" />
<CONT_DATA CI_END="-0.1120223553796936" CI_START="-0.4795993045106719" EFFECT_SIZE="-0.29581082994518276" ESTIMABLE="YES" MEAN_1="-1.9" MEAN_2="-1.42" ORDER="41" SD_1="1.62" SD_2="1.62" SE="0.09377135295096706" STUDY_ID="STD-Conaghan-2013" TOTAL_1="233" TOTAL_2="227" WEIGHT="13.780924026431293" />
<CONT_DATA CI_END="-0.07963054198439395" CI_START="-0.4725284685706212" EFFECT_SIZE="-0.2760795052775076" ESTIMABLE="YES" MEAN_1="-130.0" MEAN_2="-94.9" ORDER="634" SD_1="127.914" SD_2="125.865" SE="0.10023090467104394" STUDY_ID="STD-DeLemos-2011" TOTAL_1="202" TOTAL_2="200" WEIGHT="12.540552942476557" />
<CONT_DATA CI_END="-0.01635664412780205" CI_START="-0.45060309133222487" EFFECT_SIZE="-0.23347986773001345" ESTIMABLE="YES" MEAN_1="-41.8" MEAN_2="-35.6" ORDER="124" SD_1="26.5" SD_2="26.5" SE="0.11077919049270889" STUDY_ID="STD-Hochberg-2011-Study-307" TOTAL_1="242" TOTAL_2="124" WEIGHT="10.812094005403388" />
<CONT_DATA CI_END="0.04821607908813469" CI_START="-0.38713846772847704" EFFECT_SIZE="-0.16946119432017118" ESTIMABLE="YES" MEAN_1="-42.9" MEAN_2="-38.4" ORDER="125" SD_1="26.5" SD_2="26.5" SE="0.11106187415958478" STUDY_ID="STD-Hochberg-2011-Study-309" TOTAL_1="244" TOTAL_2="122" WEIGHT="10.770269915216854" />
<CONT_DATA CI_END="-0.08269812112356123" CI_START="-0.4653398900420943" EFFECT_SIZE="-0.27401900558282777" ESTIMABLE="YES" MEAN_1="-2.0" MEAN_2="-0.8" ORDER="42" SD_1="4.32" SD_2="4.42" SE="0.09761448984184468" STUDY_ID="STD-Kivitz-2001" TOTAL_1="207" TOTAL_2="217" WEIGHT="13.024800869587306" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.4374581113083136" CI_END="-0.8009756629823886" CI_START="-1.3114694799663273" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.056222571474358" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.09" NO="9" P_CHI2="0.48745175553908593" P_Q="1.0" P_Z="5.044742027120733E-16" Q="0.0" RANDOM="YES" SCALE="18.23406931874937" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="2157" TOTAL_2="1696" UNITS="" WEIGHT="100.0" Z="8.110414390437786">
<NAME>Pain WOMAC at 13 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.5682667079185136" CI_START="-1.8317332920814868" EFFECT_SIZE="-1.2000000000000002" ESTIMABLE="YES" MEAN_1="-3.5" MEAN_2="-2.3" ORDER="243" SD_1="4.11" SD_2="3.9" SE="0.32231882680728735" STUDY_ID="STD-Fleischmann-2005" TOTAL_1="444" TOTAL_2="231" WEIGHT="16.32500985444303" />
<CONT_DATA CI_END="-0.3737112687114075" CI_START="-1.4262887312885923" EFFECT_SIZE="-0.8999999999999999" ESTIMABLE="YES" MEAN_1="-3.4" MEAN_2="-2.5" ORDER="244" SD_1="3.67" SD_2="4.12" SE="0.268519592931243" STUDY_ID="STD-Lehmann-2005" TOTAL_1="420" TOTAL_2="424" WEIGHT="23.521923818379904" />
<CONT_DATA CI_END="-0.8420616345465554" CI_START="-1.9579383654534444" EFFECT_SIZE="-1.4" ESTIMABLE="YES" MEAN_1="-3.6" MEAN_2="-2.2" ORDER="639" SD_1="4.28" SD_2="3.94" SE="0.28466766218889283" STUDY_ID="STD-Schnitzer-2011" TOTAL_1="419" TOTAL_2="416" WEIGHT="20.929002497704513" />
<CONT_DATA CI_END="-0.5329619317707215" CI_START="-1.6670380682292787" EFFECT_SIZE="-1.1" ESTIMABLE="YES" MEAN_1="-3.4" MEAN_2="-2.3" ORDER="246" SD_1="4.21" SD_2="3.84" SE="0.289310452999138" STUDY_ID="STD-Sheldon-2005" TOTAL_1="393" TOTAL_2="382" WEIGHT="20.262664270362873" />
<CONT_DATA CI_END="-0.11382769451348429" CI_START="-1.2861723054865162" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="-3.1" MEAN_2="-2.4" ORDER="249" SD_1="3.8" SD_2="3.8" SE="0.29907299833576956" STUDY_ID="STD-Tannenbaum-2004" TOTAL_1="481" TOTAL_2="243" WEIGHT="18.961399559109672" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-1.5129926903919646" CI_START="-24.687007309608052" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-13.100000000000009" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.10" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="0.026699068672770634" Q="0.0" RANDOM="YES" SCALE="62.51" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="318" TOTAL_2="313" UNITS="" WEIGHT="100.0" Z="2.2158895313878295">
<NAME>Pain WOMAC at 24 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-1.5129926903919646" CI_START="-24.687007309608052" EFFECT_SIZE="-13.100000000000009" ESTIMABLE="YES" MEAN_1="-99.2" MEAN_2="-86.1" ORDER="45" SD_1="74.3" SD_2="74.2" SE="5.911847054846354" STUDY_ID="STD-Clegg-2006" TOTAL_1="318" TOTAL_2="313" WEIGHT="100.0" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="113.87154244189327" CI_END="-0.26881411280849793" CI_START="-0.42931452559071864" CI_STUDY="95" CI_TOTAL="95" DF="26" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3490643191996083" ESTIMABLE="YES" I2="77.16725404570035" I2_Q="0.0" ID="CMP-003.11" NO="11" P_CHI2="5.725420137991932E-13" P_Q="1.0" P_Z="1.5247320301603908E-17" Q="0.0" RANDOM="YES" SCALE="6.592290148304762" SORT_BY="STUDY" STUDIES="27" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.03361256618755704" TOTALS="YES" TOTAL_1="6936" TOTAL_2="5004" UNITS="" WEIGHT="100.0" Z="8.525255257100646">
<NAME>All physical function &lt; 24 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.7051037875895929" CI_START="-1.117167919333277" EFFECT_SIZE="-0.911135853461435" ESTIMABLE="YES" MEAN_1="-9.9" MEAN_2="-3.51" ORDER="173" SD_1="7.0" SD_2="7.0" SE="0.10512033256580053" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="203" WEIGHT="3.753614745526963" />
<CONT_DATA CI_END="-0.17345096334352356" CI_START="-0.6892415867001276" EFFECT_SIZE="-0.4313462750218256" ESTIMABLE="YES" MEAN_1="-22.1" MEAN_2="-12.8" ORDER="1490" SD_1="20.7846" SD_2="23.0489" SE="0.13158165849604755" STUDY_ID="STD-Bingham-2007-Study-1" TOTAL_1="192" TOTAL_2="85" WEIGHT="3.2919559716213005" />
<CONT_DATA CI_END="-0.15165254251578858" CI_START="-0.7330224550322526" EFFECT_SIZE="-0.44233749877402057" ESTIMABLE="YES" MEAN_1="-23.4" MEAN_2="-12.1" ORDER="1491" SD_1="27.0041" SD_2="19.3649" SE="0.14831137640850434" STUDY_ID="STD-Bingham-2007-Study-2" TOTAL_1="202" TOTAL_2="60" WEIGHT="3.014757414429206" />
<CONT_DATA CI_END="0.10036583621239298" CI_START="-0.4435537365515004" EFFECT_SIZE="-0.1715939501695537" ESTIMABLE="YES" MEAN_1="-28.4" MEAN_2="-19.9" ORDER="164" SD_1="53.8" SD_2="38.9" SE="0.13875754275442342" STUDY_ID="STD-Birbara-2006-Study-1" TOTAL_1="157" TOTAL_2="78" WEIGHT="3.1711578460340677" />
<CONT_DATA CI_END="0.13488925466330148" CI_START="-0.3868234625222432" EFFECT_SIZE="-0.12596710392947086" ESTIMABLE="YES" MEAN_1="-26.3" MEAN_2="-19.3" ORDER="165" SD_1="55.9" SD_2="54.4" SE="0.13309242447839553" STUDY_ID="STD-Birbara-2006-Study-2" TOTAL_1="169" TOTAL_2="85" WEIGHT="3.266309722177083" />
<CONT_DATA CI_END="-0.0843703695138473" CI_START="-0.6351879454062204" EFFECT_SIZE="-0.3597791574600338" ESTIMABLE="YES" MEAN_1="-18.1" MEAN_2="-14.0" ORDER="166" SD_1="11.5" SD_2="11.2" SE="0.14051726976545276" STUDY_ID="STD-Boswell-2008-Study-A" TOTAL_1="105" TOTAL_2="101" WEIGHT="3.1419500976867485" />
<CONT_DATA CI_END="-0.09184913628584807" CI_START="-0.5260483768427378" EFFECT_SIZE="-0.3089487565642929" ESTIMABLE="YES" MEAN_1="-24.7" MEAN_2="-17.9" ORDER="174" SD_1="20.7846" SD_2="23.0489" SE="0.11076714775929503" STUDY_ID="STD-Boswell-2008-Study-B" TOTAL_1="163" TOTAL_2="167" WEIGHT="3.653881700944203" />
<CONT_DATA CI_END="0.050071564418506825" CI_START="-0.2622588251115284" EFFECT_SIZE="-0.10609363034651079" ESTIMABLE="YES" MEAN_1="500.1" MEAN_2="540.3" ORDER="183" SD_1="382.7" SD_2="374.1" SE="0.0796775838723715" STUDY_ID="STD-Clegg-2006" TOTAL_1="318" TOTAL_2="313" WEIGHT="4.195259970590097" />
<CONT_DATA CI_END="-0.11796505077609179" CI_START="-0.4852125428270223" EFFECT_SIZE="-0.30158879680155704" ESTIMABLE="YES" MEAN_1="-1.8" MEAN_2="-1.3" ORDER="175" SD_1="1.5" SD_2="1.8" SE="0.0936873062331073" STUDY_ID="STD-Conaghan-2013" TOTAL_1="233" TOTAL_2="228" WEIGHT="3.9548860241996824" />
<CONT_DATA CI_END="-0.138463847192798" CI_START="-0.5322510187133493" EFFECT_SIZE="-0.3353574329530737" ESTIMABLE="YES" MEAN_1="-429.2" MEAN_2="-290.1" ORDER="635" SD_1="416.4312" SD_2="411.5361" SE="0.10045775703704107" STUDY_ID="STD-DeLemos-2011" TOTAL_1="202" TOTAL_2="200" WEIGHT="3.835939029886639" />
<CONT_DATA CI_END="0.1623893524494381" CI_START="-0.4385323889886865" EFFECT_SIZE="-0.1380715182696242" ESTIMABLE="YES" MEAN_1="-16.0" MEAN_2="-14.4" ORDER="167" SD_1="10.2362" SD_2="13.7058" SE="0.1532991795201643" STUDY_ID="STD-Essex-2012b" TOTAL_1="124" TOTAL_2="65" WEIGHT="2.935348057010694" />
<CONT_DATA CI_END="-0.02796131456926826" CI_START="-0.6440702917661212" EFFECT_SIZE="-0.3360158031676947" ESTIMABLE="YES" MEAN_1="-16.3" MEAN_2="-11.1" ORDER="168" SD_1="15.7" SD_2="14.8" SE="0.15717354554895954" STUDY_ID="STD-Essex-2014" TOTAL_1="125" TOTAL_2="61" WEIGHT="2.874800683047792" />
<CONT_DATA CI_END="-0.22764551178011866" CI_START="-0.54834793285308" EFFECT_SIZE="-0.3879967223165994" ESTIMABLE="YES" MEAN_1="-11.0" MEAN_2="-6.1" ORDER="179" SD_1="13.06" SD_2="11.71" SE="0.08181334544987082" STUDY_ID="STD-Fleischmann-2005" TOTAL_1="444" TOTAL_2="231" WEIGHT="4.159360322460436" />
<CONT_DATA CI_END="-0.1829255632103334" CI_START="-0.6793555009138433" EFFECT_SIZE="-0.43114053206208836" ESTIMABLE="YES" MEAN_1="-14.0" MEAN_2="-8.2" ORDER="224" SD_1="13.7477" SD_2="12.7373" SE="0.12664261731829918" STUDY_ID="STD-Gibofsky-2003" TOTAL_1="189" TOTAL_2="96" WEIGHT="3.3765162578563346" />
<CONT_DATA CI_END="-0.00600337934719386" CI_START="-0.44013367341205384" EFFECT_SIZE="-0.22306852637962385" ESTIMABLE="YES" MEAN_1="-36.3" MEAN_2="-30.6" ORDER="176" SD_1="25.5" SD_2="25.5" SE="0.11074955904527438" STUDY_ID="STD-Hochberg-2011-Study-307" TOTAL_1="242" TOTAL_2="124" WEIGHT="3.654192007024681" />
<CONT_DATA CI_END="0.04821607908813469" CI_START="-0.38713846772847704" EFFECT_SIZE="-0.16946119432017118" ESTIMABLE="YES" MEAN_1="-36.8" MEAN_2="-32.3" ORDER="177" SD_1="26.5" SD_2="26.5" SE="0.11106187415958478" STUDY_ID="STD-Hochberg-2011-Study-309" TOTAL_1="244" TOTAL_2="122" WEIGHT="3.648682557101983" />
<CONT_DATA CI_END="-0.8070700024770271" CI_START="-1.2116379283262395" EFFECT_SIZE="-1.0093539654016332" ESTIMABLE="YES" MEAN_1="-6.6" MEAN_2="-2.2" ORDER="178" SD_1="4.3" SD_2="4.4" SE="0.10320800000418184" STUDY_ID="STD-Kivitz-2001" TOTAL_1="207" TOTAL_2="217" WEIGHT="3.7873983752748663" />
<CONT_DATA CI_END="-0.05579156057613574" CI_START="-0.32627123227975297" EFFECT_SIZE="-0.19103139642794437" ESTIMABLE="YES" MEAN_1="-10.3" MEAN_2="-8.0" ORDER="180" SD_1="11.76" SD_2="12.29" SE="0.06900118416387402" STUDY_ID="STD-Lehmann-2005" TOTAL_1="420" TOTAL_2="424" WEIGHT="4.3687995920549305" />
<CONT_DATA CI_END="-0.20103758788281184" CI_START="-0.5974518724035494" EFFECT_SIZE="-0.39924473014318057" ESTIMABLE="YES" MEAN_1="-13.2" MEAN_2="-8.1" ORDER="169" SD_1="12.8" SD_2="12.7" SE="0.1011279512398194" STUDY_ID="STD-McKenna-2001b" TOTAL_1="199" TOTAL_2="200" WEIGHT="3.824117676088991" />
<CONT_DATA CI_END="-0.031285270866970444" CI_START="-0.5208713695868405" EFFECT_SIZE="-0.2760783202269055" ESTIMABLE="YES" MEAN_1="-18.1" MEAN_2="-12.3" ORDER="170" SD_1="22.5" SD_2="19.2" SE="0.12489670794505989" STUDY_ID="STD-Rother-2007" TOTAL_1="132" TOTAL_2="127" WEIGHT="3.40664823229676" />
<CONT_DATA CI_END="-0.17330214058350304" CI_START="-0.4462432648005248" EFFECT_SIZE="-0.3097727026920139" ESTIMABLE="YES" MEAN_1="-10.9" MEAN_2="-6.8" ORDER="640" SD_1="13.86" SD_2="12.55" SE="0.069629117261834" STUDY_ID="STD-Schnitzer-2011" TOTAL_1="419" TOTAL_2="416" WEIGHT="4.358911429982857" />
<CONT_DATA CI_END="-0.21882985512544229" CI_START="-0.5027675254476139" EFFECT_SIZE="-0.3607986902865281" ESTIMABLE="YES" MEAN_1="-10.8" MEAN_2="-6.3" ORDER="181" SD_1="13.07" SD_2="11.8" SE="0.07243441016310395" STUDY_ID="STD-Sheldon-2005" TOTAL_1="393" TOTAL_2="382" WEIGHT="4.314207699424843" />
<CONT_DATA CI_END="-0.32310020993318156" CI_START="-0.6965338411433376" EFFECT_SIZE="-0.5098170255382596" ESTIMABLE="YES" MEAN_1="-27.4" MEAN_2="-16.4" ORDER="171" SD_1="21.4" SD_2="22.0" SE="0.09526543195583001" STUDY_ID="STD-Smugar-2006-Study-1" TOTAL_1="456" TOTAL_2="150" WEIGHT="3.9272597540945857" />
<CONT_DATA CI_END="-0.362786672781014" CI_START="-0.7355890515874846" EFFECT_SIZE="-0.5491878621842493" ESTIMABLE="YES" MEAN_1="-23.3" MEAN_2="-11.6" ORDER="172" SD_1="21.4" SD_2="20.9" SE="0.09510439522029185" STUDY_ID="STD-Smugar-2006-Study-2" TOTAL_1="460" TOTAL_2="151" WEIGHT="3.9300821517032354" />
<CONT_DATA CI_END="-0.10203384130027468" CI_START="-0.41168437441334227" EFFECT_SIZE="-0.2568591078568085" ESTIMABLE="YES" MEAN_1="-9.2" MEAN_2="-6.2" ORDER="182" SD_1="11.6" SD_2="11.8" SE="0.07899393446909012" STUDY_ID="STD-Tannenbaum-2004" TOTAL_1="481" TOTAL_2="243" WEIGHT="4.206679140864168" />
<CONT_DATA CI_END="0.09230749648572067" CI_START="-0.27383734127943954" EFFECT_SIZE="-0.09076492239685943" ESTIMABLE="YES" MEAN_1="-9.2" MEAN_2="-8.1" ORDER="227" SD_1="12.2" SD_2="12.0" SE="0.09340601170563947" STUDY_ID="STD-Williams-2000" TOTAL_1="227" TOTAL_2="232" WEIGHT="3.9598022395108736" />
<CONT_DATA CI_END="-0.0927644726795368" CI_START="-0.45268984737794504" EFFECT_SIZE="-0.2727271600287409" ESTIMABLE="YES" MEAN_1="-9.2" MEAN_2="-6.1" ORDER="230" SD_1="11.5" SD_2="11.2" SE="0.09181938482988812" STUDY_ID="STD-Williams-2001" TOTAL_1="236" TOTAL_2="243" WEIGHT="3.9874813011059684" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="22.14168593070466" CI_END="-0.21766343614971437" CI_START="-0.4084534263906512" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3130584312701828" ESTIMABLE="YES" I2="50.31995289597207" I2_Q="0.0" ID="CMP-003.12" NO="12" P_CHI2="0.023298317802479707" P_Q="1.0" P_Z="1.2591279270001702E-10" Q="0.0" RANDOM="YES" SCALE="6.115072742342319" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.013880580260296427" TOTALS="YES" TOTAL_1="2480" TOTAL_2="1589" UNITS="" WEIGHT="100.0" Z="6.432027692556722">
<NAME>Physical function WOMAC at 6 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.10036583621239298" CI_START="-0.4435537365515004" EFFECT_SIZE="-0.1715939501695537" ESTIMABLE="YES" MEAN_1="-28.4" MEAN_2="-19.9" ORDER="25" SD_1="53.8" SD_2="38.9" SE="0.13875754275442342" STUDY_ID="STD-Birbara-2006-Study-1" TOTAL_1="157" TOTAL_2="78" WEIGHT="7.149538973290746" />
<CONT_DATA CI_END="0.13488925466330148" CI_START="-0.3868234625222432" EFFECT_SIZE="-0.12596710392947086" ESTIMABLE="YES" MEAN_1="-26.3" MEAN_2="-19.3" ORDER="26" SD_1="55.9" SD_2="54.4" SE="0.13309242447839553" STUDY_ID="STD-Birbara-2006-Study-2" TOTAL_1="169" TOTAL_2="85" WEIGHT="7.49804420550628" />
<CONT_DATA CI_END="-0.0843703695138473" CI_START="-0.6351879454062204" EFFECT_SIZE="-0.3597791574600338" ESTIMABLE="YES" MEAN_1="-18.1" MEAN_2="-14.0" ORDER="27" SD_1="11.5" SD_2="11.2" SE="0.14051726976545276" STUDY_ID="STD-Boswell-2008-Study-A" TOTAL_1="105" TOTAL_2="101" WEIGHT="7.045046745608143" />
<CONT_DATA CI_END="0.1623893524494381" CI_START="-0.4385323889886865" EFFECT_SIZE="-0.1380715182696242" ESTIMABLE="YES" MEAN_1="-16.0" MEAN_2="-14.4" ORDER="28" SD_1="10.2362" SD_2="13.7058" SE="0.1532991795201643" STUDY_ID="STD-Essex-2012b" TOTAL_1="124" TOTAL_2="65" WEIGHT="6.337260243766052" />
<CONT_DATA CI_END="-0.02796131456926826" CI_START="-0.6440702917661212" EFFECT_SIZE="-0.3360158031676947" ESTIMABLE="YES" MEAN_1="-16.3" MEAN_2="-11.1" ORDER="29" SD_1="15.7" SD_2="14.8" SE="0.15717354554895954" STUDY_ID="STD-Essex-2014" TOTAL_1="125" TOTAL_2="61" WEIGHT="6.139691959751268" />
<CONT_DATA CI_END="-0.1829255632103334" CI_START="-0.6793555009138433" EFFECT_SIZE="-0.43114053206208836" ESTIMABLE="YES" MEAN_1="-14.0" MEAN_2="-8.2" ORDER="225" SD_1="13.7477" SD_2="12.7373" SE="0.12664261731829918" STUDY_ID="STD-Gibofsky-2003" TOTAL_1="189" TOTAL_2="96" WEIGHT="7.917879720932049" />
<CONT_DATA CI_END="-0.15732258189045925" CI_START="-0.6417083402602164" EFFECT_SIZE="-0.3995154610753378" ESTIMABLE="YES" MEAN_1="-13.2" MEAN_2="-8.1" ORDER="30" SD_1="12.8" SD_2="12.7" SE="0.12357006613145194" STUDY_ID="STD-McKenna-2001b" TOTAL_1="100" TOTAL_2="200" WEIGHT="8.12670192733156" />
<CONT_DATA CI_END="-0.031285270866970444" CI_START="-0.5208713695868405" EFFECT_SIZE="-0.2760783202269055" ESTIMABLE="YES" MEAN_1="-18.1" MEAN_2="-12.3" ORDER="31" SD_1="22.5" SD_2="19.2" SE="0.12489670794505989" STUDY_ID="STD-Rother-2007" TOTAL_1="132" TOTAL_2="127" WEIGHT="8.03583365443403" />
<CONT_DATA CI_END="-0.32310020993318156" CI_START="-0.6965338411433376" EFFECT_SIZE="-0.5098170255382596" ESTIMABLE="YES" MEAN_1="-27.4" MEAN_2="-16.4" ORDER="32" SD_1="21.4" SD_2="22.0" SE="0.09526543195583001" STUDY_ID="STD-Smugar-2006-Study-1" TOTAL_1="456" TOTAL_2="150" WEIGHT="10.319465796967828" />
<CONT_DATA CI_END="-0.362786672781014" CI_START="-0.7355890515874846" EFFECT_SIZE="-0.5491878621842493" ESTIMABLE="YES" MEAN_1="-23.3" MEAN_2="-11.6" ORDER="33" SD_1="21.4" SD_2="20.9" SE="0.09510439522029185" STUDY_ID="STD-Smugar-2006-Study-2" TOTAL_1="460" TOTAL_2="151" WEIGHT="10.333265281707048" />
<CONT_DATA CI_END="0.09230749648572067" CI_START="-0.27383734127943954" EFFECT_SIZE="-0.09076492239685943" ESTIMABLE="YES" MEAN_1="-9.2" MEAN_2="-8.1" ORDER="228" SD_1="12.2" SD_2="12.0" SE="0.09340601170563947" STUDY_ID="STD-Williams-2000" TOTAL_1="227" TOTAL_2="232" WEIGHT="10.479617431414527" />
<CONT_DATA CI_END="-0.0927644726795368" CI_START="-0.45268984737794504" EFFECT_SIZE="-0.2727271600287409" ESTIMABLE="YES" MEAN_1="-9.2" MEAN_2="-6.1" ORDER="231" SD_1="11.5" SD_2="11.2" SE="0.09181938482988812" STUDY_ID="STD-Williams-2001" TOTAL_1="236" TOTAL_2="243" WEIGHT="10.617654059290471" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="54.70712194428789" CI_END="-0.26295579159314253" CI_START="-0.649586908109427" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.45627134985128476" ESTIMABLE="YES" I2="85.37667543880856" I2_Q="0.0" ID="CMP-003.13" NO="13" P_CHI2="5.033012895339084E-9" P_Q="1.0" P_Z="3.728172552245657E-6" Q="0.0" RANDOM="YES" SCALE="1.8095267385696576" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.07417484377798242" TOTALS="YES" TOTAL_1="1779" TOTAL_2="1406" UNITS="" WEIGHT="100.00000000000001" Z="4.625987793966537">
<NAME>Physical function WOMAC at 12 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.7051037875895929" CI_START="-1.117167919333277" EFFECT_SIZE="-0.911135853461435" ESTIMABLE="YES" MEAN_1="-9.9" MEAN_2="-3.51" ORDER="34" SD_1="7.0" SD_2="7.0" SE="0.10512033256580053" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="203" WEIGHT="11.414838495842117" />
<CONT_DATA CI_END="-0.17345096334352356" CI_START="-0.6892415867001276" EFFECT_SIZE="-0.4313462750218256" ESTIMABLE="YES" MEAN_1="-22.1" MEAN_2="-12.8" ORDER="1490" SD_1="20.7846" SD_2="23.0489" SE="0.13158165849604755" STUDY_ID="STD-Bingham-2007-Study-1" TOTAL_1="192" TOTAL_2="85" WEIGHT="10.63336111283115" />
<CONT_DATA CI_END="-0.15165254251578858" CI_START="-0.7330224550322526" EFFECT_SIZE="-0.44233749877402057" ESTIMABLE="YES" MEAN_1="-23.4" MEAN_2="-12.1" ORDER="1491" SD_1="27.0041" SD_2="19.3649" SE="0.14831137640850434" STUDY_ID="STD-Bingham-2007-Study-2" TOTAL_1="202" TOTAL_2="60" WEIGHT="10.11562715376593" />
<CONT_DATA CI_END="-0.09184913628584807" CI_START="-0.5260483768427378" EFFECT_SIZE="-0.3089487565642929" ESTIMABLE="YES" MEAN_1="-24.7" MEAN_2="-17.9" ORDER="35" SD_1="20.7846" SD_2="23.0489" SE="0.11076714775929503" STUDY_ID="STD-Boswell-2008-Study-B" TOTAL_1="163" TOTAL_2="167" WEIGHT="11.253861091722163" />
<CONT_DATA CI_END="-0.11796505077609179" CI_START="-0.4852125428270223" EFFECT_SIZE="-0.30158879680155704" ESTIMABLE="YES" MEAN_1="-1.8" MEAN_2="-1.3" ORDER="36" SD_1="1.5" SD_2="1.8" SE="0.0936873062331073" STUDY_ID="STD-Conaghan-2013" TOTAL_1="233" TOTAL_2="228" WEIGHT="11.72761661851774" />
<CONT_DATA CI_END="-0.138463847192798" CI_START="-0.5322510187133493" EFFECT_SIZE="-0.3353574329530737" ESTIMABLE="YES" MEAN_1="-429.2" MEAN_2="-290.1" ORDER="636" SD_1="416.4312" SD_2="411.5361" SE="0.10045775703704107" STUDY_ID="STD-DeLemos-2011" TOTAL_1="202" TOTAL_2="200" WEIGHT="11.544681029507446" />
<CONT_DATA CI_END="-0.00600337934719386" CI_START="-0.44013367341205384" EFFECT_SIZE="-0.22306852637962385" ESTIMABLE="YES" MEAN_1="-36.3" MEAN_2="-30.6" ORDER="126" SD_1="25.5" SD_2="25.5" SE="0.11074955904527438" STUDY_ID="STD-Hochberg-2011-Study-307" TOTAL_1="242" TOTAL_2="124" WEIGHT="11.254368346113608" />
<CONT_DATA CI_END="0.04821607908813469" CI_START="-0.38713846772847704" EFFECT_SIZE="-0.16946119432017118" ESTIMABLE="YES" MEAN_1="-36.8" MEAN_2="-32.3" ORDER="127" SD_1="26.5" SD_2="26.5" SE="0.11106187415958478" STUDY_ID="STD-Hochberg-2011-Study-309" TOTAL_1="244" TOTAL_2="122" WEIGHT="11.24535608360531" />
<CONT_DATA CI_END="-0.7584733926712944" CI_START="-1.251455809170223" EFFECT_SIZE="-1.0049646009207587" ESTIMABLE="YES" MEAN_1="-6.6" MEAN_2="-2.2" ORDER="37" SD_1="4.3" SD_2="4.4" SE="0.12576313146249393" STUDY_ID="STD-Kivitz-2001" TOTAL_1="104" TOTAL_2="217" WEIGHT="10.810290068094545" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.89444862217487" CI_END="-2.7374280350679254" CI_START="-4.6679070986160855" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.7026675668420053" ESTIMABLE="YES" I2="32.139539142778666" I2_Q="0.0" ID="CMP-003.14" NO="14" P_CHI2="0.20717090223592705" P_Q="1.0" P_Z="5.543386226627697E-14" Q="0.0" RANDOM="YES" SCALE="9.634001189610936" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.3895066291736541" TOTALS="YES" TOTAL_1="2157" TOTAL_2="1696" UNITS="" WEIGHT="100.00000000000001" Z="7.518439557066807">
<NAME>Physical function WOMAC at 13 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-2.961950313305249" CI_START="-6.8380496866947515" EFFECT_SIZE="-4.9" ESTIMABLE="YES" MEAN_1="-11.0" MEAN_2="-6.1" ORDER="38" SD_1="13.06" SD_2="11.71" SE="0.9888190303402715" STUDY_ID="STD-Fleischmann-2005" TOTAL_1="444" TOTAL_2="231" WEIGHT="17.738619898457486" />
<CONT_DATA CI_END="-0.6772302039141382" CI_START="-3.922769796085863" EFFECT_SIZE="-2.3000000000000007" ESTIMABLE="YES" MEAN_1="-10.3" MEAN_2="-8.0" ORDER="39" SD_1="11.76" SD_2="12.29" SE="0.8279589874538836" STUDY_ID="STD-Lehmann-2005" TOTAL_1="420" TOTAL_2="424" WEIGHT="22.560897792361185" />
<CONT_DATA CI_END="-2.3067846404690444" CI_START="-5.893215359530957" EFFECT_SIZE="-4.1000000000000005" ESTIMABLE="YES" MEAN_1="-10.9" MEAN_2="-6.8" ORDER="641" SD_1="13.86" SD_2="12.55" SE="0.9149226075966753" STUDY_ID="STD-Schnitzer-2011" TOTAL_1="419" TOTAL_2="416" WEIGHT="19.773092424616365" />
<CONT_DATA CI_END="-2.7478628209297513" CI_START="-6.2521371790702505" EFFECT_SIZE="-4.500000000000001" ESTIMABLE="YES" MEAN_1="-10.8" MEAN_2="-6.3" ORDER="40" SD_1="13.07" SD_2="11.8" SE="0.8939639671396435" STUDY_ID="STD-Sheldon-2005" TOTAL_1="393" TOTAL_2="382" WEIGHT="20.40373710980405" />
<CONT_DATA CI_END="-1.1900768484768058" CI_START="-4.809923151523193" EFFECT_SIZE="-2.999999999999999" ESTIMABLE="YES" MEAN_1="-9.2" MEAN_2="-6.2" ORDER="41" SD_1="11.6" SD_2="11.8" SE="0.9234471479066126" STUDY_ID="STD-Tannenbaum-2004" TOTAL_1="481" TOTAL_2="243" WEIGHT="19.52365277476092" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="15.873232433028619" CI_START="-81.07323243302866" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-32.60000000000002" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.15" NO="15" P_CHI2="1.0" P_Q="1.0" P_Z="0.1874545817535153" Q="0.0" RANDOM="YES" SCALE="204.26374369945776" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="318" TOTAL_2="313" UNITS="" WEIGHT="100.0" Z="1.3181465870732654">
<NAME>Physical function WOMAC at 24 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="15.873232433028619" CI_START="-81.07323243302866" EFFECT_SIZE="-32.60000000000002" ESTIMABLE="YES" MEAN_1="-288.1" MEAN_2="-255.5" ORDER="42" SD_1="309.0" SD_2="312.2" SE="24.731695487967794" STUDY_ID="STD-Clegg-2006" TOTAL_1="318" TOTAL_2="313" WEIGHT="100.0" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.5369138041224126" CI_START="-3.863086195877588" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.2" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.16" NO="16" P_CHI2="1.0" P_Q="1.0" P_Z="0.00952196052542477" Q="0.0" RANDOM="YES" SCALE="9.99256158241071" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="202" TOTAL_2="200" UNITS="" WEIGHT="100.0" Z="2.5927223595965083">
<NAME>Quality of life: SF-36 physical component scores</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.5369138041224126" CI_START="-3.863086195877588" EFFECT_SIZE="-2.2" ESTIMABLE="YES" MEAN_1="-5.2" MEAN_2="-3.0" ORDER="643" SD_1="8.5276" SD_2="8.4853" SE="0.8485289571623761" STUDY_ID="STD-DeLemos-2011" TOTAL_1="202" TOTAL_2="200" WEIGHT="100.0" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.8630861958775875" CI_START="-1.4630861958775876" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.19999999999999998" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.17" NO="17" P_CHI2="1.0" P_Q="1.0" P_Z="0.8136638926678837" Q="0.0" RANDOM="YES" SCALE="5.670142727875054" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="202" TOTAL_2="200" UNITS="" WEIGHT="100.0" Z="0.23570203269059162">
<NAME>Quality of life: SF-36 mental component scores</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.8630861958775875" CI_START="-1.4630861958775876" EFFECT_SIZE="0.19999999999999998" ESTIMABLE="YES" MEAN_1="-0.1" MEAN_2="-0.3" ORDER="644" SD_1="8.5276" SD_2="8.4853" SE="0.8485289571623761" STUDY_ID="STD-DeLemos-2011" TOTAL_1="202" TOTAL_2="200" WEIGHT="100.0" />
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="8.919173630942645" CI_END="1.8704286327702144" CI_START="1.1620626804410987" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.474298243426592" ESTIMABLE="YES" EVENTS_1="449" EVENTS_2="252" I2="66.36459694435909" I2_Q="0.0" ID="CMP-003.18" LOG_CI_END="0.27194114210632697" LOG_CI_START="0.06522955407455495" LOG_EFFECT_SIZE="0.16858534809044098" METHOD="MH" NO="18" P_CHI2="0.03038507167357718" P_Q="1.0" P_Z="0.0013889875974081327" Q="0.0" RANDOM="YES" SCALE="4.085819852469021" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.037540367203574475" TOTALS="YES" TOTAL_1="1034" TOTAL_2="782" WEIGHT="100.0" Z="3.1969297292382683">
<NAME>Number of responders with at least 50% improvement in WOMAC pain</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors celecoxib</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.0909921334428225" CI_START="1.0263851077074269" EFFECT_SIZE="1.4649789029535865" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="30" LOG_CI_END="0.3203523989540658" LOG_CI_START="0.011310342034634989" LOG_EFFECT_SIZE="0.16583137049435043" ORDER="1652" O_E="0.0" SE="0.18153283401732745" STUDY_ID="STD-Bingham-2007-Study-1" TOTAL_1="237" TOTAL_2="124" VAR="0.03295416982636256" WEIGHT="20.914591582607176" />
<DICH_DATA CI_END="3.245302496632559" CI_START="1.476589626493627" EFFECT_SIZE="2.189059158945118" ESTIMABLE="YES" EVENTS_1="105" EVENTS_2="23" LOG_CI_END="0.5112551838776711" LOG_CI_START="0.16925981304188373" LOG_EFFECT_SIZE="0.34025749845977743" ORDER="1653" O_E="0.0" SE="0.20088977373332992" STUDY_ID="STD-Bingham-2007-Study-2" TOTAL_1="244" TOTAL_2="117" VAR="0.040356701190628494" WEIGHT="18.92708520588988" />
<DICH_DATA CI_END="1.4053417649963966" CI_START="1.0002276783892678" EFFECT_SIZE="1.1856060606060606" ESTIMABLE="YES" EVENTS_1="159" EVENTS_2="132" LOG_CI_END="0.14778195313977793" LOG_CI_START="9.886821345689364E-5" LOG_EFFECT_SIZE="0.0739404106766174" ORDER="1045" O_E="0.0" SE="0.08674977512878147" STUDY_ID="STD-Clegg-2006" TOTAL_1="318" TOTAL_2="313" VAR="0.007525523484894152" WEIGHT="32.7157508320005" />
<DICH_DATA CI_END="1.876739179263548" CI_START="1.139785666337104" EFFECT_SIZE="1.462559542711972" ESTIMABLE="YES" EVENTS_1="101" EVENTS_2="67" LOG_CI_END="0.27340392052900325" LOG_CI_START="0.056823191092064046" LOG_EFFECT_SIZE="0.16511355581053364" ORDER="1046" O_E="0.0" SE="0.12722059256315932" STUDY_ID="STD-Conaghan-2013" TOTAL_1="235" TOTAL_2="228" VAR="0.016185079172121388" WEIGHT="27.44257237950245" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="34.59681978343198" CI_END="1.153603034662048" CI_START="0.8462910427305773" CI_STUDY="95" CI_TOTAL="95" DF="27" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.9880708047004035" ESTIMABLE="YES" EVENTS_1="428" EVENTS_2="303" I2="21.958144797661465" I2_Q="0.0" ID="CMP-003.19" LOG_CI_END="0.06205638982962604" LOG_CI_START="-0.07248025573760247" LOG_EFFECT_SIZE="-0.005211932953988216" METHOD="PETO" NO="19" P_CHI2="0.14937599859643658" P_Q="1.0" P_Z="0.8792993113721372" Q="0.0" RANDOM="NO" SCALE="31.16630225034384" SORT_BY="STUDY" STUDIES="28" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="7685" TOTAL_2="5280" WEIGHT="99.99999999999999" Z="0.15185752307983275">
<NAME>Number withdrawn due to adverse events</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5980900764491854" CI_START="0.18940245044470763" EFFECT_SIZE="0.5501655900825186" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" LOG_CI_END="0.20360125470407875" LOG_CI_START="-0.7226144064957315" LOG_EFFECT_SIZE="-0.2595065758958264" ORDER="250" O_E="-2.0186666666666664" SE="0.5440636642302349" STUDY_ID="STD-Asmus-2014-Study-1" TOTAL_1="188" TOTAL_2="187" VAR="3.3783182222222217" WEIGHT="2.1098760872910347" />
<DICH_DATA CI_END="1.260141562062084" CI_START="0.19032564632649362" EFFECT_SIZE="0.4897318217783519" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="12" LOG_CI_END="0.10041933572790009" LOG_CI_START="-0.720502686712357" LOG_EFFECT_SIZE="-0.3100416754922284" ORDER="251" O_E="-3.07012987012987" SE="0.48221365961095547" STUDY_ID="STD-Asmus-2014-Study-2" TOTAL_1="194" TOTAL_2="191" VAR="4.300520113003878" WEIGHT="2.6858229309649007" />
<DICH_DATA CI_END="4.776951065149925" CI_START="0.9185987122143581" EFFECT_SIZE="2.0947794864275635" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="8" LOG_CI_END="0.6791507924149819" LOG_CI_START="-0.03687416775609903" LOG_EFFECT_SIZE="0.3211383123294414" ORDER="48" O_E="4.18" SE="0.42059660598520876" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="203" VAR="5.652863157894737" WEIGHT="3.5304077404896574" />
<DICH_DATA CI_END="2.856764687503413" CI_START="0.390461565634169" EFFECT_SIZE="1.0561518889492127" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.45587446889951344" LOG_CI_START="-0.4084217086611593" LOG_EFFECT_SIZE="0.02372638011917706" ORDER="1482" O_E="0.21195652173913082" SE="0.5076918530342182" STUDY_ID="STD-Bingham-2007-Study-1" TOTAL_1="241" TOTAL_2="127" VAR="3.879713101296467" WEIGHT="2.4230144585345426" />
<DICH_DATA CI_END="0.6812965986664717" CI_START="0.09909129296576483" EFFECT_SIZE="0.25982794471541826" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="-0.16666377924505826" LOG_CI_START="-1.003964504778615" LOG_EFFECT_SIZE="-0.5853141420118366" ORDER="1483" O_E="-5.571428571428571" SE="0.4918345908838475" STUDY_ID="STD-Bingham-2007-Study-2" TOTAL_1="247" TOTAL_2="117" VAR="4.133918030021927" WEIGHT="2.581774191960889" />
<DICH_DATA CI_END="4.78321076788184" CI_START="0.11193133068315053" EFFECT_SIZE="0.7317042750913709" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.6797195180894647" LOG_CI_START="-0.9510483331472702" LOG_EFFECT_SIZE="-0.1356644075289028" ORDER="49" O_E="-0.34042553191489366" SE="0.9579211082475123" STUDY_ID="STD-Birbara-2006-Study-1" TOTAL_1="157" TOTAL_2="78" VAR="1.08978421608571" WEIGHT="0.6806077777699651" />
<DICH_DATA CI_END="4.3631607711265525" CI_START="0.26964793302104206" EFFECT_SIZE="1.08467381427449" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.6398012159037845" LOG_CI_START="-0.5692029044356971" LOG_EFFECT_SIZE="0.03529915573404369" ORDER="50" O_E="0.161157024793388" SE="0.7101750049543266" STUDY_ID="STD-Birbara-2006-Study-2" TOTAL_1="157" TOTAL_2="85" VAR="1.982755823256523" WEIGHT="1.2382993025666513" />
<DICH_DATA CI_END="1.5897903261085915" CI_START="0.2441979199753634" EFFECT_SIZE="0.6230758307242167" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="0.20133984996910687" LOG_CI_START="-0.6122580396010836" LOG_EFFECT_SIZE="-0.20545909481598837" ORDER="51" O_E="-2.0713153724247224" SE="0.47791142770803596" STUDY_ID="STD-Clegg-2006" TOTAL_1="318" TOTAL_2="313" VAR="4.378296503890924" WEIGHT="2.7343969658823206" />
<DICH_DATA CI_END="2.1352007540972835" CI_START="0.4393275005329674" EFFECT_SIZE="0.968531058063533" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="13" LOG_CI_END="0.3294387141609758" LOG_CI_START="-0.35721161040210114" LOG_EFFECT_SIZE="-0.013886448120562648" ORDER="56" O_E="-0.19654427645788353" SE="0.40334179962227595" STUDY_ID="STD-Conaghan-2013" TOTAL_1="235" TOTAL_2="228" VAR="6.146863040443734" WEIGHT="3.838927681701444" />
<DICH_DATA CI_END="2.701828741504354" CI_START="0.6761836142102631" EFFECT_SIZE="1.3516406043795741" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="15" LOG_CI_END="0.431657817307473" LOG_CI_START="-0.16993535759315273" LOG_EFFECT_SIZE="0.13086122985716012" ORDER="631" O_E="2.412935323383085" SE="0.3533788088708708" STUDY_ID="STD-DeLemos-2011" TOTAL_1="202" TOTAL_2="200" VAR="8.007906522646628" WEIGHT="5.001213435210439" />
<DICH_DATA CI_END="7.182206165185008" CI_START="0.43378883351003006" EFFECT_SIZE="1.765095134666727" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="0.8562578673894871" LOG_CI_START="-0.3627216316841897" LOG_EFFECT_SIZE="0.2467681178526487" ORDER="54" O_E="1.108247422680412" SE="0.716034591801714" STUDY_ID="STD-Essex-2012b" TOTAL_1="127" TOTAL_2="67" VAR="1.950437294906156" WEIGHT="1.2181152684829637" />
<DICH_DATA CI_END="11.75089305821319" CI_START="0.1747573589775922" EFFECT_SIZE="1.4330230411551166" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.0700708738856686" LOG_CI_START="-0.7575645271927571" LOG_EFFECT_SIZE="0.15625317334645572" ORDER="55" O_E="0.3121693121693121" SE="1.0735620815346096" STUDY_ID="STD-Essex-2014" TOTAL_1="127" TOTAL_2="62" VAR="0.8676522005352355" WEIGHT="0.5418786832906949" />
<DICH_DATA CI_END="1.8534434606690866" CI_START="0.5509360642874251" EFFECT_SIZE="1.0105092011457846" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="17" LOG_CI_END="0.26797934240553745" LOG_CI_START="-0.2588987977693963" LOG_EFFECT_SIZE="0.004540272318070587" ORDER="52" O_E="0.10914454277286012" SE="0.30949082762761265" STUDY_ID="STD-Fleischmann-2005" TOTAL_1="446" TOTAL_2="232" VAR="10.440094632087956" WEIGHT="6.5201986800428" />
<DICH_DATA CI_END="3.25532916560611" CI_START="0.3866650595071892" EFFECT_SIZE="1.1219278254569565" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.512594909211006" LOG_CI_START="-0.41266507061845903" LOG_EFFECT_SIZE="0.04996491929627351" ORDER="53" O_E="0.3894736842105271" SE="0.543502292262595" STUDY_ID="STD-Gibofsky-2003" TOTAL_1="189" TOTAL_2="96" VAR="3.3853006125395027" WEIGHT="2.1142368305347166" />
<DICH_DATA CI_END="2.8182426848653908" CI_START="0.47211220878772575" EFFECT_SIZE="1.1534846244539414" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="7" LOG_CI_END="0.44997838840420473" LOG_CI_START="-0.32595476859949696" LOG_EFFECT_SIZE="0.06201180990235392" ORDER="128" O_E="0.6873315363881396" SE="0.4557869773550473" STUDY_ID="STD-Hochberg-2011-Study-307" TOTAL_1="247" TOTAL_2="124" VAR="4.813668460273759" WEIGHT="3.006301747914674" />
<DICH_DATA CI_END="4.043009853261113" CI_START="0.7913133215756869" EFFECT_SIZE="1.788655236804254" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="6" LOG_CI_END="0.606704799758536" LOG_CI_START="-0.10165152296437481" LOG_EFFECT_SIZE="0.2525266383970806" ORDER="129" O_E="3.3584905660377373" SE="0.4160920103877861" STUDY_ID="STD-Hochberg-2011-Study-309" TOTAL_1="247" TOTAL_2="124" VAR="5.775921026045625" WEIGHT="3.607261617562784" />
<DICH_DATA CI_END="3.51048989054726" CI_START="0.9957643869283799" EFFECT_SIZE="1.8696579402872247" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="16" LOG_CI_END="0.5453677266981793" LOG_CI_START="-0.0018434101323229891" LOG_EFFECT_SIZE="0.27176215828292816" ORDER="57" O_E="6.0564705882352925" SE="0.3214345305130504" STUDY_ID="STD-Kivitz-2001" TOTAL_1="207" TOTAL_2="218" VAR="9.678653470000652" WEIGHT="6.044652448429862" />
<DICH_DATA CI_END="2.4820171606697676" CI_START="0.6533868841094699" EFFECT_SIZE="1.2734667089940956" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="16" LOG_CI_END="0.394804779885685" LOG_CI_START="-0.1848295876690503" LOG_EFFECT_SIZE="0.10498759610831733" ORDER="58" O_E="2.0853080568720372" SE="0.3404800967380454" STUDY_ID="STD-Lehmann-2005" TOTAL_1="420" TOTAL_2="424" VAR="8.626140760795757" WEIGHT="5.387322010428501" />
<DICH_DATA CI_END="19.569904435818767" CI_START="0.5531709814923205" EFFECT_SIZE="3.2902132521270993" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.291588704906958" LOG_CI_START="-0.25714061039264124" LOG_EFFECT_SIZE="0.5172240472571584" ORDER="59" O_E="1.4390243902439024" SE="0.9097312661407365" STUDY_ID="STD-McKenna-2001a" TOTAL_1="63" TOTAL_2="60" VAR="1.208297168937303" WEIGHT="0.7546231987007225" />
<DICH_DATA CI_END="2.1655175141785863" CI_START="0.46677653272825004" EFFECT_SIZE="1.0053918424328794" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="14" LOG_CI_END="0.3355617005481313" LOG_CI_START="-0.3308909863087946" LOG_EFFECT_SIZE="0.0023353571196683886" ORDER="60" O_E="0.035087719298244835" SE="0.3914776072537637" STUDY_ID="STD-McKenna-2001b" TOTAL_1="199" TOTAL_2="200" VAR="6.5250846414281325" WEIGHT="4.075140098389946" />
<DICH_DATA CI_END="1.6806377405025106" CI_START="0.42518976818337084" EFFECT_SIZE="0.8453342364322449" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="20" LOG_CI_END="0.22547411185980631" LOG_CI_START="-0.37141719493652864" LOG_EFFECT_SIZE="-0.07297154153836119" ORDER="61" O_E="-1.3667953667953654" SE="0.35061690827178793" STUDY_ID="STD-Rother-2007" TOTAL_1="132" TOTAL_2="127" VAR="8.134564148930673" WEIGHT="5.080315485222166" />
<DICH_DATA CI_END="2.309648714558678" CI_START="0.6488564064317617" EFFECT_SIZE="1.224185592566863" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="18" LOG_CI_END="0.36354593100468136" LOG_CI_START="-0.18785140303666684" LOG_EFFECT_SIZE="0.08784726398400725" ORDER="629" O_E="1.928143712574851" SE="0.32389352347671163" STUDY_ID="STD-Schnitzer-2011" TOTAL_1="419" TOTAL_2="416" VAR="9.532251053830821" WEIGHT="5.953219097075776" />
<DICH_DATA CI_END="1.203075726669705" CI_START="0.33712588825877854" EFFECT_SIZE="0.6368578907386637" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="24" LOG_CI_END="0.08029296452996898" LOG_CI_START="-0.47220789625910337" LOG_EFFECT_SIZE="-0.1959574658645672" ORDER="62" O_E="-4.283870967741937" SE="0.32454174055087026" STUDY_ID="STD-Sheldon-2005" TOTAL_1="393" TOTAL_2="382" VAR="9.494210972097862" WEIGHT="5.929461755840416" />
<DICH_DATA CI_END="1.8839390903105258" CI_START="0.36238032842315626" EFFECT_SIZE="0.8262581111710495" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="9" LOG_CI_END="0.2750668574963221" LOG_CI_START="-0.44083538574453995" LOG_EFFECT_SIZE="-0.08288426412410897" ORDER="63" O_E="-1.0792079207920793" SE="0.42052452145293967" STUDY_ID="STD-Smugar-2006-Study-1" TOTAL_1="456" TOTAL_2="150" VAR="5.65480130371273" WEIGHT="3.531618179307459" />
<DICH_DATA CI_END="4.5123268811703365" CI_START="0.483475397142358" EFFECT_SIZE="1.4770237069559735" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="3" LOG_CI_END="0.6544005531974431" LOG_CI_START="-0.3156256211821625" LOG_EFFECT_SIZE="0.16938746600764026" ORDER="64" O_E="1.2013093289689039" SE="0.5697981765375845" STUDY_ID="STD-Smugar-2006-Study-2" TOTAL_1="460" TOTAL_2="151" VAR="3.0800508734605003" WEIGHT="1.9235978549349069" />
<DICH_DATA CI_END="1.9366020651642804" CI_START="0.6730795789790713" EFFECT_SIZE="1.141703684267846" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="21" LOG_CI_END="0.28704039064280934" LOG_CI_START="-0.17193358560019975" LOG_EFFECT_SIZE="0.05755340252130474" ORDER="65" O_E="1.8232044198894997" SE="0.2696035856029676" STUDY_ID="STD-Tannenbaum-2004" TOTAL_1="481" TOTAL_2="243" VAR="13.757789882996445" WEIGHT="8.592213633745525" />
<DICH_DATA CI_END="0.9120506225673598" CI_START="0.2366640336618184" EFFECT_SIZE="0.46459614639013536" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="20" LOG_CI_END="-0.03998105586947748" LOG_CI_START="-0.6258677377153931" LOG_EFFECT_SIZE="-0.33292439679243524" ORDER="66" O_E="-6.472303206997086" SE="0.34415273710213956" STUDY_ID="STD-Williams-2000" TOTAL_1="454" TOTAL_2="232" VAR="8.443014675659311" WEIGHT="5.272953462952102" />
<DICH_DATA CI_END="1.356838846755815" CI_START="0.2664822073295838" EFFECT_SIZE="0.601309746199092" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="12" LOG_CI_END="0.13252826908877197" LOG_CI_START="-0.5743317829471419" LOG_EFFECT_SIZE="-0.22090175692918496" ORDER="67" O_E="-2.950344827586207" SE="0.4152130935795848" STUDY_ID="STD-Williams-2001" TOTAL_1="482" TOTAL_2="243" VAR="5.800399671530209" WEIGHT="3.622549374772117" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="28.385019547420754" CI_END="1.359861051512678" CI_START="0.6624968973947831" CI_STUDY="95" CI_TOTAL="95" DF="25" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.9491594847627856" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="56" I2="11.925373318012523" I2_Q="0.0" ID="CMP-003.20" LOG_CI_END="0.13349453510244957" LOG_CI_START="-0.1788161512741438" LOG_EFFECT_SIZE="-0.022660808085847133" METHOD="PETO" NO="20" P_CHI2="0.2904360608029444" P_Q="1.0" P_Z="0.7760852710246676" Q="0.0" RANDOM="NO" SCALE="867.3438408563752" SORT_BY="STUDY" STUDIES="28" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="7745" TOTAL_2="5648" WEIGHT="100.0" Z="0.284424258574862">
<NAME>Number experiencing any serious adverse events</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="15.875406991882377" CI_START="0.061639511645682855" EFFECT_SIZE="0.9892180417663683" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2007248679522327" LOG_CI_START="-1.2101408107457228" LOG_EFFECT_SIZE="-0.004707971396745059" ORDER="252" O_E="-0.00540540540540535" SE="1.4161544336447573" STUDY_ID="STD-Asmus-2014-Study-1" TOTAL_1="186" TOTAL_2="184" VAR="0.4986304168374042" WEIGHT="1.6781379581246745" />
<DICH_DATA CI_END="15.39205603945664" CI_START="0.05970602879886116" EFFECT_SIZE="0.9586441160125496" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.187296635877631" LOG_CI_START="-1.223981813897704" LOG_EFFECT_SIZE="-0.018342589010036717" ORDER="253" O_E="-0.021052631578947434" SE="1.4163968974188599" STUDY_ID="STD-Asmus-2014-Study-2" TOTAL_1="194" TOTAL_2="186" VAR="0.49845971685219165" WEIGHT="1.6775634682520884" />
<DICH_DATA CI_END="284.2081739859958" CI_START="0.07458878874976352" EFFECT_SIZE="4.604209318699302" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.4536365643232028" LOG_CI_START="-1.1273264453157614" LOG_EFFECT_SIZE="0.6631550595037208" ORDER="1484" O_E="0.34510869565217395" SE="2.1034753979147074" STUDY_ID="STD-Bingham-2007-Study-1" TOTAL_1="241" TOTAL_2="127" VAR="0.2260086838374291" WEIGHT="0.7606309972403142" />
<DICH_DATA CI_END="2.961187184303358" CI_START="6.702817001705855E-4" EFFECT_SIZE="0.044551426244489684" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.4714658611348646" LOG_CI_START="-3.173742637421765" LOG_EFFECT_SIZE="-1.3511383881434502" ORDER="1485" O_E="-0.6785714285714286" SE="2.141213516125243" STUDY_ID="STD-Bingham-2007-Study-2" TOTAL_1="247" TOTAL_2="117" VAR="0.2181122448979592" WEIGHT="0.7340555749016903" />
<DICH_DATA CI_END="11.609901695887325" CI_START="0.17251365099971963" EFFECT_SIZE="1.415226670645151" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.064828542467736" LOG_CI_START="-0.7631765335224092" LOG_EFFECT_SIZE="0.15082600447266328" ORDER="1014" O_E="0.3012048192771086" SE="1.073779230407674" STUDY_ID="STD-Birbara-2006-Study-1" TOTAL_1="168" TOTAL_2="81" VAR="0.8673013078353053" WEIGHT="2.9188978382845017" />
<DICH_DATA CI_END="11.609901695887325" CI_START="0.17251365099971963" EFFECT_SIZE="1.415226670645151" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.064828542467736" LOG_CI_START="-0.7631765335224092" LOG_EFFECT_SIZE="0.15082600447266328" ORDER="1015" O_E="0.3012048192771086" SE="1.073779230407674" STUDY_ID="STD-Birbara-2006-Study-2" TOTAL_1="168" TOTAL_2="81" VAR="0.8673013078353053" WEIGHT="2.9188978382845017" />
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="68" O_E="0.0" SE="0.0" STUDY_ID="STD-Boswell-2008-Study-A" TOTAL_1="109" TOTAL_2="107" VAR="0.0" WEIGHT="0.0" />
<DICH_DATA CI_END="4.975106358844346" CI_START="0.05317346139879427" EFFECT_SIZE="0.5143380463536659" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6968023696175144" LOG_CI_START="-1.274305067775602" LOG_EFFECT_SIZE="-0.28875134907904376" ORDER="69" O_E="-0.49595687331536387" SE="1.1578382658638928" STUDY_ID="STD-Boswell-2008-Study-B" TOTAL_1="185" TOTAL_2="186" VAR="0.745940526441976" WEIGHT="2.5104587880245024" />
<DICH_DATA CI_END="116.92451939432895" CI_START="0.4553605172658577" EFFECT_SIZE="7.296767067164981" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0679055934634163" LOG_CI_START="-0.341644628259592" LOG_EFFECT_SIZE="0.8631304826019122" ORDER="70" O_E="0.9920760697305864" SE="1.4153817277060563" STUDY_ID="STD-Clegg-2006" TOTAL_1="318" TOTAL_2="313" VAR="0.4991750047031705" WEIGHT="1.6799707656274196" />
<DICH_DATA CI_END="19.01671594627203" CI_START="0.5618900765840315" EFFECT_SIZE="3.268838322619759" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.2791355194596166" LOG_CI_START="-0.2503486378158543" LOG_EFFECT_SIZE="0.5143934408218811" ORDER="71" O_E="1.4673913043478262" SE="0.8984265650522947" STUDY_ID="STD-Conaghan-2013" TOTAL_1="233" TOTAL_2="227" VAR="1.2388959416995111" WEIGHT="4.1694975591721795" />
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="630" O_E="0.0" SE="0.0" STUDY_ID="STD-DeLemos-2011" TOTAL_1="202" TOTAL_2="200" VAR="0.0" WEIGHT="0.0" />
<DICH_DATA CI_END="284.17307275401805" CI_START="0.07468579590770286" EFFECT_SIZE="4.606917854072436" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.4535829233156474" LOG_CI_START="-1.1267619864773664" LOG_EFFECT_SIZE="0.6634104684191405" ORDER="72" O_E="0.34536082474226804" SE="2.1031123230055524" STUDY_ID="STD-Essex-2012b" TOTAL_1="127" TOTAL_2="67" VAR="0.22608672547560849" WEIGHT="0.7608936459495" />
<DICH_DATA CI_END="4.773301798954783" CI_START="0.11457488657259113" EFFECT_SIZE="0.739527222076368" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.6788188941351703" LOG_CI_START="-0.9409105640279469" LOG_EFFECT_SIZE="-0.13104583494638822" ORDER="73" O_E="-0.3333333333333335" SE="0.9514371015151422" STUDY_ID="STD-Fleischmann-2005" TOTAL_1="462" TOTAL_2="231" VAR="1.104688503532434" WEIGHT="3.7178231553536043" />
<DICH_DATA CI_END="2.6236913066814846" CI_START="0.08615776666843859" EFFECT_SIZE="0.4754486127975074" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.418912736309097" LOG_CI_START="-1.0647055670933636" LOG_EFFECT_SIZE="-0.3228964153921334" ORDER="74" O_E="-0.9789473684210526" SE="0.8714847354476501" STUDY_ID="STD-Gibofsky-2003" TOTAL_1="189" TOTAL_2="96" VAR="1.316680582107604" WEIGHT="4.431281343755188" />
<DICH_DATA CI_END="29.67652524560033" CI_START="0.7143346892789872" EFFECT_SIZE="4.604234077476506" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="1.4724130490663956" LOG_CI_START="-0.14609825930197326" LOG_EFFECT_SIZE="0.6631573948822111" ORDER="130" O_E="1.6893732970027249" SE="0.9507215542957683" STUDY_ID="STD-Hochberg-2011-Study-307" TOTAL_1="243" TOTAL_2="124" VAR="1.106351985855941" WEIGHT="3.7234215960733903" />
<DICH_DATA CI_END="11.744035102008365" CI_START="0.1800778774854474" EFFECT_SIZE="1.4542492614006224" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.0698173406463953" LOG_CI_START="-0.7445396368535514" LOG_EFFECT_SIZE="0.16263885189642194" ORDER="131" O_E="0.3297002724795641" SE="1.0657622697953544" STUDY_ID="STD-Hochberg-2011-Study-309" TOTAL_1="245" TOTAL_2="122" VAR="0.8803985477655932" WEIGHT="2.9629765280946527" />
<DICH_DATA CI_END="2.582016891162869" CI_START="0.2889557163854812" EFFECT_SIZE="0.8637641694961535" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.41195907902832263" LOG_CI_START="-0.539168709503138" LOG_EFFECT_SIZE="-0.06360481523740766" ORDER="75" O_E="-0.4691943127962084" SE="0.5586971711418653" STUDY_ID="STD-Lehmann-2005" TOTAL_1="420" TOTAL_2="424" VAR="3.20366469468085" WEIGHT="10.781916120052749" />
<DICH_DATA CI_END="372.3848896839504" CI_START="0.1466175227450357" EFFECT_SIZE="7.38905609893065" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.570992050236215" LOG_CI_START="-0.8338141226232083" LOG_EFFECT_SIZE="0.8685889638065036" ORDER="76" O_E="0.5" SE="2.0" STUDY_ID="STD-McKenna-2001a" TOTAL_1="63" TOTAL_2="63" VAR="0.25" WEIGHT="0.8413736414077853" />
<DICH_DATA CI_END="6.8547392913343455" CI_START="0.002698820966569262" EFFECT_SIZE="0.13601365416684918" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8359909417676903" LOG_CI_START="-2.568825924561665" LOG_EFFECT_SIZE="-0.8664174913969873" ORDER="77" O_E="-0.49874686716791977" SE="2.0000062813971713" STUDY_ID="STD-McKenna-2001b" TOTAL_1="199" TOTAL_2="200" VAR="0.24999842965810518" WEIGHT="0.8413683564306721" />
<DICH_DATA CI_END="1.4248449550513311" CI_START="0.041618685220949206" EFFECT_SIZE="0.24351626983209743" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.15376760902588374" LOG_CI_START="-1.3807116437376994" LOG_EFFECT_SIZE="-0.6134720173559078" ORDER="78" O_E="-1.7386541471048513" SE="0.9013607088681332" STUDY_ID="STD-Pincus-2004-PACES_x002d_a" TOTAL_1="350" TOTAL_2="289" VAR="1.230843266951775" WEIGHT="4.142396326069878" />
<DICH_DATA CI_END="14.315141955795747" CI_START="0.14553029785824187" EFFECT_SIZE="1.4433595784522895" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.1557956590508125" LOG_CI_START="-0.8370465817787263" LOG_EFFECT_SIZE="0.15937453863604317" ORDER="79" O_E="0.2678018575851393" SE="1.1706053969914596" STUDY_ID="STD-Pincus-2004-PACES_x002d_b" TOTAL_1="373" TOTAL_2="273" VAR="0.7297581532660432" WEIGHT="2.455997099041886" />
<DICH_DATA CI_END="358.80527512243873" CI_START="0.1410645900602949" EFFECT_SIZE="7.114402226935033" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.554858819376864" LOG_CI_START="-0.8505819888777393" LOG_EFFECT_SIZE="0.8521384152495625" ORDER="80" O_E="0.49034749034749037" SE="2.0003727879726245" STUDY_ID="STD-Rother-2007" TOTAL_1="132" TOTAL_2="127" VAR="0.2499068290574082" WEIGHT="0.8410600751068178" />
<DICH_DATA CI_END="1.3598104571308713" CI_START="0.1521531734507855" EFFECT_SIZE="0.45486204100147265" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.13347837663568865" LOG_CI_START="-0.817718985154043" LOG_EFFECT_SIZE="-0.34212030425917717" ORDER="628" O_E="-2.523353293413174" SE="0.558738038818167" STUDY_ID="STD-Schnitzer-2011" TOTAL_1="419" TOTAL_2="416" VAR="3.2031960616740927" WEIGHT="10.780338938215232" />
<DICH_DATA CI_END="1.8425051305513294" CI_START="0.133182517536273" EFFECT_SIZE="0.495368016590015" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.265408705848337" LOG_CI_START="-0.8755527799392129" LOG_EFFECT_SIZE="-0.30507203704543795" ORDER="81" O_E="-1.5638709677419351" SE="0.6702064246020488" STUDY_ID="STD-Sheldon-2005" TOTAL_1="393" TOTAL_2="382" VAR="2.226295593253152" WEIGHT="7.492585720582039" />
<DICH_DATA CI_END="0.6470319040106242" CI_START="0.025594537453993" EFFECT_SIZE="0.12868753747402395" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="-0.18907430450261645" LOG_CI_START="-1.5918527146385892" LOG_EFFECT_SIZE="-0.8904635095706029" ORDER="82" O_E="-3.01980198019802" SE="0.8239989819789898" STUDY_ID="STD-Smugar-2006-Study-1" TOTAL_1="456" TOTAL_2="150" VAR="1.4728097472213468" WEIGHT="4.9567332004820175" />
<DICH_DATA CI_END="52.4742129467474" CI_START="0.2738810011018716" EFFECT_SIZE="3.7910011835777584" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="1.7199459333821567" LOG_CI_START="-0.5624380933495412" LOG_EFFECT_SIZE="0.5787539200163078" ORDER="83" O_E="0.7414075286415711" SE="1.3406836752853433" STUDY_ID="STD-Smugar-2006-Study-2" TOTAL_1="460" TOTAL_2="151" VAR="0.5563490585454499" WEIGHT="1.8723897331287132" />
<DICH_DATA CI_END="4.065982523783019" CI_START="0.7502303750794275" EFFECT_SIZE="1.7465461900230783" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="8" LOG_CI_END="0.6091655076416876" LOG_CI_START="-0.1248053562579061" LOG_EFFECT_SIZE="0.24218007569189073" ORDER="84" O_E="3.0" SE="0.43113811866899343" STUDY_ID="STD-Tannenbaum-2004" TOTAL_1="481" TOTAL_2="481" VAR="5.379812695109261" WEIGHT="18.10573038950364" />
<DICH_DATA CI_END="11.12020648651447" CI_START="0.09142725108809233" EFFECT_SIZE="1.008310423725745" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.0461128515555025" LOG_CI_START="-1.0389243378195467" LOG_EFFECT_SIZE="0.003594256867977887" ORDER="85" O_E="0.0055172413793103114" SE="1.224761166139448" STUDY_ID="STD-Williams-2001" TOTAL_1="482" TOTAL_2="243" VAR="0.6666489275461336" WEIGHT="2.243603342840341" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.932433240466248" CI_END="14.901356983515567" CI_START="0.2444525718290594" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.9085793246190461" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="23.711355881929588" I2_Q="0.0" ID="CMP-003.21" LOG_CI_END="1.1732258189906977" LOG_CI_START="-0.611805389264153" LOG_EFFECT_SIZE="0.2807102148632722" METHOD="PETO" NO="21" P_CHI2="0.26885322221202623" P_Q="1.0" P_Z="0.5376044651775731" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2010" TOTAL_2="1253" WEIGHT="100.0" Z="0.6164395431073761">
<NAME>Number experiencing gastro-intestinal events (perforation, ulcer, bleeds)</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="384.070407328942" CI_START="0.15108507614994726" EFFECT_SIZE="7.617565670096613" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.5844108460122106" LOG_CI_START="-0.8207784321918987" LOG_EFFECT_SIZE="0.8818162069101559" ORDER="86" O_E="0.5075000000000001" SE="2.0002250379758704" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="203" VAR="0.24994375000000002" WEIGHT="27.479518095318397" />
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="87" O_E="0.0" SE="0.0" STUDY_ID="STD-Boswell-2008-Study-A" TOTAL_1="109" TOTAL_2="107" VAR="0.0" WEIGHT="0.0" />
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="88" O_E="0.0" SE="0.0" STUDY_ID="STD-Boswell-2008-Study-B" TOTAL_1="185" TOTAL_2="186" VAR="0.0" WEIGHT="0.0" />
<DICH_DATA CI_END="366.62068876150846" CI_START="0.14431248311801925" EFFECT_SIZE="7.273784569095499" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.564216968977096" LOG_CI_START="-0.8406961005434362" LOG_EFFECT_SIZE="0.8617604342168298" ORDER="89" O_E="0.4960380348652932" SE="2.000062791627882" STUDY_ID="STD-Clegg-2006" TOTAL_1="318" TOTAL_2="313" VAR="0.24998430283227138" WEIGHT="27.48397658763204" />
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="90" O_E="0.0" SE="0.0" STUDY_ID="STD-Essex-2014" TOTAL_1="96" TOTAL_2="47" VAR="0.0" WEIGHT="0.0" />
<DICH_DATA CI_END="3.248448187395724" CI_START="8.122702918057922E-4" EFFECT_SIZE="0.05136747956725073" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.5116759441789367" LOG_CI_START="-3.090299430479494" LOG_EFFECT_SIZE="-1.289311743150279" ORDER="91" O_E="-0.6631578947368421" SE="2.1158181651400265" STUDY_ID="STD-Gibofsky-2003" TOTAL_1="189" TOTAL_2="96" VAR="0.22337950138504153" WEIGHT="24.558969969977042" />
<DICH_DATA CI_END="354.3828354091645" CI_START="0.04025653017527818" EFFECT_SIZE="3.777065435923725" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.5494726785998587" LOG_CI_START="-1.395163660909637" LOG_EFFECT_SIZE="0.577154508845111" ORDER="92" O_E="0.24752475247524752" SE="2.317098912092674" STUDY_ID="STD-Smugar-2006-Study-1" TOTAL_1="456" TOTAL_2="150" VAR="0.18625624938731497" WEIGHT="20.47753534707252" />
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="93" O_E="0.0" SE="0.0" STUDY_ID="STD-Smugar-2006-Study-2" TOTAL_1="460" TOTAL_2="151" VAR="0.0" WEIGHT="0.0" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.5362025263616788" CI_END="15.875655767140662" CI_START="0.730130633429983" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="3.404600211681068" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-003.22" LOG_CI_END="1.2007316735021905" LOG_CI_START="-0.13659942987655377" LOG_EFFECT_SIZE="0.5320661218128184" METHOD="PETO" NO="22" P_CHI2="0.9698823207237863" P_Q="1.0" P_Z="0.1188616360389514" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1785" TOTAL_2="1162" WEIGHT="100.0" Z="1.5595695538858432">
<NAME>Number experiencing cardiovascular events (myocardial infarction, stroke)</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="366.62068876150846" CI_START="0.14431248311801925" EFFECT_SIZE="7.273784569095499" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.564216968977096" LOG_CI_START="-0.8406961005434362" LOG_EFFECT_SIZE="0.8617604342168298" ORDER="94" O_E="0.4960380348652932" SE="2.000062791627882" STUDY_ID="STD-Clegg-2006" TOTAL_1="318" TOTAL_2="313" VAR="0.24998430283227138" WEIGHT="15.426444249676315" />
<DICH_DATA CI_END="372.3848896839504" CI_START="0.1466175227450357" EFFECT_SIZE="7.38905609893065" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.570992050236215" LOG_CI_START="-0.8338141226232083" LOG_EFFECT_SIZE="0.8685889638065036" ORDER="95" O_E="0.5" SE="2.0" STUDY_ID="STD-Rother-2007" TOTAL_1="132" TOTAL_2="132" VAR="0.25" WEIGHT="15.427412916428986" />
<DICH_DATA CI_END="18.671148663410307" CI_START="0.20092375811768334" EFFECT_SIZE="1.9368730876922111" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2711710369011553" LOG_CI_START="-0.6969687073066936" LOG_EFFECT_SIZE="0.2871011647972309" ORDER="627" O_E="0.49461077844311374" SE="1.1560950281965483" STUDY_ID="STD-Schnitzer-2011" TOTAL_1="419" TOTAL_2="416" VAR="0.7481917808289852" WEIGHT="46.170654174108364" />
<DICH_DATA CI_END="354.3828354091645" CI_START="0.04025653017527818" EFFECT_SIZE="3.777065435923725" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.5494726785998587" LOG_CI_START="-1.395163660909637" LOG_EFFECT_SIZE="0.577154508845111" ORDER="96" O_E="0.24752475247524752" SE="2.317098912092674" STUDY_ID="STD-Smugar-2006-Study-1" TOTAL_1="456" TOTAL_2="150" VAR="0.18625624938731497" WEIGHT="11.493808270253925" />
<DICH_DATA CI_END="354.9898388644554" CI_START="0.040132555065535785" EFFECT_SIZE="3.774473374648897" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.5502159221022676" LOG_CI_START="-1.3965031897418898" LOG_EFFECT_SIZE="0.5768563661801889" ORDER="97" O_E="0.2471358428805237" SE="2.3183223428719435" STUDY_ID="STD-Smugar-2006-Study-2" TOTAL_1="460" TOTAL_2="151" VAR="0.1860597180442568" WEIGHT="11.48168038953241" />
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" NO="4">
<NAME>Celecoxib versus tNSAIDs (all eligible studies)</NAME>
<CONT_OUTCOME CHI2="9.898972045326138" CI_END="0.10400302831420792" CI_START="-0.0954892761898165" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.004256876062195714" ESTIMABLE="YES" I2="29.28558674630166" I2_Q="0.0" ID="CMP-004.01" NO="1" P_CHI2="0.1943714385481532" P_Q="1.0" P_Z="0.9333382341816334" Q="0.0" RANDOM="YES" SCALE="1.1238613623084368" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0059602356404316464" TOTALS="YES" TOTAL_1="1148" TOTAL_2="1129" UNITS="" WEIGHT="99.99999999999999" Z="0.08364557008148626">
<NAME>All pain under 24 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>tNSAIDs</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors tNSAIDs</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.15631963082650893" CI_START="-0.23818932125798456" EFFECT_SIZE="-0.040934845215737814" ESTIMABLE="YES" MEAN_1="-27.5" MEAN_2="-27.0" ORDER="186" SD_1="9.9499" SD_2="14.0712" SE="0.10064188811537604" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="198" WEIGHT="16.09779479546185" />
<CONT_DATA CI_END="0.9206943388578462" CI_START="0.11487969795194364" EFFECT_SIZE="0.5177870184048949" ESTIMABLE="YES" MEAN_1="-17.0" MEAN_2="-30.0" ORDER="191" SD_1="23.5" SD_2="26.3" SE="0.2055687367885496" STUDY_ID="STD-Emery-2008" TOTAL_1="50" TOTAL_2="48" WEIGHT="5.3713104305941215" />
<CONT_DATA CI_END="0.26274453864868275" CI_START="-0.18316818803136511" EFFECT_SIZE="0.03978817530865882" ESTIMABLE="YES" MEAN_1="-4.9" MEAN_2="-5.0" ORDER="189" SD_1="2.6" SD_2="2.4" SE="0.11375533688306279" STUDY_ID="STD-Essex-2012a" TOTAL_1="163" TOTAL_2="147" WEIGHT="13.703217311423296" />
<CONT_DATA CI_END="0.35213201488923274" CI_START="-0.19454442241752" EFFECT_SIZE="0.07879379623585638" ESTIMABLE="YES" MEAN_1="-36.2" MEAN_2="-38.0" ORDER="184" SD_1="19.1" SD_2="25.7391" SE="0.13946083744876608" STUDY_ID="STD-Essex-2012b" TOTAL_1="100" TOTAL_2="106" WEIGHT="10.1929281379326" />
<CONT_DATA CI_END="0.1583825589487781" CI_START="-0.4079722870760486" EFFECT_SIZE="-0.12479486406363524" ESTIMABLE="YES" MEAN_1="-39.7" MEAN_2="-36.9" ORDER="185" SD_1="18.7061" SD_2="25.4747" SE="0.14448093191817846" STUDY_ID="STD-Essex-2014" TOTAL_1="96" TOTAL_2="96" WEIGHT="9.651502351287329" />
<CONT_DATA CI_END="0.109592317202632" CI_START="-0.27588362617415074" EFFECT_SIZE="-0.08314565448575938" ESTIMABLE="YES" MEAN_1="-23.3" MEAN_2="-22.3" ORDER="188" SD_1="9.5" SD_2="14.0712" SE="0.09833750681578024" STUDY_ID="STD-Kivitz-2001" TOTAL_1="207" TOTAL_2="207" WEIGHT="16.570027368161565" />
<CONT_DATA CI_END="0.2633144210999535" CI_START="-0.1297726291322073" EFFECT_SIZE="0.06677089598387312" ESTIMABLE="YES" MEAN_1="-34.9" MEAN_2="-36.8" ORDER="190" SD_1="28.1" SD_2="28.7" SE="0.10027915138563293" STUDY_ID="STD-McKenna-2001b" TOTAL_1="199" TOTAL_2="199" WEIGHT="16.17104778881507" />
<CONT_DATA CI_END="0.11561095459059681" CI_START="-0.3676060519332742" EFFECT_SIZE="-0.12599754867133872" ESTIMABLE="YES" MEAN_1="-18.7" MEAN_2="-15.0" ORDER="187" SD_1="29.1548" SD_2="29.4156" SE="0.12327190967166364" STUDY_ID="STD-Sowers-2005" TOTAL_1="136" TOTAL_2="128" WEIGHT="12.24217181632415" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.3156624824477188" CI_START="-5.315662482447719" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.23710821451820674" Q="0.0" RANDOM="YES" SCALE="13.230165573045436" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="458" TOTAL_2="458" UNITS="" WEIGHT="100.0" Z="1.182245777376684">
<NAME>All pain over 24 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>tNSAIDs</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors tNSAIDs</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.3156624824477188" CI_START="-5.315662482447719" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="40.0" MEAN_2="42.0" ORDER="192" SD_1="25.6" SD_2="25.6" SE="1.6916956171650301" STUDY_ID="STD-Dahlberg-2009" TOTAL_1="458" TOTAL_2="458" WEIGHT="100.0" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="18.584673537723525" CI_END="0.20647247800687646" CI_START="-0.09432090236203422" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.05607578782242111" ESTIMABLE="YES" I2="67.71533281001096" I2_Q="0.0" ID="CMP-004.03" NO="3" P_CHI2="0.004925715586826751" P_Q="1.0" P_Z="0.464915044898085" Q="0.0" RANDOM="YES" SCALE="0.5743182609155232" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.027735690002634046" TOTALS="YES" TOTAL_1="1044" TOTAL_2="1132" UNITS="" WEIGHT="100.0" Z="0.7307775483746306">
<NAME>All physical function under 24 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>tNSAIDs</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors tNSAIDs</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.05678011718022974" CI_START="-0.4528610458604379" EFFECT_SIZE="-0.2548205815203338" ESTIMABLE="YES" MEAN_1="-9.9" MEAN_2="-8.1" ORDER="195" SD_1="7.0" SD_2="7.1" SE="0.10104290992192815" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="198" WEIGHT="15.517498139627916" />
<CONT_DATA CI_END="0.256281981522353" CI_START="-0.19582807002241662" EFFECT_SIZE="0.03022695574996819" ESTIMABLE="YES" MEAN_1="-15.4" MEAN_2="-15.7" ORDER="198" SD_1="9.9" SD_2="9.9" SE="0.11533631615452018" STUDY_ID="STD-Essex-2012a" TOTAL_1="155" TOTAL_2="146" WEIGHT="14.348038694364895" />
<CONT_DATA CI_END="0.4705925194324363" CI_START="-0.02778637435387435" EFFECT_SIZE="0.22140307253928096" ESTIMABLE="YES" MEAN_1="-16.0" MEAN_2="-18.3" ORDER="193" SD_1="10.23" SD_2="10.4809" SE="0.12713980912849923" STUDY_ID="STD-Essex-2012b" TOTAL_1="124" TOTAL_2="125" WEIGHT="13.412621472612622" />
<CONT_DATA CI_END="0.22706575916828436" CI_START="-0.26492274943623095" EFFECT_SIZE="-0.018928495133973284" ESTIMABLE="YES" MEAN_1="-16.3" MEAN_2="-16.0" ORDER="194" SD_1="15.7" SD_2="15.9" SE="0.1255095788711573" STUDY_ID="STD-Essex-2014" TOTAL_1="125" TOTAL_2="129" WEIGHT="13.53965196864289" />
<CONT_DATA CI_END="0.49553275891633974" CI_START="0.10801703563612383" EFFECT_SIZE="0.3017748972762318" ESTIMABLE="YES" MEAN_1="-6.6" MEAN_2="-7.9" ORDER="196" SD_1="4.3" SD_2="4.3" SE="0.09885786839372827" STUDY_ID="STD-Kivitz-2001" TOTAL_1="207" TOTAL_2="207" WEIGHT="15.698201153815766" />
<CONT_DATA CI_END="0.3811607656272442" CI_START="-0.09986801047180657" EFFECT_SIZE="0.14064637757771883" ESTIMABLE="YES" MEAN_1="-13.2" MEAN_2="-15.1" ORDER="199" SD_1="12.8" SD_2="13.8" SE="0.12271367736686602" STUDY_ID="STD-McKenna-2001b" TOTAL_1="100" TOTAL_2="199" WEIGHT="13.75922830717661" />
<CONT_DATA CI_END="0.22259048387256894" CI_START="-0.26015177784918203" EFFECT_SIZE="-0.018780646988306556" ESTIMABLE="YES" MEAN_1="-14.6" MEAN_2="-14.2" ORDER="197" SD_1="20.9914" SD_2="21.496" SE="0.1231507990783403" STUDY_ID="STD-Sowers-2005" TOTAL_1="136" TOTAL_2="128" WEIGHT="13.7247602637593" />
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="13.561426826584324" CI_END="1.0694172995653988" CI_START="0.6802224156799395" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.852901881156498" ESTIMABLE="YES" EVENTS_1="158" EVENTS_2="181" I2="41.00915705773906" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="0.029147205241246556" LOG_CI_START="-0.1673490606630688" LOG_EFFECT_SIZE="-0.06910092771091111" METHOD="PETO" NO="4" P_CHI2="0.09393754359173567" P_Q="1.0" P_Z="0.16804809378547453" Q="0.0" RANDOM="NO" SCALE="11.17068221533397" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1873" TOTAL_2="1866" WEIGHT="100.0" Z="1.378502833001848">
<NAME>Number withdrawn due to adverse events</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>tNSAIDs</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors tNSAIDs</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.655095263043958" CI_START="0.8947543722620165" EFFECT_SIZE="2.0408740382259714" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="8" LOG_CI_END="0.6679285729201524" LOG_CI_START="-0.048296170731053606" LOG_EFFECT_SIZE="0.3098162010945494" ORDER="1370" O_E="4.030379746835443" SE="0.4207139597903784" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="198" VAR="5.6497099823746195" WEIGHT="7.526792823319381" />
<DICH_DATA CI_END="2.607880408076274" CI_START="0.7969976057250933" EFFECT_SIZE="1.4416915208373007" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="19" LOG_CI_END="0.41628767168280334" LOG_CI_START="-0.09854298327382746" LOG_EFFECT_SIZE="0.1588723442044879" ORDER="118" O_E="4.0" SE="0.30241407517436786" STUDY_ID="STD-Dahlberg-2009" TOTAL_1="458" TOTAL_2="458" VAR="10.934426229508198" WEIGHT="14.5673248942215" />
<DICH_DATA CI_END="2.491405028789388" CI_START="0.47905947690881984" EFFECT_SIZE="1.0924885307681027" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="12" LOG_CI_END="0.3964443367172593" LOG_CI_START="-0.3196105640598382" LOG_EFFECT_SIZE="0.0384168863287106" ORDER="133" O_E="0.5" SE="0.4206141932453913" STUDY_ID="STD-Emery-2008" TOTAL_1="126" TOTAL_2="126" VAR="5.652390438247012" WEIGHT="7.530363844856148" />
<DICH_DATA CI_END="0.9529665190635" CI_START="0.413840268692523" EFFECT_SIZE="0.6279935670882444" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="64" LOG_CI_END="-0.02092235732746359" LOG_CI_START="-0.38316725262612883" LOG_EFFECT_SIZE="-0.20204480497679614" ORDER="1371" O_E="-10.275042444821729" SE="0.2127844446395871" STUDY_ID="STD-Essex-2012a" TOTAL_1="296" TOTAL_2="293" VAR="22.08616170863813" WEIGHT="29.424158755380507" />
<DICH_DATA CI_END="2.955903343189299" CI_START="0.3439456502027573" EFFECT_SIZE="1.008300598685604" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.4706902287059268" LOG_CI_START="-0.46351017859666016" LOG_EFFECT_SIZE="0.003590025054633284" ORDER="1372" O_E="0.027450980392156765" SE="0.5487539436161365" STUDY_ID="STD-Essex-2012b" TOTAL_1="127" TOTAL_2="128" VAR="3.32081507112649" WEIGHT="4.42413630485508" />
<DICH_DATA CI_END="1.1365888783635527" CI_START="0.11240326705818857" EFFECT_SIZE="0.3574301375514737" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" LOG_CI_END="0.055603402114333525" LOG_CI_START="-0.9492210655932644" LOG_EFFECT_SIZE="-0.44680883173946545" ORDER="1373" O_E="-2.953125" SE="0.5902388662927772" STUDY_ID="STD-Essex-2014" TOTAL_1="127" TOTAL_2="129" VAR="2.870413028492647" WEIGHT="3.824090838330102" />
<DICH_DATA CI_END="1.6164314316881754" CI_START="0.5246492322185728" EFFECT_SIZE="0.9209014657221313" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="29" LOG_CI_END="0.20855728675700724" LOG_CI_START="-0.2801309583555879" LOG_EFFECT_SIZE="-0.0357868357992903" ORDER="1374" O_E="-1.0" SE="0.2870578942249655" STUDY_ID="STD-Kivitz-2001" TOTAL_1="207" TOTAL_2="207" VAR="12.135593220338983" WEIGHT="16.16757253779936" />
<DICH_DATA CI_END="1.2174522535783483" CI_START="0.30987337174088725" EFFECT_SIZE="0.6142117181801927" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="22" LOG_CI_END="0.08545193792440152" LOG_CI_START="-0.5088157422598" LOG_EFFECT_SIZE="-0.2116819021676992" ORDER="127" O_E="-4.0" SE="0.34907577701265957" STUDY_ID="STD-McKenna-2001b" TOTAL_1="199" TOTAL_2="199" VAR="8.206549118387908" WEIGHT="10.93312669167101" />
<DICH_DATA CI_END="1.5148516373143117" CI_START="0.22397635226533774" EFFECT_SIZE="0.5824868616104864" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="0.18037010065953807" LOG_CI_START="-0.6497978326605647" LOG_EFFECT_SIZE="-0.23471386600051333" ORDER="1375" O_E="-2.2727272727272734" SE="0.48764475342977376" STUDY_ID="STD-Sowers-2005" TOTAL_1="136" TOTAL_2="128" VAR="4.2052603462904194" WEIGHT="5.60243330956692" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.895106614207021" CI_END="1.2770017905910191" CI_START="0.6568866867550814" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.9158850775078939" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="82" I2="32.147113499862314" I2_Q="0.0" ID="CMP-004.05" LOG_CI_END="0.10619150622445973" LOG_CI_START="-0.18250953997026131" LOG_EFFECT_SIZE="-0.03815901687290079" METHOD="PETO" NO="5" P_CHI2="0.20712001695997706" P_Q="1.0" P_Z="0.6043774211305166" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1204" TOTAL_2="1200" WEIGHT="100.0" Z="0.5181158831402207">
<NAME>Number experiencing any serious adverse events</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>tNSAIDs</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors tNSAIDS</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3014568549118712" CI_START="0.6197747640355231" EFFECT_SIZE="0.8981147561171785" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="68" LOG_CI_END="0.11442977522337058" LOG_CI_START="-0.20776611132236658" LOG_EFFECT_SIZE="-0.046668168049498" ORDER="121" O_E="-3.0" SE="0.18925945865232655" STUDY_ID="STD-Dahlberg-2009" TOTAL_1="458" TOTAL_2="458" VAR="27.918032786885245" WEIGHT="80.28912636643405" />
<DICH_DATA CI_END="19.35282527145773" CI_START="0.5643221858014535" EFFECT_SIZE="3.304728227649383" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.2867443755686907" LOG_CI_START="-0.24847287551102107" LOG_EFFECT_SIZE="0.5191357500288348" ORDER="134" O_E="1.4698795180722892" SE="0.9017942127321779" STUDY_ID="STD-Emery-2008" TOTAL_1="126" TOTAL_2="123" VAR="1.2296601875828226" WEIGHT="3.5363645763389457" />
<DICH_DATA CI_END="2.938621894121037" CI_START="0.42738785080784336" EFFECT_SIZE="1.1206834056348223" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.4681437099717019" LOG_CI_START="-0.3691778275208183" LOG_EFFECT_SIZE="0.04948294122544176" ORDER="135" O_E="0.4709897610921505" SE="0.49184681593156354" STUDY_ID="STD-Essex-2012a" TOTAL_1="294" TOTAL_2="292" VAR="4.133712532230861" WEIGHT="11.888092918162382" />
<DICH_DATA CI_END="16.202665111980412" CI_START="0.06269790631499123" EFFECT_SIZE="1.0079053424028093" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2095864557913898" LOG_CI_START="-1.2027469614185309" LOG_EFFECT_SIZE="0.003419747186429325" ORDER="113" O_E="0.0039215686274509665" SE="1.4170165905121086" STUDY_ID="STD-Essex-2012b" TOTAL_1="127" TOTAL_2="128" VAR="0.49802383698577474" WEIGHT="1.4322606140082679" />
<DICH_DATA CI_END="0.9533084170540844" CI_START="0.018636373327002676" EFFECT_SIZE="0.13328995294467577" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="-0.020766572440967464" LOG_CI_START="-1.729638598275692" LOG_EFFECT_SIZE="-0.8752025853583297" ORDER="128" O_E="-2.0" SE="1.003799887028271" STUDY_ID="STD-McKenna-2001b" TOTAL_1="199" TOTAL_2="199" VAR="0.9924433249370277" WEIGHT="2.8541555250563544" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.842364195622825" CI_END="2.4312887366942735" CI_START="0.1514049573508451" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.6067200074884513" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" I2="38.04679122004495" I2_Q="0.0" ID="CMP-004.06" LOG_CI_END="0.38583653815504837" LOG_CI_START="-0.8198599047905683" LOG_EFFECT_SIZE="-0.21701168331776" METHOD="PETO" NO="6" P_CHI2="0.1837107946540384" P_Q="1.0" P_Z="0.4804726546160084" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="877" TOTAL_2="878" WEIGHT="100.00000000000001" Z="0.7055425700487137">
<NAME>Number experiencing gastro-intestinal events (perforation, ulcer, bleeds)</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>tNSAIDs</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors tNSAIDs</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.972693403334655" CI_START="0.05318770834145358" EFFECT_SIZE="0.5142821855830063" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6965916831725634" LOG_CI_START="-1.2741887213940597" LOG_EFFECT_SIZE="-0.2887985191107482" ORDER="199" O_E="-0.4962025316455696" SE="1.157646165162772" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="198" VAR="0.7461881108796667" WEIGHT="37.42824713565291" />
<DICH_DATA CI_END="2.162219751032808" CI_START="0.008433767220724125" EFFECT_SIZE="0.1350394685277707" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.3348998301404462" LOG_CI_START="-2.073978390059376" LOG_EFFECT_SIZE="-0.8695392799594648" ORDER="201" O_E="-1.0" SE="1.4149869906848755" STUDY_ID="STD-Dahlberg-2009" TOTAL_1="458" TOTAL_2="458" VAR="0.4994535519125683" WEIGHT="25.05222302687944" />
<DICH_DATA CI_END="119.74275476340345" CI_START="0.46331610232621256" EFFECT_SIZE="7.448405629313134" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0782492451641277" LOG_CI_START="-0.33412260584066794" LOG_EFFECT_SIZE="0.8720633196617297" ORDER="202" O_E="1.0" SE="1.417039166713468" STUDY_ID="STD-Emery-2008" TOTAL_1="126" TOTAL_2="126" VAR="0.49800796812749004" WEIGHT="24.97971360683599" />
<DICH_DATA CI_END="6.820467167072353" CI_START="0.0026853936013588454" EFFECT_SIZE="0.1353352832366127" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8338141226232082" LOG_CI_START="-2.570992050236215" LOG_EFFECT_SIZE="-0.8685889638065036" ORDER="200" O_E="-0.5" SE="2.0" STUDY_ID="STD-Essex-2014" TOTAL_1="96" TOTAL_2="96" VAR="0.25" WEIGHT="12.539816230631667" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.253092833755319" CI_START="0.1736671466016267" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.4664987211828483" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="11" I2="0.0" I2_Q="0.0" ID="CMP-004.07" LOG_CI_END="0.0979832463287145" LOG_CI_START="-0.7602823312311736" LOG_EFFECT_SIZE="-0.3311495424512296" METHOD="PETO" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.1304198437259062" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="458" TOTAL_2="458" WEIGHT="100.0" Z="1.5124483462254175">
<NAME>Number experiencing cardiovascular events (myocardial infarction, stroke)</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>tNSAIDs</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors tNSAIDs</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.253092833755319" CI_START="0.1736671466016267" EFFECT_SIZE="0.4664987211828483" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="11" LOG_CI_END="0.0979832463287145" LOG_CI_START="-0.7602823312311736" LOG_EFFECT_SIZE="-0.3311495424512296" ORDER="124" O_E="-3.0" SE="0.5041494487418058" STUDY_ID="STD-Dahlberg-2009" TOTAL_1="458" TOTAL_2="458" VAR="3.9344262295081966" WEIGHT="100.0" />
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" NO="5">
<NAME>Celecoxib versus naproxen 1000 mg</NAME>
<CONT_OUTCOME CHI2="2.232240824318334" CI_END="0.04845637835348383" CI_START="-0.13746135934705536" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.044502490496785764" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.01" NO="1" P_CHI2="0.8161656516390238" P_Q="1.0" P_Z="0.3480904260185028" Q="0.0" RANDOM="YES" SCALE="0.6988957513115232" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="899" TOTAL_2="882" UNITS="" WEIGHT="100.00000000000001" Z="0.9382996982948246">
<NAME>All pain ≤ 24 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Naproxen 1000 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors naproxen</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.15631963082650893" CI_START="-0.23818932125798456" EFFECT_SIZE="-0.040934845215737814" ESTIMABLE="YES" MEAN_1="-27.5" MEAN_2="-27.0" ORDER="609" SD_1="9.9499" SD_2="14.0712" SE="0.10064188811537604" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="198" WEIGHT="22.20894492739999" />
<CONT_DATA CI_END="0.26274453864868275" CI_START="-0.18316818803136511" EFFECT_SIZE="0.03978817530865882" ESTIMABLE="YES" MEAN_1="-4.9" MEAN_2="-5.0" ORDER="612" SD_1="2.6" SD_2="2.4" SE="0.11375533688306279" STUDY_ID="STD-Essex-2012a" TOTAL_1="163" TOTAL_2="147" WEIGHT="17.383687931836345" />
<CONT_DATA CI_END="0.35213201488923274" CI_START="-0.19454442241752" EFFECT_SIZE="0.07879379623585638" ESTIMABLE="YES" MEAN_1="-36.2" MEAN_2="-38.0" ORDER="607" SD_1="19.1" SD_2="25.7391" SE="0.13946083744876608" STUDY_ID="STD-Essex-2012b" TOTAL_1="100" TOTAL_2="106" WEIGHT="11.565940168521806" />
<CONT_DATA CI_END="0.1583825589487781" CI_START="-0.4079722870760486" EFFECT_SIZE="-0.12479486406363524" ESTIMABLE="YES" MEAN_1="-39.7" MEAN_2="-36.9" ORDER="608" SD_1="18.7061" SD_2="25.4747" SE="0.14448093191817846" STUDY_ID="STD-Essex-2014" TOTAL_1="96" TOTAL_2="96" WEIGHT="10.77616941503765" />
<CONT_DATA CI_END="0.109592317202632" CI_START="-0.27588362617415074" EFFECT_SIZE="-0.08314565448575938" ESTIMABLE="YES" MEAN_1="-23.3" MEAN_2="-22.3" ORDER="611" SD_1="9.5" SD_2="14.0712" SE="0.09833750681578024" STUDY_ID="STD-Kivitz-2001" TOTAL_1="207" TOTAL_2="207" WEIGHT="23.26200219253125" />
<CONT_DATA CI_END="0.11561095459059681" CI_START="-0.3676060519332742" EFFECT_SIZE="-0.12599754867133872" ESTIMABLE="YES" MEAN_1="-18.7" MEAN_2="-15.0" ORDER="610" SD_1="29.1548" SD_2="29.4156" SE="0.12327190967166364" STUDY_ID="STD-Sowers-2005" TOTAL_1="136" TOTAL_2="128" WEIGHT="14.803255364672976" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.3406013598225118" CI_END="5.072329391068667" CI_START="-3.969596351531898" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.5513665197683845" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.02" NO="2" P_CHI2="0.5594824889877783" P_Q="1.0" P_Z="0.8110801309177347" Q="0.0" RANDOM="YES" SCALE="21.936531778555107" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="196" TOTAL_2="202" UNITS="" WEIGHT="100.0" Z="0.2390328237127095">
<NAME>Pain VAS at 6 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Naproxen 1000 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors naproxen</GRAPH_LABEL_2>
<CONT_DATA CI_END="7.9662946357607805" CI_START="-4.366294635760786" EFFECT_SIZE="1.7999999999999972" ESTIMABLE="YES" MEAN_1="-36.2" MEAN_2="-38.0" ORDER="98" SD_1="19.1" SD_2="25.7391" SE="3.146126502527459" STUDY_ID="STD-Essex-2012b" TOTAL_1="100" TOTAL_2="106" WEIGHT="53.75431554697723" />
<CONT_DATA CI_END="5.748066187697511" CI_START="-7.548066187697509" EFFECT_SIZE="-0.8999999999999986" ESTIMABLE="YES" MEAN_1="24.3" MEAN_2="25.2" ORDER="99" SD_1="23.5" SD_2="23.5" SE="3.3919328314890516" STUDY_ID="STD-Essex-2014" TOTAL_1="96" TOTAL_2="96" WEIGHT="46.24568445302276" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.6839457231849075" CI_END="0.7551148421442563" CI_START="-2.689527684684265" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.9672064212700043" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.03" NO="3" P_CHI2="0.7103675632040662" P_Q="1.0" P_Z="0.2710447724163503" Q="0.0" RANDOM="YES" SCALE="10.650462358313733" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="442" TOTAL_2="533" UNITS="" WEIGHT="99.99999999999997" Z="1.1006597848923636">
<NAME>Pain VAS at 12 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Naproxen 1000 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors naproxen</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.2718065618845626" CI_START="-3.2718065618845626" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="-27.5" MEAN_2="-27.0" ORDER="100" SD_1="9.9499" SD_2="14.0712" SE="1.4142130078655624" STUDY_ID="STD-Bensen-1999" TOTAL_1="99" TOTAL_2="198" WEIGHT="38.61023896247569" />
<CONT_DATA CI_END="1.312845241259681" CI_START="-3.312845241259681" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="-23.3" MEAN_2="-22.3" ORDER="238" SD_1="9.5" SD_2="14.0712" SE="1.180044765874837" STUDY_ID="STD-Kivitz-2001" TOTAL_1="207" TOTAL_2="207" WEIGHT="55.454293775213806" />
<CONT_DATA CI_END="3.3694675666758016" CI_START="-10.7694675666758" EFFECT_SIZE="-3.6999999999999993" ESTIMABLE="YES" MEAN_1="-18.7" MEAN_2="-15.0" ORDER="101" SD_1="29.1548" SD_2="29.4156" SE="3.6069374858103815" STUDY_ID="STD-Sowers-2005" TOTAL_1="136" TOTAL_2="128" WEIGHT="5.935467262310482" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.2572111228130856" CI_END="1.2284403590335014" CI_START="-0.5354733672855652" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.3464834958739681" ESTIMABLE="YES" I2="20.458864716179107" I2_Q="0.0" ID="CMP-005.04" NO="4" P_CHI2="0.26217974037341607" P_Q="1.0" P_Z="0.4413077088886307" Q="0.0" RANDOM="YES" SCALE="3.937025319410971" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.08285840210052546" TOTALS="YES" TOTAL_1="249" TOTAL_2="254" UNITS="" WEIGHT="100.0" Z="0.7699868344101444">
<NAME>Pain WOMAC at 6 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Naproxen 1000 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors naproxen</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.9178780514783773" CI_START="-0.31787805147837767" EFFECT_SIZE="0.7999999999999998" ESTIMABLE="YES" MEAN_1="-4.9" MEAN_2="-5.7" ORDER="219" SD_1="4.5" SD_2="4.5" SE="0.5703564250649792" STUDY_ID="STD-Essex-2012b" TOTAL_1="124" TOTAL_2="125" WEIGHT="49.60927731932983" />
<CONT_DATA CI_END="1.0069489724236529" CI_START="-1.206948972423654" EFFECT_SIZE="-0.10000000000000053" ESTIMABLE="YES" MEAN_1="-5.2" MEAN_2="-5.1" ORDER="232" SD_1="4.5" SD_2="4.5" SE="0.5647802618594656" STUDY_ID="STD-Essex-2014" TOTAL_1="125" TOTAL_2="129" WEIGHT="50.39072268067017" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.8422352724041335" CI_END="0.597015452268485" CI_START="-0.6508694903110033" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.026927019021259192" ESTIMABLE="YES" I2="29.632848504188754" I2_Q="0.0" ID="CMP-005.05" NO="5" P_CHI2="0.2414443466234668" P_Q="1.0" P_Z="0.9325915621616597" Q="0.0" RANDOM="YES" SCALE="8.164991863343696" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.09975698758725766" TOTALS="YES" TOTAL_1="540" TOTAL_2="533" UNITS="" WEIGHT="100.0" Z="0.08458470118823676">
<NAME>Pain WOMAC at 12 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Naproxen 1000 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors naproxen</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.15830126544150852" CI_START="-0.8183012654415078" EFFECT_SIZE="-0.3299999999999996" ESTIMABLE="YES" MEAN_1="-3.05" MEAN_2="-2.72" ORDER="217" SD_1="2.8" SD_2="2.1" SE="0.2491378766615949" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="198" WEIGHT="62.62429072588919" />
<CONT_DATA CI_END="1.3322650607563487" CI_START="-0.33226506075634865" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="-2.0" MEAN_2="-2.5" ORDER="102" SD_1="4.32" SD_2="4.32" SE="0.4246328337261038" STUDY_ID="STD-Kivitz-2001" TOTAL_1="207" TOTAL_2="207" WEIGHT="36.184808274714285" />
<CONT_DATA CI_END="5.5838962011243325" CI_START="-5.783896201124332" EFFECT_SIZE="-0.09999999999999964" ESTIMABLE="YES" MEAN_1="-15.2" MEAN_2="-15.1" ORDER="239" SD_1="23.3238" SD_2="23.7588" SE="2.9000003295765535" STUDY_ID="STD-Sowers-2005" TOTAL_1="136" TOTAL_2="128" WEIGHT="1.190900999396529" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.656629999722306" CI_START="-0.45662999972230667" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.06" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.7247538711667445" Q="0.0" RANDOM="YES" SCALE="2.3445969892399563" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="163" TOTAL_2="147" UNITS="" WEIGHT="100.0" Z="0.35211253175679386">
<NAME>Pain WOMAC at 6 months</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Naproxen 1000 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors naproxen</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.656629999722306" CI_START="-0.45662999972230667" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" MEAN_1="-4.9" MEAN_2="-5.0" ORDER="133" SD_1="2.6" SD_2="2.4" SE="0.284000116386287" STUDY_ID="STD-Essex-2012a" TOTAL_1="163" TOTAL_2="147" WEIGHT="100.0" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="16.32492963912145" CI_END="0.16253086880966858" CI_START="-0.17706271170445717" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.00726592144739431" ESTIMABLE="YES" I2="69.37199663012403" I2_Q="0.0" ID="CMP-005.07" NO="7" P_CHI2="0.0059750985835093084" P_Q="1.0" P_Z="0.9331593820629313" Q="0.0" RANDOM="YES" SCALE="0.8157340450098544" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.030841287235853845" TOTALS="YES" TOTAL_1="944" TOTAL_2="873" UNITS="" WEIGHT="100.0" Z="0.08387051563124363">
<NAME>All physical function ≤ 24 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Naproxen 1000 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors naproxen</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.05678011718022974" CI_START="-0.4528610458604379" EFFECT_SIZE="-0.2548205815203338" ESTIMABLE="YES" MEAN_1="-9.9" MEAN_2="-8.1" ORDER="615" SD_1="7.0" SD_2="7.1" SE="0.10104290992192815" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="198" WEIGHT="18.282664335434074" />
<CONT_DATA CI_END="0.256281981522353" CI_START="-0.19582807002241662" EFFECT_SIZE="0.03022695574996819" ESTIMABLE="YES" MEAN_1="-15.4" MEAN_2="-15.7" ORDER="618" SD_1="9.9" SD_2="9.9" SE="0.11533631615452018" STUDY_ID="STD-Essex-2012a" TOTAL_1="155" TOTAL_2="146" WEIGHT="17.00174573491205" />
<CONT_DATA CI_END="0.1883711652639264" CI_START="-0.4123251413918616" EFFECT_SIZE="-0.11197698806396762" ESTIMABLE="YES" MEAN_1="-16.0" MEAN_2="-14.4" ORDER="613" SD_1="14.5" SD_2="13.7" SE="0.15324166959036079" STUDY_ID="STD-Essex-2012b" TOTAL_1="124" TOTAL_2="65" WEIGHT="13.815565284507093" />
<CONT_DATA CI_END="0.22706575916828436" CI_START="-0.26492274943623095" EFFECT_SIZE="-0.018928495133973284" ESTIMABLE="YES" MEAN_1="-16.3" MEAN_2="-16.0" ORDER="614" SD_1="15.7" SD_2="15.9" SE="0.1255095788711573" STUDY_ID="STD-Essex-2014" TOTAL_1="125" TOTAL_2="129" WEIGHT="16.107692097873173" />
<CONT_DATA CI_END="0.49553275891633974" CI_START="0.10801703563612383" EFFECT_SIZE="0.3017748972762318" ESTIMABLE="YES" MEAN_1="-6.6" MEAN_2="-7.9" ORDER="616" SD_1="4.3" SD_2="4.3" SE="0.09885786839372827" STUDY_ID="STD-Kivitz-2001" TOTAL_1="207" TOTAL_2="207" WEIGHT="18.47928815728588" />
<CONT_DATA CI_END="0.22259048387256894" CI_START="-0.26015177784918203" EFFECT_SIZE="-0.018780646988306556" ESTIMABLE="YES" MEAN_1="-14.6" MEAN_2="-14.2" ORDER="617" SD_1="20.9914" SD_2="21.496" SE="0.1231507990783403" STUDY_ID="STD-Sowers-2005" TOTAL_1="136" TOTAL_2="128" WEIGHT="16.31304438998773" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.072274057010418" CI_END="0.4427979509795148" CI_START="-6.431615624034144" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.9944088365273145" ESTIMABLE="YES" I2="6.740259781340182" I2_Q="0.0" ID="CMP-005.08" NO="8" P_CHI2="0.30043276918878103" P_Q="1.0" P_Z="0.08773440498497284" Q="0.0" RANDOM="YES" SCALE="19.05729816815738" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.4367688338308443" TOTALS="YES" TOTAL_1="187" TOTAL_2="126" UNITS="" WEIGHT="100.0" Z="1.70747174592863">
<NAME>Physical function WOMAC at 6 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Naproxen 1000 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors naproxen</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.595926758144178" CI_START="-5.795926758144177" EFFECT_SIZE="-1.5999999999999996" ESTIMABLE="YES" MEAN_1="-16.0" MEAN_2="-14.4" ORDER="103" SD_1="14.5" SD_2="13.7" SE="2.140818296275397" STUDY_ID="STD-Essex-2012b" TOTAL_1="124" TOTAL_2="65" WEIGHT="61.266421207574595" />
<CONT_DATA CI_END="0.16878440411216644" CI_START="-10.568784404112169" EFFECT_SIZE="-5.200000000000001" ESTIMABLE="YES" MEAN_1="-16.3" MEAN_2="-11.1" ORDER="104" SD_1="15.7" SD_2="14.8" SE="2.7392260503052372" STUDY_ID="STD-Essex-2014" TOTAL_1="63" TOTAL_2="61" WEIGHT="38.733578792425405" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="19.53335760151924" CI_END="1.7776703653603978" CI_START="-4.316167445728969" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.2692485401842857" ESTIMABLE="YES" I2="89.76110487095957" I2_Q="0.0" ID="CMP-005.09" NO="9" P_CHI2="5.7330774071218116E-5" P_Q="1.0" P_Z="0.41423822258759035" Q="0.0" RANDOM="YES" SCALE="18.073540871342168" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="5.581673272013342" TOTALS="YES" TOTAL_1="540" TOTAL_2="533" UNITS="" WEIGHT="100.00000000000001" Z="0.8164580362359624">
<NAME>Physical function WOMAC at 12 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Naproxen 1000 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors naproxen</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.40949302334202" CI_START="-3.190506976657981" EFFECT_SIZE="-1.8000000000000007" ESTIMABLE="YES" MEAN_1="-9.9" MEAN_2="-8.1" ORDER="105" SD_1="7.0" SD_2="7.1" SE="0.7094553714385173" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="198" WEIGHT="39.71595522924444" />
<CONT_DATA CI_END="2.1284119817713663" CI_START="0.47158801822863516" EFFECT_SIZE="1.3000000000000007" ESTIMABLE="YES" MEAN_1="-6.6" MEAN_2="-7.9" ORDER="106" SD_1="4.3" SD_2="4.3" SE="0.4226669409773718" STUDY_ID="STD-Kivitz-2001" TOTAL_1="207" TOTAL_2="207" WEIGHT="41.954538906677364" />
<CONT_DATA CI_END="-0.5956267264411927" CI_START="-11.4043732735588" EFFECT_SIZE="-5.9999999999999964" ESTIMABLE="YES" MEAN_1="31.3" MEAN_2="37.3" ORDER="107" SD_1="23.3" SD_2="21.5" SE="2.7573839704136454" STUDY_ID="STD-Sowers-2005" TOTAL_1="136" TOTAL_2="128" WEIGHT="18.3295058640782" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="2.537815390855051" CI_START="-1.9378153908550533" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.29999999999999893" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.10" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="0.7927421734593423" Q="0.0" RANDOM="YES" SCALE="6.057734995689283" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="155" TOTAL_2="146" UNITS="" WEIGHT="100.0" Z="0.26275143059828004">
<NAME>Physical function WOMAC at 6 months</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Naproxen 1000 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors naproxen</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.537815390855051" CI_START="-1.9378153908550533" EFFECT_SIZE="0.29999999999999893" ESTIMABLE="YES" MEAN_1="-15.4" MEAN_2="-15.7" ORDER="134" SD_1="9.9" SD_2="9.9" SE="1.1417635265273518" STUDY_ID="STD-Essex-2012a" TOTAL_1="155" TOTAL_2="146" WEIGHT="100.0" />
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="8.604223414041646" CI_END="1.2311884835784845" CI_START="0.5361329810071696" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="OR" EFFECT_SIZE="0.8124535382916549" ESTIMABLE="YES" EVENTS_1="104" EVENTS_2="128" I2="41.8890031163038" I2_Q="0.0" ID="CMP-005.11" LOG_CI_END="0.09032454449260095" LOG_CI_START="-0.2707274756904783" LOG_EFFECT_SIZE="-0.09020146559893864" METHOD="MH" NO="11" P_CHI2="0.12593045376738932" P_Q="1.0" P_Z="0.32742493648887727" Q="0.0" RANDOM="YES" SCALE="14.64390924118625" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.10524059280832053" TOTALS="YES" TOTAL_1="1090" TOTAL_2="1083" WEIGHT="99.99999999999999" Z="0.9793138608503144">
<NAME>Number withdrawn due to adverse events</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Naproxen 1000 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors naproxen</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.025059156341933" CI_START="0.8771398954954143" EFFECT_SIZE="2.0994475138121547" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="8" LOG_CI_END="0.701141178753551" LOG_CI_START="-0.05693113525829969" LOG_EFFECT_SIZE="0.3221050217476256" ORDER="1370" O_E="0.0" SE="0.4452954297690353" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="198" VAR="0.19828801977318986" WEIGHT="14.818871288818354" />
<DICH_DATA CI_END="0.954176939682464" CI_START="0.40905939500119803" EFFECT_SIZE="0.6247519841269841" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="64" LOG_CI_END="-0.020371083574279376" LOG_CI_START="-0.3882136283044324" LOG_EFFECT_SIZE="-0.20429235593935588" ORDER="1371" O_E="0.0" SE="0.2160725316244546" STUDY_ID="STD-Essex-2012a" TOTAL_1="296" TOTAL_2="293" VAR="0.046687338922600935" WEIGHT="29.6058229127038" />
<DICH_DATA CI_END="2.9622351821815878" CI_START="0.34323274439078083" EFFECT_SIZE="1.0083333333333333" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.4716195357074852" LOG_CI_START="-0.46441128716983476" LOG_EFFECT_SIZE="0.003604124268825241" ORDER="1372" O_E="0.0" SE="0.5498291387854379" STUDY_ID="STD-Essex-2012b" TOTAL_1="127" TOTAL_2="128" VAR="0.30231208185753633" WEIGHT="11.03649104010121" />
<DICH_DATA CI_END="1.220336470331688" CI_START="0.08527014898144546" EFFECT_SIZE="0.3225806451612903" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" LOG_CI_END="0.08647959056120548" LOG_CI_START="-1.0692029782297507" LOG_EFFECT_SIZE="-0.4913616938342727" ORDER="1373" O_E="0.0" SE="0.6788536616287858" STUDY_ID="STD-Essex-2014" TOTAL_1="127" TOTAL_2="129" VAR="0.46084229390681003" WEIGHT="7.945747076757178" />
<DICH_DATA CI_END="1.6176650051154826" CI_START="0.5240080229596018" EFFECT_SIZE="0.9206896551724137" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="29" LOG_CI_END="0.20888859051924896" LOG_CI_START="-0.2806620635880107" LOG_EFFECT_SIZE="-0.03588673653438089" ORDER="1374" O_E="0.0" SE="0.28756447753742487" STUDY_ID="STD-Kivitz-2001" TOTAL_1="207" TOTAL_2="207" VAR="0.08269332874137213" WEIGHT="23.933685868038914" />
<DICH_DATA CI_END="1.5380050301755" CI_START="0.21659341895329176" EFFECT_SIZE="0.5771670190274841" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="0.18695775586456062" LOG_CI_START="-0.6643547432586717" LOG_EFFECT_SIZE="-0.23869849369705554" ORDER="1375" O_E="0.0" SE="0.5000651760498209" STUDY_ID="STD-Sowers-2005" TOTAL_1="136" TOTAL_2="128" VAR="0.25006518029773844" WEIGHT="12.659381813580529" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0050001846714541505" CI_END="2.754500023697017" CI_START="0.44567398497866717" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.1079751812134073" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-005.12" LOG_CI_END="0.44004278044558404" LOG_CI_START="-0.3509827159473787" LOG_EFFECT_SIZE="0.044530032249102694" METHOD="PETO" NO="12" P_CHI2="0.9436269829840527" P_Q="1.0" P_Z="0.8253504529338591" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="421" TOTAL_2="420" WEIGHT="100.0" Z="0.2206686379557384">
<NAME>Number experiencing any serious adverse events</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Naproxen 1000 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors naproxen</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.938621894121037" CI_START="0.42738785080784336" EFFECT_SIZE="1.1206834056348223" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.4681437099717019" LOG_CI_START="-0.3691778275208183" LOG_EFFECT_SIZE="0.04948294122544176" ORDER="135" O_E="0.4709897610921505" SE="0.49184681593156354" STUDY_ID="STD-Essex-2012a" TOTAL_1="294" TOTAL_2="292" VAR="4.133712532230861" WEIGHT="89.2475780725403" />
<DICH_DATA CI_END="16.202665111980412" CI_START="0.06269790631499123" EFFECT_SIZE="1.0079053424028093" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2095864557913898" LOG_CI_START="-1.2027469614185309" LOG_EFFECT_SIZE="0.003419747186429325" ORDER="113" O_E="0.0039215686274509665" SE="1.4170165905121086" STUDY_ID="STD-Essex-2012b" TOTAL_1="127" TOTAL_2="128" VAR="0.49802383698577474" WEIGHT="10.752421927459686" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.333749377346103" CI_END="2.6213666529720303" CI_START="0.05162626331849802" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.3678741158068393" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-005.13" LOG_CI_END="0.4185277703650699" LOG_CI_START="-1.2871293078190362" LOG_EFFECT_SIZE="-0.43430076872698326" METHOD="PETO" NO="13" P_CHI2="0.5634597744424941" P_Q="1.0" P_Z="0.3182276426657158" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="293" TOTAL_2="294" WEIGHT="100.0" Z="0.9981066839873516">
<NAME>Number experiencing gastro-intestinal events (perforation, ulcer, bleeds)</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Naproxen 1000 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors naproxen</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.972693403334655" CI_START="0.05318770834145358" EFFECT_SIZE="0.5142821855830063" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6965916831725634" LOG_CI_START="-1.2741887213940597" LOG_EFFECT_SIZE="-0.2887985191107482" ORDER="114" O_E="-0.4962025316455696" SE="1.157646165162772" STUDY_ID="STD-Bensen-1999" TOTAL_1="197" TOTAL_2="198" VAR="0.7461881108796667" WEIGHT="74.9043381195102" />
<DICH_DATA CI_END="6.820467167072353" CI_START="0.0026853936013588454" EFFECT_SIZE="0.1353352832366127" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8338141226232082" LOG_CI_START="-2.570992050236215" LOG_EFFECT_SIZE="-0.8685889638065036" ORDER="115" O_E="-0.5" SE="2.0" STUDY_ID="STD-Essex-2014" TOTAL_1="96" TOTAL_2="96" VAR="0.25" WEIGHT="25.0956618804898" />
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" NO="6">
<NAME>Celecoxib versus diclofenac 100 mg</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.3156624824477188" CI_START="-5.315662482447719" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.23710821451820674" Q="0.0" RANDOM="YES" SCALE="12.321912117455025" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="458" TOTAL_2="458" UNITS="" WEIGHT="100.0" Z="1.182245777376684">
<NAME>Pain VAS at 1 year</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Diclofenac 100 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors diclofenac</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.3156624824477188" CI_START="-5.315662482447719" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="40.0" MEAN_2="42.0" ORDER="116" SD_1="25.6" SD_2="25.6" SE="1.6916956171650301" STUDY_ID="STD-Dahlberg-2009" TOTAL_1="458" TOTAL_2="458" WEIGHT="100.0" />
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.607880408076274" CI_START="0.7969976057250933" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.4416915208373007" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="19" I2="0.0" I2_Q="0.0" ID="CMP-006.02" LOG_CI_END="0.41628767168280334" LOG_CI_START="-0.09854298327382746" LOG_EFFECT_SIZE="0.1588723442044879" METHOD="PETO" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.22641082700309423" Q="0.0" RANDOM="NO" SCALE="8.219729149487055" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="458" TOTAL_2="458" WEIGHT="100.0" Z="1.2096563006974714">
<NAME>Number withdrawn due to adverse events</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Diclofenac 100 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors diclofenac</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.607880408076274" CI_START="0.7969976057250933" EFFECT_SIZE="1.4416915208373007" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="19" LOG_CI_END="0.41628767168280334" LOG_CI_START="-0.09854298327382746" LOG_EFFECT_SIZE="0.1588723442044879" ORDER="118" O_E="4.0" SE="0.30241407517436786" STUDY_ID="STD-Dahlberg-2009" TOTAL_1="458" TOTAL_2="458" VAR="10.934426229508198" WEIGHT="100.0" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.3019262223735937" CI_START="0.6193241588546952" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.8979500891265597" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="68" I2="0.0" I2_Q="0.0" ID="CMP-006.03" LOG_CI_END="0.11458637430600131" LOG_CI_START="-0.2080819785199923" LOG_EFFECT_SIZE="-0.04674780210699554" METHOD="MH" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.5700930689272736" Q="0.0" RANDOM="YES" SCALE="13.266363146798842" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="458" TOTAL_2="458" WEIGHT="100.0" Z="0.5679144402210855">
<NAME>Number experiencing any serious adverse events</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Diclofenac 100 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors diclofenac</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3019262223735937" CI_START="0.6193241588546952" EFFECT_SIZE="0.8979500891265597" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="68" LOG_CI_END="0.11458637430600131" LOG_CI_START="-0.2080819785199923" LOG_EFFECT_SIZE="-0.04674780210699554" ORDER="121" O_E="0.0" SE="0.189536987684095" STUDY_ID="STD-Dahlberg-2009" TOTAL_1="458" TOTAL_2="458" VAR="0.03592426970036078" WEIGHT="100.0" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.162219751032808" CI_START="0.008433767220724125" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.1350394685277707" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-006.04" LOG_CI_END="0.3348998301404462" LOG_CI_START="-2.073978390059376" LOG_EFFECT_SIZE="-0.8695392799594648" METHOD="PETO" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.1570723103891563" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="458" TOTAL_2="458" WEIGHT="100.0" Z="1.4149869906848755">
<NAME>Number experiencing gastro-intestinal events (perforation, ulcer, bleeds)</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Diclofenac 100 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors diclofenac</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.162219751032808" CI_START="0.008433767220724125" EFFECT_SIZE="0.1350394685277707" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.3348998301404462" LOG_CI_START="-2.073978390059376" LOG_EFFECT_SIZE="-0.8695392799594648" ORDER="122" O_E="-1.0" SE="1.4149869906848755" STUDY_ID="STD-Dahlberg-2009" TOTAL_1="458" TOTAL_2="458" VAR="0.4994535519125683" WEIGHT="100.0" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.253092833755319" CI_START="0.1736671466016267" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.4664987211828483" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="11" I2="0.0" I2_Q="0.0" ID="CMP-006.05" LOG_CI_END="0.0979832463287145" LOG_CI_START="-0.7602823312311736" LOG_EFFECT_SIZE="-0.3311495424512296" METHOD="PETO" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.1304198437259062" Q="0.0" RANDOM="NO" SCALE="117.9278788208772" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="458" TOTAL_2="458" WEIGHT="100.0" Z="1.5124483462254175">
<NAME>Number experiencing cardiovascular events (myocardial infarction, stroke)</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Diclofenac 100 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors diclofenac</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.253092833755319" CI_START="0.1736671466016267" EFFECT_SIZE="0.4664987211828483" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="11" LOG_CI_END="0.0979832463287145" LOG_CI_START="-0.7602823312311736" LOG_EFFECT_SIZE="-0.3311495424512296" ORDER="124" O_E="-3.0" SE="0.5041494487418058" STUDY_ID="STD-Dahlberg-2009" TOTAL_1="458" TOTAL_2="458" VAR="3.9344262295081966" WEIGHT="100.0" />
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" NO="7">
<NAME>Celecoxib versus diclofenac 150 mg</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="7.480577191120956" CI_START="-3.6805771911209586" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.8999999999999986" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.5045791104115013" Q="0.0" RANDOM="YES" SCALE="15.267287626711902" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="199" TOTAL_2="199" UNITS="" WEIGHT="100.0" Z="0.6673022239619059">
<NAME>Pain VAS at 6 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Diclofenac 150 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors diclofenac</GRAPH_LABEL_2>
<CONT_DATA CI_END="7.480577191120956" CI_START="-3.6805771911209586" EFFECT_SIZE="1.8999999999999986" ESTIMABLE="YES" MEAN_1="-34.9" MEAN_2="-36.8" ORDER="125" SD_1="28.1" SD_2="28.7" SE="2.8472855803166985" STUDY_ID="STD-McKenna-2001b" TOTAL_1="199" TOTAL_2="199" WEIGHT="100.0" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.1159586485905706" CI_START="-0.5159586485905711" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.2999999999999998" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.4711485744329035" Q="0.0" RANDOM="YES" SCALE="2.008858689777396" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="199" TOTAL_2="199" UNITS="" WEIGHT="100.00000000000001" Z="0.720611511842747">
<NAME>Pain WOMAC at 6 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Diclofenac 150 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors diclofenac</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.1159586485905706" CI_START="-0.5159586485905711" EFFECT_SIZE="0.2999999999999998" ESTIMABLE="YES" MEAN_1="-4.0" MEAN_2="-4.3" ORDER="242" SD_1="4.0" SD_2="4.3" SE="0.41631308280496404" STUDY_ID="STD-McKenna-2001b" TOTAL_1="199" TOTAL_2="199" WEIGHT="100.00000000000001" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="22.888636639329505" CI_START="3.1113633606704933" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="13.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.009976360401691767" Q="0.0" RANDOM="YES" SCALE="36.589849705666644" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="50" TOTAL_2="48" UNITS="" WEIGHT="100.0" Z="2.576647593428848">
<NAME>Pain on walking at 12 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Diclofenac 150 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors diclofenac</GRAPH_LABEL_2>
<CONT_DATA CI_END="22.888636639329505" CI_START="3.1113633606704933" EFFECT_SIZE="13.0" ESTIMABLE="YES" MEAN_1="-17.0" MEAN_2="-30.0" ORDER="132" SD_1="23.5" SD_2="26.3" SE="5.0453154840240995" STUDY_ID="STD-Emery-2008" TOTAL_1="50" TOTAL_2="48" WEIGHT="100.0" />
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="4.515139562169811" CI_START="-0.7151395621698096" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.9000000000000004" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.1544494791618148" Q="0.0" RANDOM="YES" SCALE="8.471998172335429" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="199" TOTAL_2="199" UNITS="" WEIGHT="100.0" Z="1.4239896120635018">
<NAME>Physical function WOMAC at 6 weeks</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Diclofenac 150 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors diclofenac</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.515139562169811" CI_START="-0.7151395621698096" EFFECT_SIZE="1.9000000000000004" ESTIMABLE="YES" MEAN_1="-13.2" MEAN_2="-15.1" ORDER="137" SD_1="12.8" SD_2="13.8" SE="1.3342793963550845" STUDY_ID="STD-McKenna-2001b" TOTAL_1="199" TOTAL_2="199" WEIGHT="100.0" />
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="1.1099854320127192" CI_END="1.3151318087134545" CI_START="0.45885269547086527" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.776821585261148" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="34" I2="9.908727523863469" I2_Q="0.0" ID="CMP-007.05" LOG_CI_END="0.11896928204874438" LOG_CI_START="-0.33832671274533355" LOG_EFFECT_SIZE="-0.10967871534829457" METHOD="PETO" NO="5" P_CHI2="0.29208514957321285" P_Q="1.0" P_Z="0.3471340926249784" Q="0.0" RANDOM="NO" SCALE="10.55192043033702" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="325" TOTAL_2="325" WEIGHT="100.0" Z="0.9401627584780314">
<NAME>Number withdrawn due to adverse events</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Diclofenac 150 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors diclofenac</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.491405028789388" CI_START="0.47905947690881984" EFFECT_SIZE="1.0924885307681027" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="12" LOG_CI_END="0.3964443367172593" LOG_CI_START="-0.3196105640598382" LOG_EFFECT_SIZE="0.0384168863287106" ORDER="133" O_E="0.5" SE="0.4206141932453913" STUDY_ID="STD-Emery-2008" TOTAL_1="126" TOTAL_2="126" VAR="5.652390438247012" WEIGHT="40.785158309900766" />
<DICH_DATA CI_END="1.2174522535783483" CI_START="0.30987337174088725" EFFECT_SIZE="0.6142117181801927" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="22" LOG_CI_END="0.08545193792440152" LOG_CI_START="-0.5088157422598" LOG_EFFECT_SIZE="-0.2116819021676992" ORDER="127" O_E="-4.0" SE="0.34907577701265957" STUDY_ID="STD-McKenna-2001b" TOTAL_1="199" TOTAL_2="199" VAR="8.206549118387908" WEIGHT="59.214841690099234" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.6610143335982634" CI_END="2.933663457365851" CI_START="0.21153054064790028" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.7877559375946251" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" I2="82.3353211797226" I2_Q="0.0" ID="CMP-007.06" LOG_CI_END="0.4674102911732172" LOG_CI_START="-0.6746269205947871" LOG_EFFECT_SIZE="-0.10360831471078495" METHOD="PETO" NO="6" P_CHI2="0.01734611184972079" P_Q="1.0" P_Z="0.7221213228696708" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="325" TOTAL_2="322" WEIGHT="100.0" Z="0.35562512891792136">
<NAME>Number experiencing any serious adverse events</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Diclofenac 150 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors diclofenac</GRAPH_LABEL_2>
<DICH_DATA CI_END="19.35282527145773" CI_START="0.5643221858014535" EFFECT_SIZE="3.304728227649383" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.2867443755686907" LOG_CI_START="-0.24847287551102107" LOG_EFFECT_SIZE="0.5191357500288348" ORDER="134" O_E="1.4698795180722892" SE="0.9017942127321779" STUDY_ID="STD-Emery-2008" TOTAL_1="126" TOTAL_2="123" VAR="1.2296601875828226" WEIGHT="55.337664544186616" />
<DICH_DATA CI_END="0.9533084170540844" CI_START="0.018636373327002676" EFFECT_SIZE="0.13328995294467577" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="-0.020766572440967464" LOG_CI_START="-1.729638598275692" LOG_EFFECT_SIZE="-0.8752025853583297" ORDER="128" O_E="-2.0" SE="1.003799887028271" STUDY_ID="STD-McKenna-2001b" TOTAL_1="199" TOTAL_2="199" VAR="0.9924433249370277" WEIGHT="44.662335455813384" />
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="119.74275476340345" CI_START="0.46331610232621256" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="7.448405629313134" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-007.07" LOG_CI_END="2.0782492451641277" LOG_CI_START="-0.33412260584066794" LOG_EFFECT_SIZE="0.8720633196617297" METHOD="PETO" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.15647147662889568" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="126" TOTAL_2="126" WEIGHT="100.0" Z="1.417039166713468">
<NAME>Number experiencing gastro-intestinal events (perforation, ulcer, bleeds)</NAME>
<GROUP_LABEL_1>Celecoxib 200 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Diclofenac 150 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors celecoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors diclofenac</GRAPH_LABEL_2>
<DICH_DATA CI_END="119.74275476340345" CI_START="0.46331610232621256" EFFECT_SIZE="7.448405629313134" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0782492451641277" LOG_CI_START="-0.33412260584066794" LOG_EFFECT_SIZE="0.8720633196617297" ORDER="135" O_E="1.0" SE="1.417039166713468" STUDY_ID="STD-Emery-2008" TOTAL_1="126" TOTAL_2="126" VAR="0.49800796812749004" WEIGHT="100.0" />
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES />
<FEEDBACK />
<APPENDICES />
<EXTENSIONS />
</COCHRANE_REVIEW>
